ML082190067

Transmittal of 2007 Annual Radioactive Effluent Release Report Offsite Dose Calculation Manual

ML082190067
Person / Time
Site:	Kewaunee
Issue date:	07/30/2008
From:	Wilson M Dominion Energy Kewaunee
To:	Document Control Desk, Office of Nuclear Reactor Regulation
References
08-0221A, FOIA/PA-2010-0209
Download: ML082190067 (148)

Text

Dominion N490 Energy Highway 42, Kewaunee, Inc.

Kewaunee, WI 54216-9511 L30,2008 ATTN: Document Control Desk Serial No. 08-0221A U. S. Nuclear Regulatory Commission LIC/NW/RO Washington, DC 20555-0001 -Docket No.: 50-305 License No.: DPR-43 DOMINION ENERGY KEWAUNEE, INC.

KEWAUNEE POWER STATION 2007 ANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT OFF=SITE DOSE CALCULATION MANUAL Pursuant to Kewaunee Power Station (KPS) Technical Specification (TS) 6.18.b.3, enclosed is a copy of the KPS Offsite Dose Calculation Manual (ODCM), Revision 11, dated February 22, 2007.

KPS TS 6.18.b.3 states that the ODCM shall be submitted to the NRC as a part of, or concurrent with, the Radioactive Effluent Release Report for the period of the report in which any change to the ODCM was made. It was recently discovered that the KPS ODCM was revised on February 22, 2007 and not submitted with the 2007 Radioactive Effluent Release Report, as required. This non-conformance has been documented in the KPS corrective action program and actions have been implemented to ensure that future ODCM revisions are submitted as a part of, or concurrent with, the Radioactive Effluent Release Report for the period of the report in which any change to the ODCM was made. We apologize for any inconvenience this may have caused.

If you have questions or require additional information, please feel free to contact Mr.

Mike Hale (920) 388-8103.

Very truly yours, Mich el J. Wilson Director Safety and Licensing Commitments made by this letter: NONE

Attachment:

1. Kewaunee Power Station Offsite Dose Calculation Manual (ODCM) Revision 11, February 22, 2007

Serial No. 08-0221A Page 2 of 2 cc: Regional Administrator, Region III U. S. Nuclear Regulatory Commission 2443 Warrenville Road Suite 210 Lisle, IL 60532-4352 Ms. P. S. Tam Senior Project Manager U.S. Nuclear Regulatory Commission One White Flint North, Mail Stop 08-H4A 11555 Rockville Pike Rockville, MD 20852-2738 NRC Senior Resident Inspector Kewaunee Power Station Mr. W. A. Nestel Institute of Nuclear Power Operations 700 Galleria Parkway Atlanta, GA 30339 Mr. Don Hendrikse WI Division of Public Health Radiation Protection Section Room 150 Madison, WI 53701-2659 Ms. Deborah Russo American Nuclear Insurers 95 Glastonbury Blvd.

Glastonbury, CT 06033

KEWAUNEE POWER STATION OFFSITE DOSE CALCULATION MANUAL (ODCM)

Revision 11 February 22 2007 Reviewed By: Tom Webb Date: 02-20-2007 Plant Operations Review Committee Approved By: James M. Hale Date: 02-19-2007 Manager, Radiological Protection and Chemistry Approved By: Thomas Breene Date: 02-19-2007 Manager, Regulatory Affairs

Abstract This document has been developed in accordance with the commitment made by letter dated August 21, 1984 (from D.C. Hintz to S.A. Varga). It provides the current methodologies and parameters to be used in the calculation of offsite doses due to radioactive gaseous and liquid effluents and gaseous and liquid effluent monitoring alarm/trip setpoints for the Kewaunee Power Station (KPS). J. Stewart Bland Consultants, Inc. of Maryland was contracted to develop this document; however, rigorous review and final acceptance of this document has been provided by KPS. Implementation of this document is the responsibility of the current owner/operator of KPS.

REV. 11 02/22/2007

KEWAUNEE POWER STATION OFFSITE DOSE CALCULATION MANUAL Table of Contents In tro d u c tio n ........................................................................................ ...................................... 0 -1 D efin itio n s .............................................................................................................................. 0 -2 1.0 L iqu id E ffl u en t .............................................................................................................. 1-1 1.1 Radiation Monitoring Instrumentation and Controls .......................................... 1-1 1.2 Liquid Effluent Monitor Setpoint Determination ................................................ 1-1 1.2.1 Liquid Effluent Monitors (Radwaste, Steam Generator Blowdown and S erv ice W ater) ......................................................................................... 1-2 1.2.2 Conservative Default Values .................................................................... 1-3 1.3 Liquid Effluent Concentration Limits - 10CFR20 ............................................... 1-4 1.4 Liquid Effluent Dose Calculations - 10CFR50 .................................................... 1-5 1.5 Liquid Effluent Dose Projections ......................................................................... 1-7 1.6 Onsite Disposal of Low-Level Radioactively Contaminated Waste Streams ...... 1-8 1.7 Heating Boiler Blowdown Operation with Primary-to-Secondary Leak ............. 1-9 Figure 1 Liquid Radioactive Effluent Flow Diagram .................................... 1-10 Table 1.1 Parameters for Liquid Alarm Setpoint Determinations .................... 1-11 Table 1.2 Site Related Ingestion Dose Commitment Factors .......................... 1-12 Table 1.3 Bioaccumulation Factors (BFi) ........................................................ 1-14 2.0 G aseous E ffl uents .......................................................................................................... 2-1 2.1 Radiation Monitoring Instrumentation and Controls .......................................... 2-1 2.1.1 Waste Gas Holdup System ...................................................................... 2-1 2.1.2 Condenser Evacuation System ................................................................ 2-1 2.1.3 C ontainm ent P urge .................................................................................. 2-1 2.1.4 A uxiliary B uilding V ent .......................................................................... 2-1 2.1.5 Containment Mini-Purge/Vent System .................................................... 2-2 2.1.6 Steam Generator PORV Release With Primary-to-Secondary Leakage..2-2 2.1.7 Non-routine Discharge Locations ............................................................ 2-2 2.1.8 M iscellaneous R eleases ............................................................................ 2-2 2.2 Gaseous Effluent Monitor Setpoint Determination ............................................. 2-3 2.2.1 Containment and Auxiliary Building Vent Monitor ................................ 2-3 2.2.2 Conservative Default Values .................................................................... 2-4 REV. 11 02/22/2007

KEWAUNEE POWER STATION OFFSITE DOSE CALCULATION MANUAL Table of Contents (con't) 2.3 Gaseous Effluent Instantaneous Dose Rate Calculations - IOCFR20 .................. 2-5 2.3.1 Site Boundary Dose Rate - Noble Gas .................................................... 2-5 2.3.2 Site Boundary Dose Rate - Radioiodine and Particulates ....................... 2-6 2.4 Gaseous Effluent Dose Calculations - IOCFR50 ................................................ 2-7 2.4.1 Unrestricted Area Dose - Noble Gases ................................................... 2-7 2.4.2 Unrestricted Area Dose - Radioiodine and Particulates .......................... 2-8 2.5 Gaseous Effl uent D ose Projection ............ :........................................................ 2-10 2.6 Environmental Radiation Protection Standards - 40CFR190 ........................... 2-11 2.7 Incineration of Radioactively Contaminated Oil .............................................. 2-11 2 .8 T o tal D ose .......................................................................................................... 2 -1 1 Figure 2 Gaseous Radioactive Effluent Flow Diagram ............................... 2-12 Figure 3 Simplified Heating Boiler Fuel Oil Piping System ....................... 2-13 Table 2.1 Dose Factors for Noble Gases ....................................................... 2-14 Table 2.2 Parameters for Gaseous Alarm Setpoint Determinations ............... 2-15 Table 2.3 Controlling Locations, Pathways and Atmospheric Dispersion for D ose C alculations ...................................................................... 2-16 Table 2.4 Inhalation Pathway Dose Factors - ADULT ............................. 2-17 Table 2.5 Inhalation Pathway Dose Factors - TEEN ..................................... 2-19 Table 2.6 Inhalation Pathway Dose Factors - CHILD ................................... 2-21 Table 2.7 Inhalation Pathway Dose Factors - INFANT ................................ 2-23 Table 2.8 Vegetation Pathway Dose Factors - ADULT ................................ 2-25 Table 2.9 Vegetation Pathway Dose Factors - TEEN ................................... 2-27 Table 2.10 Vegetation Pathway Dose Factors - CHILD ................................. 2-29 Table 2.11 Grass-Cow-Milk Pathway Dose Factors - ADULT ....................... 2-31 Table 2.12 Grass-Cow-Milk Pathway Dose Factors - TEEN .......................... 2-33 Table 2.13 Grass-Cow-Milk Pathway Dose Factors - CHILD ........................ 2-35 Table 2.14 Grass-Cow-Milk Pathway Dose Factors - INFANT ..................... 2-37 Table 2.15 Ground Plane Pathway Dose Factors ............................................ 2-39 3/4 Radiological Effluent Specifications and Surveillance Requirements ..................... 3-1 3/4.0 Applicability and Surveillance Requirements ..................................................... 3-1 3/4.1 Radioactive Liquid Effluent Monitoring Instrumentation .................................. 3-2 3/4.2 Radioactive Gaseous Effluent Monitoring Instrumentation ................................ 3-3 ii REV. 11 02/22/2007

KEWAUNEE POWER STATION OFFSITE DOSE CALCULATION MANUAL Table of Contents (con't) 3/4.3 Liquid Effluents ........................ .................... 3-4 C o ncen tratio n .......................................... ............................................................ 3 -4 D o se .................................................................................................................. 3 -5 Liquid Radw aste Treatm ent System ................................................................... 3-6 3/4.4 G aseous E ffl uents ................................................................................................ 3-7 D o se R ate ....................................................................... .................................... 3 -7 D ose-N oble G ases ............................................................................................... 3-9 Dose-Iodine- 131, Iodine- 133, Tritium and Radionuclides in Particulate Form 3-10 Gaseous Radwaste Treatment System ............................................................... 3-12

.3/4.5 Total D o se ......................................................................................................... 3-14 3/4.6 R eporting R equirem ents ................................................................................... 3-16 Table 3.1 Radioactive Liquid Effluent Monitoring Instrumentation .............. 3-17 Table 3.2 Radioactive Gaseous Effluent Monitoring Instrumentation ............ 3-18 Table 4.0 Frequency N otation ......................................................................... 3-20 Table 4.1 Radioactive Liquid Effluent Monitoring Instrumentation Surveillance Requirem ents ................................................................................... 3-2 1 Table 4.2 Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirem ents ............................................................. 3-22 Table 4.3 Radioactive Liquid Waste Sampling and Analysis Program .......... 3-23 Table 4.4 Radioactive Gaseous Waste Sampling and Analysis Program ....... 3-25 Appendices Appendix A Technical Basis for Effective Dose Factors - Liquid Radioactive Effluents ..... A-1 Table A-I Adult Dose Contributions Fish and Drinking Water Pathways .... A-5 Table A-2 Adult Liver and Total Body Dose Assessment ............................. A-6 Appendix B Technical Basis for Effective Dose Factors - Gaseous Radioactive Effluents .. B-1 Table B-I Effective Dose Factors - Noble Gases ....................................... B-5 Appendix C Evaluation of Conservative, Default Effective EC Value for Liquid Effluents . C-I Table C- I Calculation of Effective EC (ECe) ................................................ C-4 S ite M ap s ............................................................................................................ D -1 Appendix D Figure D-1 Gaseous and Liquid Effluent Release Points ................................ D-3 Appendix E Onsite Disposal of Low-Level Radioactively Contaminated Waste Streams .... E-1 iii REV. 11 02/22/2007

KEWAUNEE POWER STATION OFFSITE DOSE CALCULATION MANUAL Introduction The Kewaunee Offsite Dose Calculation Manual (ODCM) describes the methodology and

.parameters used in:

I) The calculation of radioactive liquid and gaseous effluent monitoring instrumentation alarm/trip setpoints; and

2) The calculation of radioactive liquid and gaseous concentrations, dose rates and cumulative quarterly and yearly doses.

The methodology stated in this manual is acceptable for use in demonstrating compliance with 10CFR20.1302, IOCFR50, Appendix I, and 40CFR 190.

More conservative calculational methods and/or conditions (e.g., location and/or exposure pathways) expected to yield higher computed doses than appropriate for the maximally exposed person may be assumed in the dose evaluations.

The ODCM will be maintained at the station for use as a reference guide and training document of accepted methodologies and calculations. Changes will be made to the ODCM calculational methodologies and parameters as is deemed necessary to assure reasonable conservatism in keeping with the principles of 10CFR50.36a and Appendix I for demonstrating radioactive effluents are ALARA.

Rev. 11 0-1 02/22/2007

Definitions

1. ACTION ACTION shall be that part of a specification which prescribes remedial measures

• required under designated conditions.

2. GASEOUS RADWASTE TREATMENT SYSTEM A GASEOUS RADWASTE TREATMENT SYSTEM is any system designed and installed to reduce radioactive gaseous effluents by collecting off-gases from the primary coolant system and providing for delay or holdup for the purpose of reducing the total radioactivity released to the environment.

3. INSTRUMENTATION SURVEILLANCE

a. CHANNEL CHECK

b. CHANNEL FUNCTIONAL TEST

c. CHANNEL CALIBRATION

d. SOURCE CHECK As defined in the Technical Specifications.

4. MEMBER(S) OF THE PUBLIC MEMBER(S) OF THE PUBLIC shall include all persons who are not occupationally associated with the plant. This category does not include employees of the utility, its contractors or vendors. Also excluded from this category are persons who enter the site to service equipment or to make deliveries. This category does include persons who use portions of the site for recreational, occupational, or other purposes not associated with the plant.

5. OPERABLE-OPERABILITY As defined in the Technical Specifications.

6. PURGE - PURGING PURGE or PURGING is the controlled process of discharging air or gas from a confinement to maintain temperature, pressure, humidity, concentration, or other OPERATING condition, in such a manner that replacement air or gas is required to purify the confinement.

Rev. 11 0-2 02/22/2007

7. RADIOLOGICAL ENVIRONMENTAL MONITORING MANUAL (REMM)

The REMM shall contain the current methodology and parameters used in the conduct of the radiological environmental monitoring program.

8. SITE BOUNDARY The SITE BOUNDARY shall be that line beyond which the land is neither owned, nor leased, nor otherwise controlled by the licensee.

9. UNRESTRICTED AREA An UNRESTRICTED AREA shall be any area at or beyond the SITE BOUNDARY access to which is not controlled by the licensee for purposes of protection of individuals from exposure to radiation and radioactive materials, or any area within the SITE BOUNDARY used for residential quarters or for industrial, commercial, institutional, and/or recreational purposes.

10. VENTILATION EXHAUST TREATMENT SYSTEM A VENTILATION EXHAUST TREATMENT SYSTEM is any system designed and installed to reduce gaseous radioiodine or radioactive material in particulate form in effluents by passing ventilation or vent exhaust gases through charcoal and/or HEPA filters for the purpose of removing iodines or particulates from the gaseous exhaust stream prior to the release to the environment. Such a system is not considered to have any effect on noble gas effluents. Engineered Safety Feature atmospheric cleanup systems (i.e., Auxiliary Building special ventilation, Shield Building ventilation, spent fuel pool ventilation) are not considered to be VENTILATION EXHAUST TREATMENT SYSTEM components.

Rev. 11 0-3 02/22/2007

1.0 Liquid Effluents 1.1 Radiation Monitoring Instrumentation and Controls The liquid effluent monitoring instrumentation and controls installed at Kewaunee for controlling and monitoring normal radioactive material releases in accordance with 10 CFR 50, Appendix A, Criteria 60 and 64, are summarized as follows:

1) Alarm (and Automatic Termination) - R-18 provides this function on the liquid radwaste effluent line, R-19 on the Steam Generator blowdown.

2) Alarm (only) - R-20 and R-16 provide alarm functions for the Service Water discharges.

3) Composite Samples - Samples are collected weekly from the steam generator blowdown and analyzed by gamma spectroscopy. Samples are collected weekly from the Turbine Building Sump and analyzed by gamma spectroscopy. The weekly samples are composited for monthly tritium and gross alpha analyses and for quarterly Sr-89, Sr-90 , and Fe-55 analyses. During periods of identified primary-to-secondary leakage (with the secondary activity > I.0E-05 ltCi/ml), grab samples from the Turbine Building sump are collected daily and analyzed by gamma spectroscopy.

These samples are composited for monthly tritium and gross alpha analyses and for quarterly Sr-89, Sr-90, and Fe-55 analyses.

4) Liquid Tank Controls - All radioactive liquid tanks are located inside the Auxiliary Building and contain the suitable confinement systems and drains to prevent direct, unmonitored release to the environment. A liquid radioactive waste flow diagram with the applicable, associated radiation monitoring instrumentation and controls is presented as Figure 1.

1.2 Liquid Effluent Monitor Setpoint Determination Per the requirements of Technical Specification 6.16.b.l.B and ODCM Specification 3.1, alarm setpoints shall be established for the liquid effluent monitoring instrumentation to ensure that the release concentration limits of ODCM Specification 3.3.1 are met (i.e., the concentration of radioactive material released in liquid effluents to unrestricted areas shall be limited to ten times the concentrations specified in 10 CFR 20, Appendix B, Table 2, Column 2, for radionuclides and 2.OE-04 ltCi/mI for dissolved or entrained noble gases). The following equation' must be satisfied to meet the liquid effluent restrictions:

c < lOxC(F+f) (1.1) f Adapted from NUREG-0133 to include the application of 10 times the Effluent Concentration (EC) of 10 CFR 20, Appendix B, Table 2, Column 2.

l-.

REV. 11 02/22/2007

where:

1OxC = ten times the effluent concentration limit of 10 CFR 20, Appendix B, Table 2, Column 2, in ltCi/ml. For dissolved and entrained noble gases equals 2x10 4 ltCi/ml.

c = the setpoint, in LtCi/ml, of the radioactivity monitor measuring the radioactivity concentration in the effluent line prior to dilution and subsequent release; the setpoint, which is inversely proportional to the volumetric flow of the effluent line and proportional to the volumetric flow of the dilution stream plus the effluent stream, represents a value which, if exceeded, would result in concentrations exceeding the limits of ODCM Specification 3.3. 1.

f = the flow rate at the radiation monitor location in volume per unit time, but in the same units as F, below.

F = the dilution water flow rate as measured prior to the release point, in volume per unit time.

[Note that if no dilution is provided, c < C. Also, note that when (F) is large compared to (f), then (F + f) z F.]

1.2.1 Liquid Effluent Monitors (Radwaste, Steam Generator Blowdown and Service Water)

The setpoints for the liquid effluent monitors at the Kewaunee Power Station are determined by the following equations:

SP* CW<X(C xSEN1 ) + bkg (1.2)

C Ci xRR lOxEC, where:

SP = alarm setpoint corresponding to the maximum allowable release rate (cpm)

Ci = the concentration of radionuclide "i" in the liquid effluent (tCi), to include gamma emitters only 10 x ECi = ten times the EC value corresponding to radionuclide "i" from 10 CFR 20, Appendix B, Table 2, Column 2 (lCi/ml) 1-2 REV. 11 02/22/2007

SENi the sensitivity value to which the monitor is calibrated for radionuclide "i" (cpm per pCi/ml). The default calibration value from Table 1.1 may be used for gamma emitting radionuclides in lieu of nuclide specific values.

CW = the circulating water flow rate (dilution water flow) at the time of release (gal/min)

RR the liquid effluent release rate (gal/min) bkg = the background of the monitor (cpm)

The radioactivity monitor setpoint equation (1.2) remains valid during outages when the circulating water dilution is at its lowest. Reduction of the waste stream flow (RR) may be necessary during these periods to meet the discharge criteria. At its lowest value, CW will equal RR and equation (1.2) reverts to the following equation:

I (Ci x SEN)

SP* I bkg (1.3)

(10x EC) 1.2.2 Conservative Default Values Non-gamma emitting radionuclides (H-3, Fe-55, Sr-89/90) are not detected by the effluent monitor and, therefore, are not directly included in the above setpoint equation. These non-gamma radionuclides can, however, contribute a sizable fraction of the total EC limit (refer to Appendix C). The method specified below for establishing default setpoints provides conservatism to account for these non-gamma emitters and ensures that the setpoint meets the requirements of ODCM Specification 3.1 including all radionuclides. Refer to Appendix C for further discussion.

Conservative alarm setpoints have been determined through the use of generic, default parameters. Table 1.1 summarizes all current default values in use for Kewaunee. They are based upon the following:

a) substitution of the default effective EC (ECe) value of 1.OE-06 ltCi/mI (refer to Appendix C for justification),

where, 1-3 REV. 11 02/22/2007

EC- Ci (1.4)

Ci

~(EC) b) substitution of the lowest operational circulating water flow, in gal/min; and, c) substitution of the highest effluent release rate, in gal/min, d) substitution of the default monitor sensitivity.

The default setpoint equation is provided below:

sP ECxlOxSENxCWRR bkg (1.5) 1.3 Liquid Effluent Concentration Limits - 10 CFR 20 ODCM Specification 3.3.1 limits the concentration of radioactive material in liquid effluents (after dilution in the Circulating Water System) to less than ten times the concentrations as specified in 10 CFR 20, Appendix B, Table 2, Column 2 for radionuclides other than noble gases. Noble gases are limited to a diluted concentration of 2E-04 gCi/ml. Release rates are controlled and radiation monitor alarm setpoints are established to ensure that these concentration limits are not exceeded. In the event any liquid release results in an alarm setpoint being exceeded, an evaluation of compliance with the concentration limits of ODCM Specification 3.3.1 may be performed using the following equation:

where:

Y [(Ci - (10 x ECi))x(RR +CW)]< 1 (1.6)

Ci concentration of radionuclide "i" in the undiluted liquid effluent (gtCi/ml) 10 x ECi = ten times the EC value corresponding to radionuclide "i" from 10 CFR 20, Appendix B, Table 2, Column 2 (ptCi/ml) 2E-04 gCi/ml for dissolved or entrained noble gases RR the liquid effluent release rate (gal/min)

CW the circulating water flow rate (dilution water flow) at the time of the release (gal/min) 1-4 REV. 11 02/22/2007

1.4 Liquid Effluent Dose Calculation - 10 CFR 50 ODCM Specification 3.3.2 limits the dose or dose commitment to members of the public from radioactive materials in liquid effluents from the Kewaunee Power Station to:

• during any calendar quarter;

< 1.5 mrem to total body

< 5.0 mrem to any organ

• during any calendar year;

_ 3.0 mrem to total body

_ 10.0 mrem to any organ.

Per Surveillance Requirement 4.3.2, the following calculational methods may be used for determining the dose or dose commitment due to the liquid radioactive effluents from Kewaunee.

Do = 1.6 7 E,02x VOL x (Cix Aio) (1.7)

CW where:

Do = dose or dose commitment to organ "o", including total body (mrem)

Aio = site-related ingestion dose commitment factor to the total body or any organ "o" for radionuclide "i" (mrem/hr per lLCi/ml) (Table 1.2)

Ci = average concentration of radionuclide "i", in undiluted liquid effluent representative of the volume VOL (ptCi/ml)

VOL = volume of liquid effluent released (gal)

CW = average circulating water discharge rate during release period (gal/min) 1.67E-02 = conversion factor (hr/min) 1-5 REV. 11 02/22/2007

The site-related ingestion dose/dose commitment factors (Aio) are presented in Table 1.2 and have been derived in accordance with guidance of NUREG-0133 by the equation:

Ao = 1.14E + 05[(Uw + Dw)+ (UFx BFi)]DFi (1.8) where:

Aio = composite dose parameter for the total body or critical organ "o" of an adult for radionuclide "i", for the fish ingestion and water consumption pathways (mrem/hr per btCi/ml) 1.1 4E+05 = conversion factor (pCi/ltCi x ml/kg - hr/yr)

Uw = adult water consumption (730 kg/yr)

Dw = dilution factor from the near field area within 11/4 mile of the release point to the nearest potable water intake for the adult water consumption (84 2, unitless)

UF = adult fish consumption (21 kg/yr)

BFi = bioaccumulation factor for radionuclide "i" in fish from Table 1.3 (pCi/kg per pCi/1)

DFi = dose conversion factor for nuclide "i" for adults in pre-selected organ "o", from Table E- I1 of Regulatory Guide 1.109, 1977 and NUREG 0172, 1977 (mrem/pCi)

The radionuclides included in the periodic dose assessment per the requirements of ODCM Specification 3.3.2 and Surveillance Requirement 4.3.2 are those as identified by gamma spectral analysis of the liquid waste samples collected and analyzed per Surveillance Requirement 4.3.1.1, Table 4.3.

Radionuclides requiring radiochemical analysis (e.g., Sr-89 and Sr-90) will be added to the dose analysis at a frequency consistent with the required minimum analysis frequency of Table 4.3.

In lieu of the individual radionuclide dose assessment as presented above, the following simplified dose calculational equation may be used for demonstrating compliance with the dose limits of ODCM Specification 3.3.2. (Refer to Appendix A for the derivation and justification for this simplified method.)

2 Adapted from the Kewaunee Final Environmental Statement,Section V.

1-6 REV. 11 02/22/2007

Total Body Dtb= 9.67E + 03 x VOL X-Ci (1.9)

CW Maximum Organ

1. 18E + 04 x VOL X--, (1.10)

CW where:

Ci average concentration of radionuclide "i", in undiluted liquid effluent representative of the volume VOL (tCi/ml)

VOL volume of liquid effluent released (gal)

CW average circulating water discharge rate during release period (gal/min)

Dtb conservatively evaluated total body dose (mrem)

Dmax = conservatively evaluated maximum organ dose (mrem) 9.67E+03 = product of the hour-to-minute conversion factor (hr/min) and the conservative total body dose conversion factor (Cs- 134, total body

-- 5.79E+05 mremlhr per p.Ci/ml) 1.18E+04 = product of the hour-to-minute conversion factor (hr/min) and the conservative maximum organ dose conversion factor (Cs-134, liver

-- 7.09E+05 mrem/hr per ýtCi/ml) 1.5 Liquid Effluent Dose Proiections ODCM Specification 3.3.3 requires that the liquid radioactive waste processing system be used to reduce the radioactive material levels in the liquid waste prior to release when the quarterly projected doses exceed:

• 0.18 mrem to the total body, or

• 0.62 mrem to any organ.

The applicable liquid waste streams and processing systems are as delineated in Figure 1.

1-7 REV. 11 02/22/2007

Dose projections are made at least once per 31 days by the following equations:

Dtbp= Dtb(91 - d) (1.11)

Dmaxp = Dnax(91 - d) (1.12) where:

Dtbp = the total body dose projection for current calendar quarter (mrem)

Dtb = the total body dose to date for current calendar quarter as determined by equation (1.7) or (1.9) (mrem)

Dmaxp = the maximum organ dose projection for current calendar quarter (mrem)

Dmax = the maximum organ dose to date for current calendar quarter as determined by equation (1.7) or (1.10) (mrem) d = the number of days to date for current calendar quarter 91 = the number of days in a calendar quarter 1.6 Onsite Disposal of Low-Level Radioactively Contaminated Waste Streams During the normal operation of Kewaunee, the potential exists for in-plant process streams, which are not normally radioactive to become contaminated with very low levels of radioactive materials. These waste streams are normally separated from the radioactive streams. However, due mainly to infrequent, minor system leaks, and anticipated operational occurrences, the potential exists for these systems to become slightly contaminated. At Kewaunee, the secondary system demineralizer resins, the service water pretreatment system sludges, the make-up water system resins, and the sewage treatment plant sludges are waste streams that have the potential to become contaminated at very low levels. During the yearly testing of a batch of pre-treatment sludge, it was found that approximately 15,000 cubic feet of sludge had been contaminated with Cs-137 and Co-60.

The potential radiation doses to members of the public from these onsite disposal methods are well below 1 mrem per year. This dose is in keeping with the guidelines of the National Council on Radiation Protection (NCRP) in their Report No. 91, in which the NCRP established a "negligible individual risk level" at a dose rate of 1 mrem per year.

1-8 REV. 11 02/22/2007

It is for these type wastes that the NRC acknowledged in Information Notice No. 83-05 and 88-22 that the levels of radioactive material are so low that control and disposal as a radwaste are not warranted. The potential risks to man are negligible and the disposal costs as a radwaste are unwarranted and costly.

This waste material will be monitored and evaluated prior to disposal to ensure its radioactive material content is negligible. It shall then be disposed of in a normal conventional manner with records being maintained of all materials disposed of using these methods.

Approvals for specific alternate disposal methods are listed in Appendix E. Currently, only service water pretreatment (SWPT) facility lagoon sludge and sewage treatment plant sludge have been approved for disposal by land spreading.

1.7 Heating Boiler Blowdown Operation with Primary-to-Secondary Leak During operation with a primary-to-secondary leak, the potential exists for non-radioactive systems to become contaminated. One such system is the heating system. Activity is transferred from the reactor coolant system into the secondary main steam system through the leak and then into the heating system. Heating boiler operation following operation with a primary-to-secondary leak will result in the heating boiler becoming contaminated.

When the heating boiler is operated, it must be periodically blown down to remove impurities, which collect in the system. This blowdown is normally directed to the steam generator blowdown tank but can be diverted to the circulating water discharge. Either way, the blowdown becomes a release path for radioactivity to the environment. The heating boiler blowdown is sampled, using current plant procedures, whenever the primary-to-secondary leakage exceeds 10 gallons per day and the gross gamma activity or tritium activity exceeds 1.OE-05 ltCi/ml. The results of these samples allow for the activity being released to the environment to be quantified. This is similar to the method used for the turbine building sump release path. The radioactive effluent limits of 10 CFR Part 20, 40 CFR 190, and Technical Specifications can therefore be maintained.

1-9 REV. 11 02/22/2007

Figure 1 Liquid Radioactive Effluent Flow Diagram D~x- mr, Sump _ KN SIMO N

\

%diik~" mtofRI>

falulp rltode N~~xG na (11ý4nnwn xlletnatt Qrvg. S~-C 4AkUp TArwk~iT~

~j W\acla Ho~m Up n r Hat Shvw*erC'ARinu

>p Sy 9Slandjpn RAijr n

PadialWn Mmta" (CMp~anerf CwtvAg, (Dord.-MMerfl fan etd1hol

ýfIrm Hýfirrj R-Alff nkmdcýr, Ji - JLý

\ Wrogio O CCMFftnPL 1.1t0 1-10 REV. 11 02/22/2007

Table 1.1 Parameters for Liquid Alarm Setpoint Determinations Parameter Actual Value Default Value* Units Comments ECe calculated .0E-06** lLCi/ml Calculate for each batch to be released Taken from gamma spectral analysis of C, measured N/A kCi/ml iliquid effluent iTaken from 10 CFR 20, Appendix B, ECi as determined N/A liCi/ml Table 2, Col. 2 Sensitivity (SEN)

R- 18 as determined 1.0E+08 Radwaste effluent R- 19 as determined 1.0E+08 cpm per Steam Generator blowdown R-20 as determined 1.0E+08 ltCi/ml Service Water - component cooling R-16 as determined 9.8E+07 Service Water - Containment fan cooling Circulating Water System default =

CW as determined 2.58E+05 gpm winter, single CW pump Release Rate (RR)

R-18 as determined 8.OE+01 Determined prior to release; release rate can be adjusted for Technical Specification compliance R-19 as determined 2.0E+02 gpm Steam Generator A and B combined R-20 as determined 5.OE+03 Service Water - component cooling R-16 as determined 1.5E+03 Service Water - Containment fan cooling Background (bkg)

R-18 as determined 2.0E+03 cpm Nominal values only; actual values may

.R-19 as determined 8.0E+0 I be used in lieu of these reference values R-20 as determined 6.OE+01 R-16 as determined 8.0E+01 SetPoint,,(SP)

R-1p calculated 5.0E+05 + bkg cpm Default alarm setpoints; more R-19 calculated 5.00E+05 + bkg conservative values may be used as deem R-20 calculated 5.16E+04 + bkg appropriate and desirable for assuring R-16 calculated 1.69E+05 + bkg regulatory compliance and for t I I

+maintaining releases ALARA.

Setpoint* (SP) with no Circulating Water System flow, CW=0 R-18 calculated 6.25E+04+ bkg For outages with no Circulating Water R-19 calculated 2.50E+04 + bkg cpm System flow (CW=0) and a dilution flow R-20 calculated 1.00E+03 + bkg as provided by the Service Water system R-16 calculated 3.26E+03 + bkg of 5,000 gpm total.***

Refer to Calculation # C 10690 for the default setpoint calculation.

• • Refer to Appendix C for derivation

• • • SW flow is based on N-SW-02 Operating Parameters and Service Water Pump Flow Curves.

• • • • The default alarm setpoints for R-1 8 and R-19 are based upon the linear calibration range of those radiation monitors in accordance with CAP 37265 and DCR 26981.

1-11 REV. 11 02/22/2007

Table 1.2 Site Related Ingestion Dose Commitment Factors (mrem/hr per p.Ci/ml)

Nuclide Bone Liver T.Body Thyroid Kidney Lung GI-LLI H-3 - 3.30E-1 3.30E-1 3.30E-1 3.30E-1 3.30E-1 3.30E-1 C-14 3.13E+4 6.26E+3 6.26E+3 6.26E+3 6.26E+3 6.26E+3 6.26E+3 Na-24 4.09E+2 4.09E+2 4.09E+2 4.09E+2 4.09E+2 4.09E+2 4.09E+2 P-32 1.39E+6 8.62E+4 5.36E+4 - 1.56E+5 Cr-51 1.28E+0 7.63E-1 2.81E-1 1.69E+0 3.21E+2 Mn-54 4.38E+3 8.36E+2 - 1.30E+3 1.34E+4 Mn-56 1.10E+2 1.96E+1 - 1.40E+2 3.52E+3 Fe-55 6.61 E+2 4.57E+2 1.06E+2 - 2.55E+2 2.62E+2 Fe-59 1.04E+3 2.45E+3 9.40E+2 - 6.85E+2 8.17E+3 Co-57 2.11E+1 3.51E+1 - 5.36E+2 Co-58 8.99E+1 2.02E+2 - 1.82E+3 Co-60 2.58E+2 5.70E+2 4.85E+3 Ni-63 3.13E+4 2.17E+3 1.05E+3 4.52E+2 Ni-65 1.27E+2 1.65E+1 7.52E+0 - 4.18E+2 Cu-64 1.01 E+1 4.72E+O 2.53E+1 8.57E+2 Zn-65 2.32E+4 7.38E+4 3.33E+4 4.93E+4 4.65E+4 Zn-69 4.93E+1 9.43E+1 6.56E+0 6.13E+1 - 1.42E+1 Br-82 - - 2.27E+3 - 2.61 E+3 Br-83 - - 4.05E+1 - 5.83E+1 Br-84 - - 5.24E+1 - 4.12E-4 Br-85 - - 2.15E+0 - -

Rb-86 - 1.01 E+5 4.71E+4 - 1.99E+4 Rb-88 - 2.90E+2 1.54E+2 - - - 4.OOE-9 Rb-89 - 1.92E+2 1.35E+2 - - --

Sr-89 2.24E+4 6.44E+2 - - - 3.60E+3 Sr-90 5.52E+5 1.35E+5 - - - 1.59E+4 Sr-91 4.13E+2 - 1.67E+1 - - - 1.97E+3 Sr-92 1.57E+2 - 6.77E+O - - 3.1OE+3 Y-90 5.85E-1 - 1.57E-2 - - 6.21 E+3 Y-91m 5.53E-3 - 2.14E-4 - - - 1.62E-2 Y-91 8.58E+O - 2.29E-1 - - - 4.72E+3 Y-92 5.14E-2 - 1.50E-3 - - - 9.OOE+2 Y-93 1.63E-1 - 4.50E-3 - - - 5.17E+3 Zr-95 2.70E-1 8.67E-2 5.87E-2 - 1.36E-1 - 2.75E+2 Zr-97 1.49E-2 3.01E-3 1.38E-3 - 4.55E-3 - 9.34E+2 Nb-95 4.47E+2 2.49E+2 1.34E+2 - 2.46E+2 - 1.51 E+6 Nb-97 3.75E+0 9.48E-1 3.46E-1 - 1.11E+O - 3.50E+3 Mo-99 - 1.07E+2 2.04E+1 - 2.43E+2 - 2.49E+2 Tc-99m 9.11E-3 2.58E-2 3.28E-1 - 3.91E-1 1.26E-2 1.52E+1 Tc-101 9.37E-3 1.35E-2 1.32E-1 - 2.43E-1 6.90E-3 Ru-103 4.61E+0 1.99E+O - 1.76E+1 5.39E+2 Ru-105 3.84E-1 1.52E-1 - 4.96E+0 2.35E+2 Ru-106 6.86E+1 8.68E+O - 1.32E+2 4.44E+3 Rh-103m Rh-106 1-12 REV. 11 02/22/2007

Table 1.2 Site Related Ingestion Dose Commitment Factors (mrem/hr per l.Ci/ml)

Nuclide Bone Liver T.Body Thyroid Kidney Lung GI-LLI Ag-11Om 1.04E+O 9.62E-1 5.71E-1 1.89E+O 3.92E+2 Sb-124 9.48E+O 1.79E-1 3.76E+O 2.30E-2 7.38E+O 2.69E+2 Sb-125 6.06E+O 6.77E-2 1.44E+O 6.16E-3 4.67E+O 6.67E+1 Te-125m 2.57E+3 9.31E+2 3.44E+2 7.73E+2 1.04E+4 1.03E+4 Te-127m 6.49E+3 2.32E+3 7.91E+2 1.66E+3 2.64E+4 - 2.18E+4 Te-127 1.05E+2 3.79E+1 2.28E+1 7.81E+1 4.29E+2 - 8.32E+3 Te-129m 1.10E+4 4.11E+3 1.74E+3 3.79E+3 4.60E+4 - 5.55E+4 Te-129 3.01E+I 1.13E+1 7.33E+O 2.31E+1 1.27E+2 - 2.27E+1 Te-131m 1.66E+3 8.11E+2 6.76E+2 1.28E+3 8.22E+3 - 8.05E+4 Te-131 1.89E+1 7.89E+O 5.96E+O 1.55E+1 8.27E+1 - 2.67E+O Te-132 2.42E+3 1.56E+3 1.47E+3 1.73E+3 1.50E+4 - 7.39E+4 1-130 2.79E+1 8.23E+1 3.25E+1 6.97E+3 1.28E+2 - 7.08E+1 1-131 1.54E+2 2.20E+2 1.26E+2 7.20E+4 3.76E+2 - 5.79E+1 1-132 7.49E+0 2.OOE+1 7.01E+O 7.01E+2 3.19E+1 - 3.76E+O 1-133 5.24E+1 9.11E+1 2.78E+1 1.34E+4 1.59E+2 - 8.19E+1 1-134 3.91E+O 1.06E+1 3.80E+O 1.84E+2 1.69E+1 - 9.26E-3 1-135 1.63E+1 4.28E+1 1.58E+1 2.82E+3 6.86E+1 - 4.83E+1 Cs-134 2.98E+5 7.09E+5 5.79E+5 2.29E+5 7.61 E+4 1.24E+4 Cs-136 3.12E+4 1.23E+5 8.86E+4 6.85E+4 9.39E+3 1.40E+4 Cs-137 3.82E+5 5.22E+5 3.42E+5 1.77E+5 5.89E+4 1.01 E+4 Cs-138 2.64E+2 5.22E+2 2.59E+2 3.84E+2 3.79E+1 2.23E-3 Ba-139 1.02E+O 7.30E-4 3.OOE-2 6.83E-4 4.14E-4 1.82E+0 Ba-140 2.15E+2 2.69E-1 1.41 E+I 9.16E-2 1.54E-1 4.42E+2 Ba-141 4.98E-1 3.76E-4 1.68E-2 3.50E-4 2.13E-4 Ba-142 2.25E-1 2.31 E-4 1.42E-2 1.95E-4 1.31 E-4 La-140 1.52E-1 7.67E-2 2.03E-2 - 5.63E+3 La-142 7.79E-3 3.54E-3 8.82E-4 2.59E+1 Ce-141 3.17E-2 2.14E-2 2.43E-3 9.95E-3 8.19E+1 Ce-143 5.58E-3 4.13E+0 4.57E-4 1.82E-3 - 1.54E+2 Ce-144 1.65E+O 6.90E-1 8.87E-2 - 4.10E-1 - 5.58E+2 Pr-143 5.60E-1 2.25E-1 2.77E-2 - 1.30E-1 - 2.45E+3 Pr-144 1.83E-3 7.61E-4 9.31E-5 - 4.29E-4 -

Nd-147 3.83E-1 4.42E-1 2.65E-2 - 2.59E-1 - 2.12E+3 W-187 2.96E+2 2.47E+2 8.65E+1 - - 8.1OE+4 Np-239 2.97E-2 2.92E-3 1.61 E-3 - 9.1OE-3 - 5.98E+2 1-13 REV. 11 02/22/2007

Table 1.3 Bioaccumulation Factors(BFi)

(pCi/kg per pCi/liter)*

Element Freshwater Fish H 9.OE-01 C 4.6E+03 Na 1.OE+02 P 3.OE+03 Cr 2.OE+02 Mn 4.OE+02 Fe 1.OE+02 Co 5.OE+01 Ni 1.OE+02 Cu 5.OE+01 Zn 2.OE+03 Br 4.2E+02 Rb 2.OE+03 Sr 3.OE+01 Y 2.5E+01 Zr 3.3E+00 Nb 3.OE+04 Mo 1.OE+01 Tc 1.5E+01 Ru 1.OE+01 Rh 1.OE+01 Ag 2.3E+00 Sb 1.OE+00 Te 4.OE+02 I 1.5E+01 Cs 2.OE+03 Ba 4.OE+00 La 2.5E+01 Ce 1.OE+00 Pr 2.5E+01 Nd 2.5E+01 W 1.2E+03 Np 1.OE+01 Values in this Table are taken from Regulatory Guide 1.109 except for phosphorus which is adapted from NUREG/CR-1336 and silver and antimony which are taken from UCRL 50564, Rev. 1, October 1972.

1-14 REV. 11 02/22/2007

2.0 Gaseous Effluents 2.1 Radiation Monitoring Instrumentation and Controls The gaseous effluent monitoring instrumentation and controls at Kewaunee for controlling and monitoring normal radioactive material releases in accordance with 10 CFR 50, Appendix A, Criteria 60 and 64, are summarized as follows:

2.1.1 Waste Gas Holdup System The vent header gases are collected by the waste gas holdup system. Gases may be recycled to provide cover gas for the CVCS hold-up tanks or held in the waste gas tanks for decay prior to release. Waste gas decay tanks are batch released after sampling and analysis. The tanks are discharged via the Auxiliary Building vent. R-13 and/or R-14 provide noble gas monitoring and automatic isolation.

2.1.2 Condenser Evacuation System The air ejector discharge is monitored by R-15. Releases from this system are normally via the Auxiliary Building vent and are monitored by R-13 and/or R-14.

2.1.3 Containment Purge Containment purge and ventilation is via the containment stack for the 36-inch RBV system but via the auxiliary building stack for the 2-inch vent and mini-purge blower system. The stack radiation monitoring system consists of:

• a noble gas activity monitor providing alarm and automatic termination of release (R-12 and R-21),

" an iodine sampler, and

• a particulate sampler.

Effluent flow rates are determined empirically as a function of fan operation (fan curves).

Sampler flow rates are determined by flow rate instrumentation.

2.1.4 Auxiliary Building Vent The Auxiliary Building vent receives discharges from the waste gas holdup system, condenser evacuation system, fuel storage area ventilation, Auxiliary Building radwaste processing area ventilation, 2-inch containment pressure relief purge/vent system, and Auxiliary Building general area. All effluents pass through the R-13 and/or R-14 channels which contain:

• a noble gas monitor,

• an iodine sampler, and

• a particulate sampler.

2-1 REV. 11 02/22/2007

The noble gas monitor provides auto isolation of any waste gas decay tank release and diverts other releases through the special ventilation system. Effluent flow rates are determined by installed flow measurement equipment or as a function of fan operation (fan curves). Sampler flow rates are determined by flow rate instrumentation.

2.1.5 Containment Mini-Purge/Vent System Slight pressure buildup in containment is a recurring event resulting from normal operation of the plant. Prior to exceeding 2 psig in containment, this excess pressure is vented off. Air from containment is routed to the Auxiliary Building ventilation system, via the post-LOCA hydrogen recombiner piping and then out through the Auxiliary Building vent stack. The system is also designed to allow a continuous supply of fresh air to be introduced into containment via a mini-blower to purge gases. An alarm of the Auxiliary Building vent stack monitor (R-13 or R-14) or the containment building airborne radioactivity monitors (R-11, R-12) provides automatic isolation.

2.1.6 Steam Generator PORV Release With Primary-to-Secondary Leakage IF the plant is operating with Steam Generator leakage from the primary side to the secondary, THEN release of steam through the Steam Generator PORVs will constitute a radiological release. There are no monitors on this release path, so accurate data collection is important. The appropriate procedures provide directions for release permit preparations.

2.1.7 Non-routine Discharge Locations Periodically, non-routine breaches are made in the Auxiliary and Containment buildings that might allow the release of the atmosphere, which contains some levels of radioactivity. These breaches include, but are not limited to, opening the Containment equipment hatch during outages, holes cut in walls or ceilings to allow for moving equipment in or out of the Radiologically Controlled Areas (RCAs). All efforts to maintain these areas at negative pressure will be made. IF negative pressure cannot be maintained (i.e., more exhaust than supply fan volume), THEN supply ventilation to the area must be secured. Criteria for determining if and when a release occurs from these areas is provided in implementing procedures. As possible, the effects of these possible releases shall be evaluated before hand. Any actual releases shall be documented and included in the monthly, quarterly and annual reports as appropriate.

2.1.8 Miscellaneous Releases IF the plant is experiencing primary-to-secondary leaks in the steam generators, THEN the secondary steam side will become contaminated. Any release of steam will constitute an effluent, gaseous release, which will need to be accounted for in the effluent release program.

Historically, if this condition had existed, the affects were considered to be minimal, and therefore were NOT included in the ODCM. The potential sources are too numerous to specifically call out here. However, in the event conditions arise that such releases occur, the methods outlined in the ODCM for dose calculation of the releases will be applied, and the results included in the annual effluent release report.

A gaseous radioactive waste flow diagram with the applicable, associated radiation monitoring instrumentation and controls is presented as Figure 2.

2-2 REV. 11 02/22/2007

2.2 Gaseous Effluent Monitor Setpoint Determination 2.2.1 Containment and Auxiliary Building Vent Monitor Per the requirements of ODCM Specification 3.2, alarm setpoints shall be established for the gaseous effluent monitoring instrumentation to ensure that the release rate of noble gases does not exceed corresponding dose rate at the site boundary of 500 mrem/year to the total body or 3000 mrem/year to the skin. Based on a grab sample analysis of the applicable release (i.e., grab sample of the Containment vent or Auxiliary Building vent), the radiation monitoring alarm setpoints may be established by the following calculational method:

FRACtb = [4.72E + 02x X/Qx VFx Y (Ci x K,)]+ 500 (2.1)

FRACskin =[4.72E +02x X/Qx VFx Y (Ci x (L + 1.1Mi))]÷ 3000 (2.2) where:

FRACtb fraction of the allowable release rate for the total body based on the identified radionuclide concentrations and the release flow rate

= fraction of the allowable release rate for skin based on the identified radionuclide concentrations and the release flow rate x/Q annual average meteorological dispersion for direct exposure to noble gas at the controlling site boundary location (sec/m 3, from Table 2.3)

VF = ventilation system flow rate for the applicable release point and monitor (ft3/min, from Table 2.3)

Ci = concentration of noble gas radionuclide "i" as determined by radioanalysis 3

of grab sample (ýtCi/cm )

Ki = total body dose conversion factor for noble gas radionuclide "i" (mrem/yr per ýtCi/m 3 , from Table 2. 1)

= beta skin dose conversion factor for noble gas radionuclide "i" (mrem/yr per jLCi/m 3 , from Table 2. 1)

= gamma air dose conversion factor for noble gas radionuclide "i" (mrad/yr per ltCi/m 3 , from Table 2. 1) 1.1 = mrem skin dose per mrad gamma air dose (mrem/mrad) 4.72E+02 = conversion factor (cm 3/ft3 x min/sec) 500 = total body dose rate limit (mrem/yr) 2-3 REV. 11 02/22/2007

3000 = skin dose rate limit (mrem/yr)

Based on the more limiting FRAC (i.e., higher value) as determined above, the alarm setpoint for the Containment and Auxiliary Building vent monitors at Kewaunee may be calculated:

SP=I(CiX SEN) -.FRAC] +bkg (2.3) where:

SP = alarm setpoint corresponding to the maximum allowable release rate (cpm)

SENi = the sensitivity value to which the monitor is calibrated for radionuclide "i" (cpm per ýtCi/cm 3), use the default value from Table 2.2 if radionuclide specific sensitivities are not available bkg = background of the monitor (cpm) 2.2.2 Conservative Default Values A conservative alarm setpoint can be established, in lieu of the individual radionuclide evaluation based on the grab sample analysis, to eliminate the potential of periodically having to adjust the setpoint to reflect minor changes in radionuclide distribution and variations in release flow rate. The alarm setpoint may be conservatively determined by the default values presented in Table 2.2. These values are based upon:

a) substitution of the maximum ventilation flow rate, b) substitution of a radionuclide distribution 3 comprised of 95% Xe-133, 2%

Xe-135, 1% Xe-133m, 1% Kr-88 and 1% Kr-85; and, c) application of an administrative multiplier of 0.5 to conservatively assure that any simultaneous releases do not exceed the maximum allowable release rate.

For this radionuclide distribution, the alarm setpoint based on the total body dose rate is more restrictive than the corresponding setpoint based on the skin dose rate. The resulting conservative, default setpoints are presented in Table 2.2.

3 Adopted from ANSI N237-1976/ANS-18.1, Source Term Specifications, Table 6.

2-4 REV. 11 02/22/2007

2.3 Gaseous Effluent Instantaneous Dose Rate Calculations - 10 CFR 20 2.3.1 Site Boundary Dose Rate - Noble Gases.

ODCM Specification 3.4.1.a limits the dose rate at the site boundary due to noble gas releases to < 500 mrem/yr to the total body, and < 3000 rnrem/yr to the skin. Radiation monitor alarm setpoints are established to ensure that these release limits are not exceeded. In the event any gaseous releases from the station results in the alarm setpoints being exceeded, an evaluation of the unrestricted area dose rate resulting from the release may be performed using the following equations:

Dtb=X/Q KixQi (2.4) and s= x/Qx r(L IMi)xQi (2.5) where:

Dtb =total body dose rate (mrem/yr)

D, = skin dose rate (mrem/yr)

X/Q = atmospheric dispersion for direct exposure to noble gas at the controlling site boundary (sec/m 3, from Table 2.3)

Qi = average release rate of radionuclide "i" over the release period under evaluation (p.Ci/sec)

Ki = total body dose conversion factor for noble gas radionuclide "I" (mrem/yr per pCi/m 3, from Table 2.1)

Li = beta skin dose conversion factor for noble gas radionuclide "i" (mrem/yr per .tCi/m 3, from Table 2. 1)

Mi = gamma air dose conversion factor for noble gas radionuclide "I" (mrad/yr per gCi/m 3, from Table 2.1) 1.1 = mrem skin dose per mrad gamma air dose (mrem/mrad)

Actual meteorological conditions concurrent with the release period or the default, annual average dispersion parameters as presented in Table 2.3 may be used for evaluating the gaseous effluent dose rate.

2-5 REV. 11 02/22/2007

2.3.2 Site Boundary Dose Rate - Radioiodine and Particulates.

ODCM Specification 3.4.1.b limits the dose rate to < 1500 mrem/yr to any organ for 1-131, 1-133, tritium and particulates with half-lives greater than 8 days. To demonstrate compliance with this limit, an evaluation is performed at a frequency no greater than that corresponding to the sampling and analysis time period for continuous releases (e.g.,

nominally once per 7 days) and for batch releases on the time period over which any batch release is to occur. The following equation may be used for the dose rate evaluation:

= /Qx

/ - rR x i (2.6) where:

D. = average organ dose rate over the sampling time period (mrem/yr) x/Q = atmospheric dispersion to the controlling site boundary for the inhalation pathway (sec/m 3 , from Table 2.3) 3 Ri = dose parameter for radionuclide "i", (mrem/yr per tCi/Um ) for the child inhalation pathway from Table 2.6 Q = average release rate over the appropriate sampling period and analysis frequency for radionuclide i, 1-131, 1-133, tritium or other radionuclide in particulate form with half-life greater than 8 days (gtCi/sec)

By substituting 1500 mrem/yr for D. solving forQi, an allowable release rate for 1-131 can be determined. Based on the annual average meteorological dispersion (see Table 2.3) and the most limiting potential pathway, age group and organ (inhalation pathway, child thyroid - Ri = 1.62E+07 mrem/yr per [tCi/m 3) the allowable release rate for 1-131 is 6.43 LOCi/sec. An added conservatism factor of 0.25 has been included in this calculation to account for any potential dose contribution from other radioactive particulate material.

For a 7-day period, which is the nominal sampling and analysis frequency for 1-131, the cumulative allowable release is 3.9 Ci. Therefore, as long as the 1-131 releases in any 7-day period do not exceed 3.9 Ci, no additional analyses are needed to verify compliance with the ODCM Specification 3.4.1 .b limits on allowable release rate.

2-6 REV. 11 02/22/2007

2.4 Gaseous Effluent Dose Calculations - 10 CFR 50 2.4.1 Unrestricted Area Dose - Noble Gases ODCM Specification 3.4.2 requires a periodic assessment of releases of noble gases to evaluate compliance with the quarterly dose limits of (< 5 mrad, gamma-air and < 10 mrad, beta-air) and the calendar year limits (< 10 mrad, gamma-air and < 20 mrad, beta-air). The following equations may be used to calculate the gamma-air and beta-air doses:

DT = 3.17E- 08 x x/Q x (Mi x Q) (2.7) and DIY = 3.17E-08 xX/Qx x (Ni x Qi) (2.8) where:

Dy = air dose due to gamma emissions for noble gas radionuclides (mrad)

Dp = air dose due to beta emissions for noble gas radionuclides (mrad)

X/Q = atmospheric dispersion to the controlling site boundary (sec/m 3, from Table 2.3)

Qi = cumulative release of noble gas radionuclide "I" over the period of interest (tCi)

Mi = air dose factor due to gamma emissions from noble gas radionuclide "i" (mrad/yr per gCi/m 3 from Table 2. 1)

Ni = air dose factor due to beta emissions from noble gas radionuclide "i" (mrad/yr per gCi/m 3, Table 2.1) 3.17E-08 = conversion factor (yr/sec)

In lieu of the individual noble gas radionuclide dose assessment as presented above, the following simplified dose calculational equation may be used for verifying compliance with the dose limits of ODCM Specification 3.4.2. (Refer to Appendix B for the derivation and justification for this simplified method.)

D, = 3 7 E0 8 XX/Qx Meff X Z Qi (2.9) 0.50 and 3.17E-08 Do - x X/Q x Neff XZ Qi (2.10) 0.50 2-7 REV. 11 02/22/2007

where:

Meff = 5.3E+02 effective gamma-air dose factor (mrad/yr per gCi/m 3) 3)

Neff = .IE+03 effective beta-air dose factor (mrad/yr per ýtCi/m 0.50 = conservatism factor Actual meteorological conditions concurrent with the release period or the default, annual average dispersion parameters as presented in Table 2.3, may be used for the evaluation of the gamma-air and beta-air doses.

2.4.2 Unrestricted Area Dose - Radioiodine and Particulates Per the requirements of ODCM Specification 3.4.3, a periodic assessment shall be performed to evaluate compliance with the quarterly dose limit (< 7.5 mrem) and calendar year limit (< 15 mrem) to any organ. The following equation may be used to evaluate the maximum organ dose due to releases of I- 131, 1-133, tritium and particulates with half-lives greater than 8 days:

Daop = 3.17E-08x WxSFpX x (Ri x Q) (2.11) where:

Daop = dose or dose commitment for age group "a" to organ "o", including the total body, via pathway "p" from 1-131, 1-133, tritium and radionuclides in particulate form with half-life greater than eight days (mrem)

W = atmospheric dispersion parameter to the controlling location(s) as identified in Table 2.3 X/Q = atmospheric dispersion for inhalation pathway and H-3 dose contribution via 3

other pathways (sec/m )

D/Q = atmospheric deposition for vegetation, milk and ground plane exposure pathways (I/m 2 )

Ri = dose factor for radionuclide "i", (mrem/yr per [tCi/m 3) or (M2 - mrem/yr per pCi/sec) from Table 2.4 through 2.15 for each age group "a" and the applicable pathway "p" as identified in Table 2.3. Values for Ri were derived in accordance with the methods described in NUREG-0133.

Q = cumulative release over the period of interest for radionuclide "i" -- 1-131 or radioactive material in particulate form with half-life greater than 8 days (pCi).

2-8 REV. 11 02/22/2007

SFp seasonal correction factor to account for the fraction of the period that the applicable exposure pathway does exist.

1) For milk and vegetation exposure pathways:

1. of months in the period that grazing occurs total # of months in period

= 0.5 for annual calculations

2) For inhalation and ground plane exposure pathways: 1.0 In lieu of the individual radionuclide (I- 131 and particulates) dose assessment as presented above, the following simplified dose calculational equation may be used for verifying compliance with the dose limits of ODCM Specification 3.4.3.

DMax = 3.17E -- 08xW xSFpX Ri- 131XZQi (2.12) where:

Dmax = maximum organ dose (mrem)

RI-131 = 1- 131 dose parameter for the thyroid for the identified controlling pathway

= 1.05E+12, infant thyroid dose parameter with the grass-cow-milk pathway controlling (M 2 - mrem/yr per ltCi/sec)

The ground plane exposure and inhalation pathways need not be considered when the above-simplified calculational method is used because of the overall negligible contribution of these pathways to the total thyroid dose. It is recognized that for some particulate radionuclides (e.g.

Co-60 and Cs-137), the ground plane exposure pathway may represent a higher dose contribution than either the vegetation or grass-cow-milk pathway. However, use of the 1-131 thyroid dose parameter for all radionuclides will maximize the organ dose calculation, especially considering that no other radionuclide has a higher dose parameter for any organ via any pathway than 1-131 for the thyroid via the grass-cow-milk pathway.

The location of exposure pathways and the maximum organ dose calculation may be based on the available pathways in the surrounding environment of Kewaunee as identified by the annual land-use census, see REMM Specification 2.2.2. Otherwise, the dose will be evaluated based on the predetermined controlling pathways as identified in Table 2.3.

2-9 REV. 11 02/22/2007

2.5 Gaseous Effluent Dose Projection ODCM Specification 3.4.4 requires that the Ventilation Exhaust Treatment System be used to reduce radioactive material levels prior to discharge when projected doses exceed one-half the annual design objective rate in any calendar quarter, i.e., exceeding:

• 0.62 mrad/quarter, gamma air,

• 1.25 mrad/quarter, beta air, or

• 0.94 mrem/quarter, maximum organ.

The applicable gaseous release sources and processing systems are as delineated in Figure 2.

Dose projections are performed at least once per 31 days by the following equations:

Dyp Dxy (91 +d) (2.13)

Dp D# X(91 d) (2.14)

Dmaxp= Dmrax X (91 +d) (2.15) where:

D7P = gamma air dose projection for current calendar quarter (mrad)

Dvy = gamma air dose to date for current calendar quarter as determined by equation (2.7) or (2.9) (mrad)

Dpp0 = beta air dose projection for current calendar quarter (mrad)

Do = beta air dose to date for current calendar quarter as determined by equation (2.8) or (2.10) (mrad)

Dmaxp = maximum organ dose projection for current calendar quarter (mrem)

Dmax = maximum organ dose to date for current calendar quarter as determined by equation (2.11) or (2.12) (mrem) d = number of days to date in current calendar quarter 91 = number of days in a calendar quarter 2-10 REV. 11 02/22/2007

2.6 Environmental Radiation Protection Standards 40 CFR 190 For the purpose of implementing ODCM Specification 3.5 on the EPA environmental radiation protection standard and Technical Specification 6.9.b.2 on reporting requirements, dose calculations may be performed using the above equations with the substitution of average or actual meteorological parameters for the period of interest and actual applicable pathways. Any exposure attributable to on-site sources will be evaluated based on the results of the environmental monitoring program (TLD measurements) or by calculational methods. NUREG-0543 describes acceptable methods for demonstrating compliance with 40 CFR Part 190 when radioactive effluents exceed the Appendix I portion of the specifications.

2.7 Incineration of Radioactively Contaminated Oil During plant operation, radioactively contaminated oils are generated from various pieces of equipment operating in the plant. The largest source of contaminated oil is the reactor coolant pump lubricating oil, which is periodically changed for preventive maintenance reasons. 10 CFR Part 20 allows licensees to incinerate radioactively contaminated oils on site provided that the total radioactive effluents from the facility conform to the requirements of 10 CFR Part 50, Appendix I.

Radioactively contaminated oil, which is designated for incineration, will be collected in containers, which are uniquely serialized such that the contents can be identified and tracked.

Each container will be sampled and analyzed for radioactivity. The isotopic concentrations will be recorded for each container.

The heating boiler will be utilized to incinerate the radioactively contaminated oil collected on site. A gaseous radwaste effluent dose calculation, as prescribed in Section 2.3 of the ODCM, will be performed to insure that the limits established by ODCM Specifications 3.4.1, 3.4.2 and 3.4.3 are not exceeded. Release of the activity is assumed to occur at the time the contaminated oil is transferred into the heating boiler fuel oil storage tank and will be accounted for using established plant procedures. This will be valid for an assumed release from the fuel oil storage tank vent, fill piping, or from the boiler exhaust stack. See Figure 3 for a description of the heating boiler fuel oil system.

2.8 Total Dose The purpose of this section is to describe the method used to calculate the cumulative dose contributions from liquid and gaseous effluents in accordance with KPS Technical Specifications for total dose. This method can also be used to demonstrate compliance with the Environmental Protection Agency (EPA) 40CFRI90, "Environmental Standards for the Uranium Fuel Cycle".

Compliance with the KPS Technical Specification dose objectives for the maximum individual demonstrates compliance with the EPA limits to any member of the public, since the design dose objectives from 10CFR50, Appendix I are much lower than the 40CFRI90 dose limits to the general public. With the calculated doses from the releases of radioactive materials in liquid or gaseous effluents exceeding twice the limits outlined in ODCM Specifications 3.3.2, 3.4.2, and 3.4.3, a special analysis shall be performed. The purpose of this analysis is to demonstrate if the total dose to any member of the public (real individual) from all uranium fuel cycle sources (including direct radiation contributions from the reactor unit, from outside storage areas and from all real pathways) is limited to less than or equal to 25 mrem per year to the total body or any organ, except the thyroid, which is limited to 75 mrem per year.

2-11 REV. 11 02/22/2007

If required, the total dose to a member of the public will be calculated for all significant effluent release points for all real pathways including direct radiation. Effluent releases from Point Beach Nuclear Plant must also be considered due to its proximity. Calculations will be based on the equations in Sections 1.4, 2.4.1, and 2.4.2, with the exception that usage factors and other site specific parameters may be modified using more realistic assumptions, where appropriate.

The direct radiation component from the facility can be determined using environmental TLD results. These results will be corrected for natural background and for actual occupancy time of any areas accessible to the general public at the location of maximum direct radiation. It is recognized that by including the results from the environmental TLDs into the sum of total dose corriponent, the direct radiation dose may be overestimated. The TLD measurements may include the exposure from noble gases, ground plane deposition, and shoreline deposition, which have already been included in the summation of the significant dose pathways to the general public. However, this conservative method can be used, if required, as well as any other method for estimating the direct radiation dose from contained radioactive sources within the facility.

The methodology used to incorporate the direct radiation component into total dose estimates will be outlined whenever total doses are reported.

Therefore, the total dose will be determined based on the most realistic site specific data and parameters to assess the real dose to any member of the public.

2-12 REV. 11 02/22/2007

Auxiliary Figure 2 Building Vent Gaseous Radioactive Effluent Flow Diagram To Atmosphere to Atmosphere To turbine R-13 R- 14 Containment Building Vent L Radiation Monitors Containment Purge System Auxiliary Building Fan Floors Auxiliary Building Mezzanine Auxiliary Building Basement Autolsolation p-11" Mini-Purge

,:Blower j

• The shield building v entilation andspecial ventilation are ESF systems and are not part of the Air [' Cylinder I \Sam pier/Monitor normal ef fluent processing system. They are included f or completeness only. Operated Operated p Prefilter Damperae Dampera d h HEPAFilter

• • Thecontainment air sampler (R-11) and radiation monitor (R-12)canalsobe alignedas needed DDpI SamplePoint c Charcoal Filter f orsamplingcontainmentv ent.

2-12 REV. 11 02/22/2007

Figure-3 Simplified Heating Boiler Fuel Oil Piping System

,rof Iehautstack I prnt wait 3'Yent ap sth flamreWroster  %\

3' fill unit

/3 fod &sample uuit fuel ail recite.

F----

. -. . -- 1 dl Valve Rack -

L - - - - - -

tHeafln{ Boi~ler Fýuel Oil, Storage ýTan k, hcatingbl X0000 Gallo'n- tue[ oil.PIUMps11 2-13 REV. 11 02/22/2007

Table 2.1 Dose Factors for Noble Gases Total Body Skin Dose Gamma Air Beta Air Dose Factor Factor Dose Factor Dose Factor IKi Li Mi Ni (mrem/yr (mrem/yr (mrad/yr (mrad/yr Radionuclide per gCi/m 3) per RCi/m 3 ) per itCi/m 3) per gCi/m 3)

Kr-83m 7.56E-02 1.93E+01 2.88E+02 Kr-85m 1.17E+03 1.46E+03 1.23E+03 1.97E+03 Kr-85 1.61E+01 1.34E+03 1.72E+01 1.95E+03 Kr-87 5.92E+03 9.73E+03 6.17E+03 1.03E+04 Kr-88 1.47E+04 2.37E+03 1.52E+04 2.93E+03 Kr-89 1.66E+04 1.01E+04 1.73E+04 1.06E+04 Kr-90 1.56E+04 7.29E+03 1.63E+04 7.83E+03 Xe- 131m 9.15E+01 4.76E+02 1.56E+02 1.11E+03 Xe-133m 2.51E+02 9.94E+02 3.27E+02 1.48E+03 Xe-133 2.94E+02 3.06E+02 3.53E+02 1.05E+03 Xe-135m 3.12E+03 7.11E+02 3.36E+03 7.39E+02 Xe-135 1.81E+03 1.86E+03 1.92E+03 2.46E+03 Xe- 137 1.42E+03 1.22E+04 1.51E+03 1.27E+04 Xe-138 8.83E+03 4.13E+03 9.21E+03 4.75E+03 Ar-41 8.84E+03 2.69E+03 9.30E+03 3.28E+03 2-14 REV. 11 02/22/2007

Table 2.2 Parameters for Gaseous Alarm Setpoint Determinations Parameter Actual Value Default Units Comments Value*

X/Q calculated 3.6E-06 sec/mr3 Licensing technical specification value Containment -normal plus purge VF fan curves 33,000 cfm modes 54,000 Auxiliary Building - normal operation Ci measured N/A liCi/m 3 Ki specific N/A mrei/yr er Values from Table 2.1 nuecifide N/tCi/m3 Li________

nuclide specific N/A mrem/yr

ýc/ per Values mremg~/yrye Values from from Table Table 2.1 2.1 Mi ~specific nuclide N/A ýtCi/m 3per VausfoTbl2.

mrem/yr Sensitivity**

(SEN) 2.32E+07 Containment R-12 2.32E+07 cpm per Containment R-21 as determined 2.32E+07 ýtCi/cm 3 Auxiliary Building R-13 2.32E+07 Auxiliary Building R-14 background (bkg)

R-12 4.OE+02 Nominal values only; actual R-21 R21 4.0E+01 as determined 6.OE+02 cpm values may be used in lieu of R-13 9.OE+02 these reference values.

R-14 9.0E+02 Setpoint* (SP) Default alarm setpoints; more R-12 calculated 2.2E+05 + bkg conservative values may be used R-21 calculated 2.2E+05 + bkg as deemed appropriate and R-13 calculated 1.3E+05 + bkg cpm desirable for ensuring regulatory R-14 calculated 1.3E+05 + bkg compliance and for maintaining releases ALARA.

• Refer to Calculation # C10690 for the default setpoint calculation.

• • Conservatively based on Xe-133 sensitivity 2-15 REV. 11 02/22/2007

Table 2.3 Controlling Locations, Pathways and Atmospheric Dispersion for Dose Calculations Atmospheric Dispersion ODCM Z/Q D/Q 3

Specification Location Pathway(s) (sec/m ) (1/M 2 )

3.4.1.a site boundary noble gases 3.6E-06 N/A (1300 m, N) direct exposure 3.4.1.b site boundary inhalation 3.6E-06 N/A (1300 m, N) 3.4.2 site boundary gamma-air 3.6E-06 N/A (1300 m, N) beta-air residence/dairy inhalation, 3.4.3 resile/W)y vegetation, milk and 5.6E-07 5.6E-09 (1 mile W) ground plane I 2-16 REV. 11 02/22/2007

Table 2.4 Ri Inhalation Pathway Dose Factors - ADULT (mrem/yr per RCi/m 3 )

Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body H-3 1.26E+3 1.26E+3 1.26E+3 1.26E+3 1.26E+3 1.26E+3 C-14 1.82E+4 3.41 E+3 3.41 E+3 3.41 E+3 3.41 E+3 3.41 E+3 3.41 E+3 Na-24 1.02E+4 1.02E+4 1.02E+4 1.02E+4 1.02E+4 1.02E+4 1.02E+4 P-32 1.32E+6 7.71 E+4 8.64E+4 5.01 E+4 Cr-51 5.95E+1 2.28E+1 1.44E+4 3.32E+3 1.OOE+2 Mn-54 3.96E+4 - 9.84E+3 1.40E+6 7.74E+4 6.30E+3 Mn-56 1.24E+0 - 1.30E+0 9.44E+3 2.02E+4 1.83E-1 Fe-55 2.46E+4 1.70E+4 - - 7.21 E+4 6.03E+3 3.94E+3 Fe-59 1.18E+4 2.78E+4 - - 1.02E+6 1.88E+5 1.06E+4 Co-57 6.92E+2 - - 3.70E+5 3.14E+4 6.71 E+2 Co-58 1.58E+3 - - 9.28E+5 1.06E+5 2.07E+3 Co-60 1.15E+4 - - 5.97E+6 2.85E+5 1.48E+4 Ni-63 4.32E+5 3.14E+4 - - 1.78E+5 1.34E+4 1.45E+4 Ni-65 1.54E+O 2.10E-1 - - 5.60E+3 1.23E+4 9.12E-2 Cu-64 1.46E+0 - 4.62E+0 6.78E+3 4.90E+4 6.15E-1 Zn-65 3.24E+4 1.03E+5 - 6.90E+4 8.64E+5 5.34E+4 4.66E+4 Zn-69 3.38E-2 6.51E-2 - 4.22E-2 9.20E+2 1.63E+1 4.52E-3 Br-82 - - 1.04E+4 1.35E+4 Br-83 - 2.32E+2 2.41 E+2 Br-84 - 1.64E-3 3.13E+2 Br-85 - 1.28E+1 Rb-86 - 1.35E+5 1.66E+4 5.90E+4 Rb-88 - 3.87E+2 3.34E-9 1.93E+2 Rb-89 - 2.56E+2 1.70E+2 Sr-89 3.04E+5 - 1.40E+6 3.50E+5 8.72E+3 Sr-90 9.92E+7 - - 9.60E+6 7.22E+5 6.1OE+6 Sr-91 6.19E+1 - - 3.65E+4 1.91 E+5 2.50E+0 Sr-92 6.74E+O - - 1.65E+4 4.30E+4 2.91 E-1 Y-90 2.09E+3 - - - 1.70E+5 5.06E+5 5.61 E+1 Y-91m 2.61E-1 - - - 1.92E+3 1.33E+O 1.02E-2 Y-91 4.62E+5 - - - 1.70E+6 3.85E+5 1.24E+4 Y-92 1.03E+1 - - - 1.57E+4 7.35E+4 3.02E-1 Y-93 9.44E+1 - - - 4.85E+4 4.22E+5 2.61 E+0 Zr-95 1.07E+5 3.44E+4 - 5.42E+4 1.77E+6 1.50E+5 2.33E+4 Zr-97 9.68E+1 1.96E+1 - 2.97E+1 7.87E+4 5.23E+5 9.04E+0 Nb-95 1.41 E+4 7.82E+3 - 7.74E+3 5.05E+5 1.04E+5 4.21 E+3 Nb-97 2.22E-1 5.62E-2 - 6.54E-2 2.40E+3 2.42E+2 2.05E-2 Mo-99 - 1.21 E+2 - 2.91E+2 9.12E+4 2.48E+5 2.30E+1 Tc-99m 1.03E-3 2.91E-3 - 4.42E-2 7.64E+2 4.16E+3 3.70E-2 Tc-101 4.18E-5 6.02E-5 - 1.08E-3 3.99E+2 5.90E-4 2-17 REV. 11 02/22/2007

Table 2.4 R1 Inhalation Pathway Dose Factors - ADULT (mrem/yr per pCi/m 3 )

Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body Ru-103 1.53E+3 5.83E+3 5.05E+5 1.10E+5 6.58E+2 Ru-105 7.90E-1 1.02E+O 1.10E+4 4.82E+4 3.11E-1 Ru-106 6.91E+4 1.34E+5 9.36E+6 9.12E+5 8.72E+3 Rh-103m Rh-106 Ag-110m 1.08E+4 1.OOE+4 1.97E+4 4.63E+6 3.02E+5 5.94E+3 Sb-124 3.12E+4 5.89E+2 7.55E+1 2.48E+6 4.06E+5 1.24E+4 Sb-125 5.34E+4 5.95E+2 5.40E+1 1.74E+6 1.01 E+5 1.26E+4 Te-125m 3.42E+3 1.58E+3 1.05E+3 1.24E+4 3.14E+5 7.06E+4 4.67E+2 Te-127m 1.26E+4 5.77E+3 3.29E+3 4.58E+4 9.60E+5 1.50E+5 1.57E+3 Te-127 1.40E+O 6.42E-1 1.06E+O 5.1OE+O 6.51E+3 5.74E+4 3.1OE-1 Te-129m 9.76E+3 4.67E+3 3.44E+3 3.66E+4 1.16E+6 3.83E+5 1.58E+3 Te-129 4.98E-2 2.39E-2 3.90E-2 1.87E-1 1.94E+3 1.57E+2 1.24E-2 Te-131m 6.99E+1 4.36E+1 5.50E+1 3.09E+2 1.46E+5 5.56E+5 2.90E+1 Te-131 1.11E-2 5.95E-3 9.36E-3 4.37E-2 1.39E+3 1.84E+1 3.59E-3 Te-132 2.60E+2 2.15E+2 1.90E+2 1.46E+3 2.88E+5 5.1OE+5 1.62E+2 1-130 4.58E+3 1.34E+4 1.14E+6 2.09E+4 7.69E+3 5.28E+3 1-131 2.52E+4 3.58E+4 1.19E+7 6.13E+4 6.28E+3 2.05E+4 1-132 1.16E+3 3.26E+3 1.14E+5 5.18E+3 4.06E+2 1.16E+3 1-133 8.64E+3 1.48E+4 2.15E+6 2.58E+4 8.88E+3 4.52E+3 1-134 6.44E+2 1.73E+3 2.98E+4 2.75E+3 1.01 E+O 6.15E+2 1-135 2.68E+3 6.98E+3 4.48E+5 1.11E+4 5.25E+3 2.57E+3 Cs-134 3.73E+5 8.48E+5 2.87E+5 9.76E+4 1.04E+4 7.28E+5 Cs-136 3.90E+4 1.46E+5 8.56E+4 1.20E+4 1.17E+4 1.10E+5 Cs-137 4.78E+5 6.21 E+5 2.22E+5 7.52E+4 8.40E+3 4.28E+5 Cs-138 3.31E+2 6.21E+2 4.80E+2 4,86E+1 1.86E-3 3.24E+2 Ba-139 9.36E-1 6.66E-4 6.22E-4 3.76E+3 8.96E+2 2.74E-2 Ba-140 3.90E+4 4.90E+1 1.67E+1 1.27E+6 2.18E+5 2.57E+3 Ba-141 1.OOE-1 7.53E-5 7.OOE-5 1.94E+3 1.16E-7 3.36E-3 Ba-142 2.63E-2 2.70E-5 2.29E-5 1.19E+3 1.66E-3 La-140 3.44E+2 1.74E+2 1.36E+5 4.58E+5 4.58E+1 La-142 6.83E-1 3.1OE-1 6.33E+3 2.11E+3 7.72E-2 Ce-141 1.99E+4 1.35E+4 - 6.26E+3 3.62E+5 1.20E+5 1.53E+3 Ce-143 1.86E+2 1.38E+2 - 6.08E+1 7.98E+4 2.26E+5 1.53E+1 Ce-144 3.43E+6 1.43E+6 - 8.48E+5 7.78E+6 8.16E+5 1.84E+5 Pr-143 9.36E+3 3.75E+3 - 2.16E+3 2.81E+5 2.OOE+5 4.64E+2 Pr-144 3.01E-2 1.25E-2 - 7.05E-3 1.02E+3 2.15E-8 1.53E-3 Nd-147 5.27E+3 6.1OE+3 - 3.56E+3 2.21E+5 1.73E+5 3.65E+2 W-187 8.48E+O 7.08E+O - 2.90E+4 1.55E+5 2.48E+0 Np-239 2.30E+2 2.26E+1 - 7.OOE+1 3.76E+4 1.19E+5 1.24E+1 2-18 REV. 11 02/22/2007

Table 2.5 Ri Inhalation Pathway Dose Factors - TEEN (mrem/yr per RCi/m 3 )

Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body H-3 1.27E+3 1.27E+3 1.27E+3 1.27E+3 1.27E+3 1.27E+3 C-14 2.60E+4 4.87E+3 4.87E+3 4.87E+3 4.87E+3 4.87E+3 4.87E+3 Na-24 1.38E+4 1.38E+4 1.38E+4 1.38E+4 1.38E+4 1.38E+4 1.38E+4 P-32 1.89E+6 1.10E+5 9.28E+4 7.16E+4 Cr-51 7.50E+1 3.07E+1 2.1OE+4 3.OOE+3 1.35E+2 Mn-54 5.11E+4 - 1.27E+4 1.98E+6 6.68E+4 8.40E+3 Mn-56 1.70E+O - 1.79E+O 1.52E+4 5.74E+4 2.52E-1 Fe-55 3.34E+4 2.38E+4 - - 1.24E+/-5 6.39E+3 5.54E+3 Fe-59 1.59E+4 3.70E+4 - - 1.53E+6 1.78E+5 1.43E+4 Co-57 6.92E+2 - 5.86E+5 3.14E+4 9.20E+2 Co-58 2.07E+3 - 1.34E+6 9.52E+4 2.78E+3 Co-60 1.51 E+4 - 8.72E+6 2.59E+5 1.98E+4 Ni-63 5.80E+5 4.34E+4 - 3.07E+5 1.42E+4 1.98E+4 Ni-65 2.18E+O 2.93E-1 - 9.36E+3 3.67E+4 1.27E-1 Cu-64 - 2.03E+O 6.41 E+O 1.11E+4 6.14E+4 8.48E-1 Zn-65 3.86E+4 1.34E+5 8.64E+4 1.24E+6 4.66E+4 6.24E+4 Zn-69 4.83E-2 9.20E-2 6.02E-2 1.58E+3 2.85E+2 6.46E-3 Br-82 - - - 1.82E+4 Br-83 - -- 3.44E+2 Br-84 - -- 4.33E+2 Br-85 - - - 1.83E+1 Rb-86 - 1.90E+5 - 1.77E+4 8.40E+4 Rb-88 - 5.46E+2 - 2.92E-5 2.72E+2 Rb-89 - 3.52E+2 - 3.38E-7 2.33E+2 Sr-89 4.34E+5 - 2.42E+6 3.71 E+5 1.25E+4 Sr-90 1.08E+8 - - - 1.65E+7 7.65E+5 6.68E+6 Sr-91 8.80E+1 - - - 6.07E+4 2.59E+5 3.51 E+O Sr-92 9.52E+O - - - 2.74E+4 1.19E+5 4.06E-1 Y-90 2.98E+3 - - - 2.93E+5 5.59E+5 8.OOE+1 Y-91 m 3.70E-1 -- 3.20E+3 3.02E+1 1.42E-2 Y-91 6.61 E+5 - - 2.94E+6 4.09E+5 1.77E+4 Y-92 1.47E+1 - - 2.68E+4 1.65E+5 4.29E-1 Y-93 1.35E+2 - - 8.32E+4 5.79E4-5 3.72E+O Zr-95 1.46E+5 4.58E+4 - 6.74E+4 2.69E+6 1.49E+5 3.15E+4 Zr-97 1.38E+2 2.72E+1 - 4.12E+1 1.30E+5 6.30E+5 1.26E+1 Nb-95 1.86E+4 1.03E+4 - 1.OOE+4 7.51 E+5 9.68E+4 5.66E+3 Nb-97 3.14E-1 7.78E-2 - 9.12E-2 3.93E+3 2.17E+3 2.84E-2 Mo-99 1.69E+2 - 4.11E+2 1.54E+5 2.69E+5 3.22E+1 Tc-99m 1.38E-3 3.86E-3 - 5.76E-2 1.1 5E+3 6.13E+3 4.99E-2 Tc-101 5.92E-5 8.40E-5 - 1.52E-3 6.67E+2 8.72E-7 8.24E-4 2-19 REV. 11 02/22/2007

Table 2.5 Ri Inhalation Pathway Dose Factors - TEEN (mrem/yr per gCi/m 3 )

Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body Ru-103 2.10E+3 7.43E+3 7.83E+5 1.09E+5 8.96E+2 Ru-105 1.12E+0 1.41 E+0 1.82E+4 9.04E+4 4.34E-1 Ru-106 9.84E+4 1.90E+5 1.61 E+7 9.60E+5 1.24E+4 Rh-103m Rh-106 Ag-11im 1.38E+4 1.31 E+4 2.50E+4 6.75E+6 2.73E+5 7.99E+3 Sb-124 4.30E+4 7.94E+2 9.76E+i1 3.85E+6 3.98E+5 1.68E+4 Sb-125 7.38E+4 8.08E+2 7.04E+i1 2.74E+6 9.92E+4 1.72E+4 Te-125m 4.88E+3 2.24E+3 1.40E+3 5.36E+5 7.50E+4 6.67E+2 Te-127m 1.80E+4 8.16E+3 4.38E+3 6.54E+4 1.66E+6 1.59E+5 2.18E+3 Te-127 2.01E+0 9.12E-1 1.42E+0 7.28E+0 1.12E+4 8.08E+4 4.42E-1 Te-129m 1.39E+4 6.58E+3 4.58E+3 5.19E+4 1.98E+6 4.05E+5 2.25E+3 Te-129 7.1OE-2 3.38E-2 5.18E-2 2.66E-1 3.30E+3 1.62E+3 1.76E-2 Te-131m 9.84E+1 6.01E+I 7.25E+1 4.39E+2 2.38E+5 6.21E+5 4.02E+1 Te-131 1.58E-2 8.32E-3 1.24E-2 6.18E-2 2.34E+3 1.51 E+I 5.04E-3 Te-132 3.60E+2 2.90E+2 2.46E+2 1.95E+3 4.49E+5 4.63E+5 2.19E+2 1-130 6.24E+3 1.79E+4 1.49E+6 2.75E+4 - 9.12E+3 7.17E+3 1-131 3.54E+4 4.91E+4 1.46E+7 8.40E+4 - 6.49E+3 2.64E+4 1-132 1.59E+3 4.38E+3 1.51 E+5 6.92E+3 - 1.27E+3 1.58E+3 1-133 1.22E+4 2.05E+4 2.92E+6 3.59E+4 - 1.03E+4 6.22E+3 1-134 8.88E+2 2.32E+3 3.95E+4 3.66E+3 - 2.04E+1 8.40E+2 1-135 3.70E+3 9.44E+3 6.21E+5 1.49E+4 - 6.95E+3 3.49E+3 Cs-134 5.02E+5 1.13E+6 3.75E+5 1.46E+5 9.76E+3 5.49E+5 Cs-136 5.15E+4 1.94E+5 1.10E+5 1.78E+4 1.09E+4 1.37E+5 Cs-137 6.70E+5 8.48E+5 3.04E+5 1.21 E+5 8.48E+3 3.11E+5 Cs-138 4.66E+2 8.56E+2 - 6.62E+2 7.87E+1 2.70E-1 4.46E+2 Ba-139 1.34E+0 9.44E-4 - 8.88E-4 6.46E+3 6.45E+3 3.90E-2 Ba-140 5.47E+4 6.70E+1 - 2.28E+1 2.03E+6 2.29E+5 3.52E+3 Ba-141 1.42E-1 1.06E-4 - 9.84E-5 329E+3 7.46E-4 4.74E-3 Ba-142 3.70E-2 3.70E-5 - 3.14E-5 1.91 E+3 2.27E-3 La-140 4.79E+2 2.36E+2 - 2.14E+5 4.87E+5 6.26E+1 La-142 9.60E-1 4.25E-1 - 1.02E+4 1.20E+4 1.06E-1 Ce-141 2.84E+4 1.90E+4 - 8.88E+3 6.14E+5 1.26E+5 2.17E+3 Ce-143 2.66E+2 1.94E+2 - 8.64E+1 1.30E+5 2.55E+5 2.16E+1 Ce-144 4.89E+6 2.02E+6 - 1.21 E+6 1.34E+7 8.64E+5 2.62E+5 Pr-143 1.34E+4 5.31 E+3 - 3.09E+3 4.83E+5 2.14E+5 6.62E+2 Pr-144 4.30E-2 1.76E-2 - 1.01 E-2 1.75E+3 2.35E-4 2.18E-3 Nd-147 7.86E+3 8.56E+3 - 5.02E+3 3.72E+5 1.82E+5 5.13E+2 W-187 1.20E+1 9.76E+0 - 4.74E+4 1.77E+5 3.43E+0 Np-239 3.38E+2 3.19E+1 - 1.OOE+2 6.49E+4 1.32E+5 1.77E+1 2-20 REV. 11 02/22/2007

Table 2.6 Ri Inhalation Pathway Dose Factors - CHILD (mrem/yr per gCi/m 3 )

Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body H-3 1.12E+3 1.12E+3 1.12E+3 1.12E+3 1.12E+3 1.12E+3 C-14 3.59E+4 6.73E+3 6.73E+3 6.73E+3 6.73E+3 6.73E+3 6.73E+3 Na-24 1.61 E+4 1.61 E+4 1.61 E+4 1.61 E+4 1.61 E+4 1.61 E+4 1.61 E+4 P-32 2.60E+6 1.14E+5 4.22E+4 9.88E+4 Cr-51 8.55E+1 2.43E+1 1.70E+4 1.08E+3 1.54E+2 Mn-54 4.29E+4 1.00E+4 1.58E+6 2.29E+4 9.51E+3 Mn-56 1.66E+O - 1.67E+O 1.31E+4 1.23E+5 3.12E-1 Fe-55 4.74E+4 2.52E+4 - - 1.11E+5 2.87E+3 7.77E+3 Fe-59 2.07E+4 3.34E+4 - - 1.27E+6 7.07E+4 1.67E+4 Co-57 9.03E+2 - - 5.07E+5 1.32E+4 1.07E+3 Co-58 1.77E+3 - - 1.11E+6 3.44E+4 3.16E+3 Co-60 1.31 E+4 - - 7.07E+6 9.62E+4 2.26E+4 Ni-63 8.21 E+5 4.63E+4 - - 2.75E+5 6.33E+3 2.80E+4 Ni-65 2.99E+O 2.96E-1 - - 8.18E+3 8.40E+4 1.64E-1 Cu-64 1.99E+O - 6.03E+O 9.58E+3 3.67E+4 1.07E+O Zn-65 4.26E+4 1.13E+5 - 7.14E+4 9.95E+5 1.63E+4 7.03E+4 Zn-69 6.70E-2 9.66E-2 - 5.85E-2 1.42E+3 1.02E+4 8.92E-3 Br-82 - 2.09E+4 Br-83 - 4.74E+2 Br-84 -- - - 5.48E+2 Br-85 - - - - 2.53E+1 Rb-86 - 1.98E+5 - - - 7.99E+3 1.14E+5 Rb-88 - 5.62E+2 - - - 1.72E+1 3.66E+2 Rb-89 - 3.45E+2 - - - 1.89E+O 2.90E+2 Sr-89 5.99E+5 - - 2.16E+6 1.67E+5 1.72E+4 Sr-90 1.01 E+8 - - 1.48E+7 3.43E+5 6.44E+6 Sr-91 1.21 E+2 - - - 5.33E+4 1.74E+5 4.59E+O Sr-92 1.31 E+1 - - - 2.40E+4 2.42E+5 5.25E-1 Y-90 4.11E+3 - - - 2.62E+5 2.68E+5 1.11E+2 Y-91m 5.07E-1 - - - 2.81E+3 1.72E+3 1.84E-2 Y-91 9.14E+5 - - - 2.63E+6 1.84E+5 2.44E+4 Y-92 2.04E+1 - - - 2.39E+4 2.39E+5 5.81 E-1 Y-93 1.86E+2 - - - 7.44E+4 3.89E+5 5.11E+O Zr-95 1.90E+5 4.18E+4 - 5.96E+4 2.23E+6 6.11E+4 3.70E+4 Zr-97 1.88E+2 2.72E+1 - 3.89E+1 1.13E+5 3.51E+5 1.60E+1 Nb-95 2.35E+4 9.18E+3 - 8.62E+3 6.14E+5 3.70E+4 6.55E+3 Nb-97 4.29E-1 7.70E-2 - 8.55E-2 3.42E+3 2.78E+4 3.60E-2 Mo-99 1.72E+2 - 3.92E+2 1.35E+5 1.27E+5 4.26E+1 Tc-99m 1.78E-3 3.48E-3 - 5.07E-2 9.51E+2 4.81E+3 5.77E-2 Tc-101 8.1OE-5 8.51E-5 - 1.45E-3 5.85E+2 1.63E+1 1.08E-3 2-21 REV. 11 02/22/2007

Table 2.6 Ri Inhalation Pathway Dose Factors - CHILD (mrem/yr per gCi/m 3)

Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body Ru-103 2.79E+3 7.03E+3 6.62E+5 4.48E+4 1.07E+3 Ru-105 1.53E+O 1.34E+O 1.59E+4 9.95E+4 5.55E-1 Ru-106 1.36E+5 1.84E+5 1.43E+7 4.29E+5 1.69E+4 Rh-103m Rh-106 Ag-11Om 1.69E+4 1.14E+4 2.12E+4 5.48E+6 1.OOE+5 9.14E+3 Sb-124 5.74E+4 7.40E+2 1.26E+2 3.24E+6 1.64E+5 2.OOE+4 Sb-125 9.84E+4 7.59E+2 9.10E+1 2.32E+6 4.03E+4 2.07E+4 Te-125m 6.73E+3 2.33E+3 1.92E+3 4.77E+5 3.38E+4 9.14E+2 Te-127m 2.49E+4 8.55E+3 6.07E+3 6.36E+4 1.48E+6 7.14E+4 3.02E+3 Te-127 2.77E+O 9.51E-1 1.96E+O 7.07E+O 1.OOE+4 5.62E+4 6.11E-1 Te-129m 1.92E+4 6.85E+3 6.33E+3 5.03E+4 1.76E+6 1.82E+5 3.04E+3 Te-129 9.77E-2 3.50E-2 7.14E-2 2.57E-1 2.93E+3 2.55E+4 2.38E-2 Te-131m 1.34E+2 5.92E+1 9.77E+1 4.OOE+2 2.06E+5 3.08E+5 5.07E+1 Te-131 2.17E-2 8.44E-3 1.70E-2 5.88E-2 2.05E+3 1.33E+3 6.59E-3 Te-132 4.81E+2 2.72E+2 3.17E+2 1.77E+3 3.77E+5 1.38E+5 2.63E+2 1-130 8.18E+3 1.64E+4 1.85E+6 2.45E+4 - 5.11E+3 8.44E+3 1-131 4.81 E+4 4.81 E+4 1.62E+7 7.88E+4 - 2.84E+3 2.73E+4 1-132 2.12E+3 4.07E+3 1.94E+5 6.25E+3 - 3.20E+3 1.88E+3 1-133 1.66E+4 2.03E+4 3.85E+6 3.38E+4 - 5.48E+3 7.70E+3 1-134 1.17E+3 2.16E+3 5.07E+4 3.30E+3 - 9.55E+2 9.95E+2 1-135 4.92E+3 8.73E+3 7.92E+5 1.34E+4 - 4.44E+3 4.14E+3 Cs-134 6.51E+5 1.01 E+6 - 3.30E+5 1.21 E+5 3.85E+3 2.25E+5 Cs-136 6.51E+4 1.71E+5 - 9.55E+4 1.45E+4 4.18E+3 1.16E+5 Cs-137 9.07E+5 8.25E+5 - 2.82E+5 1.04E+5 3.62E+3 1.28E+5 Cs-138 6.33E+2 8.40E+2 - 6.22E+2 6.81E+1 2.70E+2 5.55E+2 Ba-139 1.84E+O 9.84E-4 - 8.62E-4 5.77E+3 5.77E+4 5.37E-2 Ba-140 7.40E+4 6.48E+1 - 2.11E+1 1.74E+6 1.02E+5 4.33E+3 Ba-141 1.96E-1 1.09E-4 - 9.47E-5 2.92E+3 2.75E+2 6.36E-3 Ba-142 5.OOE-2 3.60E-5 - 2.91 E-5 1.64E+3 2.74E+O 2.79E-3 La-140 6.44E+2 2.25E+2 - 1.83E+5 2.26E+5 7.55E+1 La-142 1.30E+O 4.11E-1 - 8.70E+3 7.59E+4 1.29E-1 Ce-141 3.92E+4 1.95E+4 - 8.55E+3 5.44E+5 5.66E+4 2.90E+3 Ce-143 3.66E+2 1.99E+2 - 8.36E+1 1.15E+5 1.27E+5 2.87E+1 Ce-144 6.77E+6 2.12E+6 - 1.17E+6 1.20E+7 3.89E+5 3.61E+5 Pr-143 1.85E+4 5.55E+3 - 3.OOE+3 4.33E+5 9.73E+4 9.14E+2 Pr-144 5.96E-2 1.85E-2 - 9.77E-3 1.57E+3 1.97E+2 3.OOE-3 Nd-147 1.08E+4 8.73E+3 - 4.81E+3 3.28E+5 8.21E+4 6.81E+2 W-187 1.63E+1 9.66E+O - 4.11E+4 9.10E+4 4.33E+0 Np-239 4.66E+2 3.34E+1 - 9.73E+1 5.81 E+4 6.40E+4 2.35E+1 2-22 REV. 11 02/22/2007

Table 2.7 R, Inhalation Pathway Dose Factors - INFANT (mrem/yr per RCi/m 3 )

Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body H-3 - 6.47E+2 6.47E+2 .6.47E+2 6.47E+2 6.47E+2 6.47E+2 C-14 2.65E+4 5.31E+3 5.31E+3 5.31E+3 5.31E+3 5.31E+3 5.31E+3 Na-24 1.06E+4 1.06E+4 1.06E+4 1.06E+4 1.06E+4 1.06E+4 1.06E+4 P-32 2.03E+6 1.12E+5 1.61 E+4 7.74E+4 Cr-51 5.75E+1 1.32E+1 1.28E+4 3.57E+2 8.95E+1 Mn-54 2.53E+4 - 4.98E+3 1.OOE+6 7.06E+3 4.98E+3 Mn-56 1.54E+O - 1.10E+O 1.25E+4 7.17E+4 2.21E-1 Fe-55 1.97E+4 1.17E+4 - 8.69E+4 1.09E+3 3.33E+3 Fe-59 1.36E+4 2.35E+4 - 1.02E+6 2.48E+4 9.48E+3 Co-57 6.51 E+2 - 3.79E+5 4.86E+3 6.41 E+2 0o-58 1.22E+3 - 7.77E+5 1.11E+4 1.82E+3 Co-60 8.02E+3 - 4.51E+6 3.19E+4 1.18E+4 Ni-63 3.39E+5 2.04E+4 - 2.09E+5 2.42E+3 1.16E+4 Ni-65 2.39E+O 2.84E-1 8.12E+3 5.01 E+4 1.23E-1 Cu-64 1.88E+O 3.98E+O 9.30E+3 1.50E+4 7.74E-1 Zn-65 1.93E+4 6.26E+4 3.25E+4 6.47E+5 5.14E+4 3.11E+4 Zn-69 5.39E-2 9.67E-2 4.02E-2 1.47E+3 1.32E+4 7.18E-3 1r-82 - - - - 1.33E+4 Br-83 - - - - - 3.81 E+2 1r-84 - - - - - 4.OOE+2 Br-85 - - - - - 2.04E+1 Rb-86 - 1.90E+5 - - 3.04E+3 8.82E+4 Rb-88 - 5.57E+2 - - 3.39E+2 2.87E+2 Rb-89 - 3.21 E+2 - - 6.82E+1 2.06E+2 Sr-89 3.98E+5 - - - 2.03E+6 6.40E+4 1.14E+4 Sr-90 4.09E+7 - - - 1.12E+7 1.31 E+5 2.59E+6 Sr-91 9.56E+1 - - - 5.26E+4 7.34E+4 3.46E+O Sr-92 1.05E+1 - - - 2.38E+4 1.40E+5 3.91 E-1 Y-90 3.29E+3 - - - 2.69E+5 1.04E+5 8.82E+1 Y-91 m 4.07E-1 - - - 2.79E+3 2.35E+3 1.39E-2 Y-91 5.88E+5 - - - 2.45E+6 7.03E+4 1.57E+4 Y-92 1.64E+1 - - - 2.45E+4 1.27E+5 4.61 E-1 Y-93 1.50E+2 - - - 7.64E+4 1.67E+5 4.07E+O Zr-95 1.15E+5 2.79E+4 - 3.11E+4 1.75E+6 2.17E+4 2.03E+4 Zr-97 1.50E+2 2.56E+1 - 2.59E+1 1.10E+5 1.40E+5 1.17E+1 Nb-95 1.57E+4 6.43E+3 - 4.72E+3 4.79E+5 1.27E+4 3.78E+3 Nb-97 3.42E-1 7.29E-2 - 5.70E-2 3.32E+3 2.69E+4 2.63E-2 Mo-99 1.65E+2 - 2.65E+2 1.35E+5 4.87E+4 3.23E+1 Tc-99m 1.40E-3 2.88E-3 - 3.11E-2 8.11E+2 2.03E+3 3.72E-2 Tc-101 6.51E-5 8.23E-5 - 9.79E-4 5.84E+2 8.44E+2 8.12E-4 2-23 REV. 11 02/22/2007

Table 2.7 Ri Inhalation Pathway Dose Factors - INFANT (mrem/yr per RCi/m 3 )

Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body Ru-103 2.02E+3 4.24E+3 5.52E+5 1.61 E+4 6.79E+2 Ru-105 1.22E+O 8.99E-1 1.57E+4 4.84E+4 4.1OE-1 Ru-106 8.68E+4 1.07E+5 1.16E+7 1.64E+5 1.09E+4 Rh-103m Rh-106 Ag-110m 9.98E+3 7.22E+3 1.09E+4 3.67E+6 3.30E+4 5.OOE+3 Sb-124 3.79E+4 5.56E+2 1.01 E+2 2.65E+6 5.91E+4 1.20E+4 Sb-125 5.17E+4 4.77E+2 6.23E+1 1.64E+6 1.47E+4 1.09E+4 Te-125m 4.76E+3 1.99E+3 1.62E+3 4.47E+5 1.29E+4 6.58E+2 Te-127m 1.67E+4 6.90E+3 4.87E+3 3.75E+4 1.31 E+6 2.73E+4 2.07E+3 Te-127 2.23E+O 9.53E-1 1.85E+O 4.86E+O 1.03E+4 2.44E+4 4.89E-1 Te-129m 1.41 E+4 6.09E+3 5.47E+3 3.18E+4 1.68E+6 6.90E+4 2.23E+3 Te-129 7.88E-2 3.47E-2 6.75E-2 1.75E-1 3.OOE+3 2.63E+4 1.88E-2 Te-131m 1.07E+2 5.50E+1 8.93E+1 2.65E+2 1.99E+5 1.19E+5 3.63E+1 Te-131 1.74E-2 8.22E-3 1.58E-2 3.99E-2 2.06E+3 8.22E+3 5.OOE-3 Te-132 3.72E+2 2.37E+2 2.79E+2 1.03E+3 3.40E+5 4.41 E+4 1.76E+2 1-130 6.36E+3 1.39E+4 1.60E+6 1.53E+4 - 1.99E+3 5.57E+3 1-131 3.79E+4 4.44E+4 1.48E+7 5.18E+4 - 1.06E+3 1.96E+4 1-132 1.69E+3 3.54E+3 1.69E+5 3.95E+3 - 1.90E+3 1.26E+3 1-133 1.32E+4 1.92E+4 3.56E+6 2.24E+4 - 2.16E+3 5.60E+3 1-134 9.21E+2 1.88E+3 4.45E+4 2.09E+3 - 1.29E+3 6.65E+2 1-135 3.86E+3 7.60E+3 6.96E+5 8.47E+3 - 1.83E+3 2.77E+3 Cs-134 3.96E+5 7.03E+5 1.90E+5 7.97E+4 1.33E+3 7.45E+4 Cs-136 4.83E+4 1.35E+5 5.64E+4 1.18E+4 1.43E+3 5.29E+4 Cs-137 5.49E+5 6.12E+5 - 1.72E+5 7.13E+4 1.33E+3 4.55E+4 Cs-138 5.05E+2 7.81E+2 - 4.1OE+2 6.54E+1 8.76E+2 3.98E+2 Ba-139 1.48E+O 9.84E-4 - 5.92E-4 5.95E+3 5.10E+4 4.30E-2 Ba-140 5.60E+4 5.60E+1 - 1.34E+1 1.60E+6 3.84E+4 2.90E+3 Ba-141 1.57E-1 1.08E-4 - 6.50E-5 2.97E+3 4.75E+3 4.97E-3 Ba-142 3.98E-2 3.30E-5 - 1.90E-5 1.55E+3 6.93E+2 1.96E-3 La-140 5.05E+2 2.OOE+2 - 1.68E+5 8.48E+4 5.15E+1 La-142 1.03E+O 3.77E-1 - 8.22E+3 5.95E+4 9.04E-2 Ce-141 2.77E+4 1.67E+4 - 5.25E+3 5.17E+5 2.16E+4 1.99E+3 Ce-143 2.93E+2 1.93E+2 - 5.64E+1 1.1 6E+5 4.97E+4 2.21E+1 Ce-144 3.19E+6 1.21 E+6 - 5.38E+5 9.84E+6 1.48E+5 1.76E+5 Pr-143 1.40E+4 5.24E+3 - 1.97E+3 4.33E+5 3.72E+4 6.99E+2 Pr-144 4.79E-2 1.85E-2 - 6.72E-3 1.61 E+3 4.28E+3 2.41E-3 Nd-147 7.94E+3 8.13E+3 - 3.15E+3 3.22E+5 3.12E+4 5.OOE+2 W-187 1.30E+1 9.02E+O - 3.96E+4 3.56E+4 3.12E+0 Np-239 3.71E+2 3.32E+1 - 6.62E+1 5.95E+4 2.49E+4 1.88E+1 2-24 REV. 11 02/22/2007

Table 2.8 R, Vegetation Pathway Dose Factors - ADULT (mrem/yr per gCi/m 3 ) for H-3 and C-14 (m 2 x mrem/yr pCi/sec) for others Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body H-3 2.26E+3 2.26E+3 2.26E+3 2.26E+3 2.26E+3 2.26E+3 C-14 8.97E+5 1.79E+5 1.79E+5 1.79E+5 1.79E+5 1.79E+5 1.79E+5 Na-24 2.76E+5 2.76E+5 2.76E+5 2.76E+5 2.76E+5 2.76E+5 2.76E+5 P-32 1.40E+9 8.73E+7 1.58E+8 5.42E+7 Cr-51 2.79E+4 1.03E+4 6.19E+4 1.17E+7 4.66E+4 Mn-54 3.11E+8 9.27E+7 9.54E+8 5.94E+7 Mn-56 1.61 E+1 2.04E+1 5.13E+2 2.85E+O Fe-55 2.09E+8 1.45E+8 8.06E+7 8.29E+7 3.37E+7 Fe-59 1.27E+8 2.99E+8 - 8.35E+7 9.96E+8 1.14E+8 Co-57 1.17E+7 - - 2.97E+8 1.95E+7 Co-58 3.09E+7 - - 6.26E+8 6.92E+7 Co-60 1.67E+8 - - 3.14E+9 3.69E+8 Ni-63 1.04E+10 7.21E+8 - - 1.50E+8 3.49E+8 Ni-65 6.15E+1 7.99E+O - - 2.03E+2 3.65E+O Cu-64 9.27E+3 - 2.34E+4 - 7.90E+5 4.35E+3 Zn-65 3.17E+8 1.01 E+9 - 6.75E+8 - 6.36E+8 4.56E+8 Zn-69 8.75E-6 1,67E-5 - 1.09E-5 - 2.51E-6 1.1 6E-6 Br-82 - 1.73E+6 1.51 E+6 Br-83 - - 4.63E+O 3.21 E+O Br-84 -

Br-85 -

Rb-86 - 2.19E+8 4.32E+7 1.02E+8 Rb-88 -

Rb-89 -

Sr-89 9.96E+9 - 1.60E+9 2.86E+8 Sr-90 6.05E+11 - 1.75E+10 1.48E+11 Sr-91 3.20E+5 - 1.52E+6 1.29E+4 Sr-92 4.27E+2 - - - 8.46E+3 1.85E+1 Y-90 1.33E+4 - - - 1.41 E+8 3.56E+2 Y-91m 5.83E-9 - - - - 1.71 E-8 Y-91 5.13E+6 - - - - 2.82E+9 1.37E+5 Y-92 9.01E-1 - - - - 1.58E+4 2.63E-2 Y-93 1.74E+2 - - - - 5.52E+6 4.80E+O Zr-95 1.19E+6 3.81E+5 - 5.97E+5 - 1.21 E+9 2.58E+5 Zr-97 3.33E+2 6.73E+1 - 1.02E+2 - 2.08E+7 3.08E+1 Nb-95 1.42E+5 7.91 E+4 - 7.81 E+4 - 4.80E+8 4.25E+4 Nb-97 2.90E-6 7.34E-7 - 8.56E-7 - 2.71 E-3 2.68E-7 Mo-99 - 6.25E+6 - 1.41 E+7 - 1.45E+7 1.19E+6 Tc-99m 3.06E+O 8.66E+O - 1.32E+2 4.24E+O 5.12E+3 1.10E+2 Tc-101 -

2-25 REV. 11 02/22/2007

Table 2.8 Ri Vegetation Pathway Dose Factors - ADULT (mrem/yr per gCi/m 3 ) for H-3 and C-14 (M 2 x mrem/yr gCi/sec) for others Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body Ru-103 4.80E+6 1.83E+7 5.61 E+8 2.07E+6 Ru-105 5.39E+1 6.96E+2 3.30E+4 2.13E+1 Ru-106 1.93E+8 3.72E+8 1.25E+1 0 2.44E+7 Rh-103m Rh-106 -

Ag-11im 1.06E+7 9.76E+6 1.92E+7 3.98E+9 5.80E+6 Sb-124 1.04E+8 1.96E+6 2.52E+5 8.08E+7 2.95E+9 4.11E+7 Sb-125 1.36E+8 1.52E+6 1.39E+5 1.05E+8 1.50E+9 3.25E+7 Te-125m 9.66E+7 3.50E+7 2.90E+7 3.93E+8 3.86E+8 1.29E+7 Te-127m 3.49E+8 1.25E+8 8.92E+7 1.42E+9 - 1.17E+9 4.26E+7 Te-127 5.76E+3 2.07E+3 4.27E+3 2.35E+4 - 4.54E+5 1.25E+3 Te-129m 2.55E+8 9.50E+7 8.75E+7 1.06E+9 - 1.28E+9 4.03E+7 Te-129 6.65E-4 2.50E-4 5.1OE-4 2.79E-3 - 5.02E-4 1.62E-4 Te-131m 9.12E+5 4.46E+5 7.06E+5 4.52E+6 - 4.43E+7 3.72E+5 Te-131 Te-132 4.29E+6 2.77E+6 3.06E+6 2.67E+7 - 1.31 E+8 2.60E+6 1-130 3.96E+5 1.17E+6 9.90E+7 1.82E+6 - 1.01 E+6 4.61E+5 1-131 8.09E+7 1.16E+8 3.79E+10 1.98E+8 - 3.05E+7 6.63E+7 1-132 5.74E+1 1.54E+2 5.38E+3 2.45E+2 - 2.89E+1 5.38E+1 1-133 2.12E+6 3.69E+6 5.42E+8 6.44E+6 - 3.31E+6 1.12E+6 1-134 1.06E-4 2.88E-4 5.OOE-3 4.59E-4 - 2.51E-7 1.03E-4 1-135 4.08E+4 1.07E+5 7.04E+6 1.71 E+5 - 1.21 E+5 3.94E+4 Cs-134 4.66E+9 1.11E+10 3.59E+9 1.19E+9 1.94E+8 9.07E+9 Cs-136 4.20E+7 1.66E+8 9.24E+7 1.27E+7 1.89E+7 1.19E+8 Cs-137 6.36E+9 8.70E+9 2.95E+9 9.81E+8 1.68E+8 5.70E+9 Cs-138 -

Ba-139 2.95E-2 2.1OE-5 1.96E-5 1.19E-5 5.23E-2 8.64E-4 Ba-140 1.29E+8 1.62E+5 5.49E+4 9.25E+4 2.65E+8 8.43E+6 Ba-141 Ba-142 La-140 1.97E+3 9.92E+2 - 7.28E+7 2.62E+2 La-142 1.40E-4 6.35E-5 - 4.64E-1 1.58E-5 Ce-141 1.96E+5 1.33E+5 - 6.17E+4 - 5.08E+8 1.51 E+4 Ce-143 1.OOE+3 7.42E+5 - 3.26E+2 - 2.77E+7 8.21 E+I Ce-144 3.29E+7 1.38E+7 - 8.16E+6 - 1.11E+10 1.77E+6 Pr-1 43 6.34E+4 2.54E+4 - 1.47E+4 - 2.78E+8 3.14E+3 Pr-144 Nd-147 3.34E+4 3.86E+4 2.25E+4 1.85E+8 2.31 E+3 W-187 3.82E+4 3.19E+4 1.05E+7 1.12E+4 Np-239 1.42E+3 1.40E+2 4.37E+2 2.87E+7 7.72E+1 2-26 REV. 11 02/22/2007

Table 2.9 Ri Vegetation Pathway Dose Factors - TEEN (mrem/yr per gCi/m 3) for H-3 and C-14 (m 2 x mrem/yr gCi/sec) for others Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body H-3 - 2.59E+3 2.59E+3 2.59E+3 2.59E+3 2.59E+3 2.59E+3 C-14 1.45E+6 2.91 E+5 2.91 E+5 2.91 E+5 2.91 E+5 2.91 E+5 2.91 E+5 Na-24 2.45E+5 2.45E+5 2.45E+5 2.45E+5 2.45E+5 2.45E+5 2.45E+5 P-32 1.61 E+9 9.96E+7 - 1.35E+8 6.23E+7 Cr-51 3.44E+4 1.36E+4 8.85E+4 1.04E+7 6.20E+4 Mn-54 4.52E+8 - 1.35E+8 9.27E+8 8.97E+7 Mn-56 1.45E+1 - 1.83E+1 9.54E+2 2.58E+0 Fe-55 3.25E+8 2.31 E+8 - - 1.46E+8 9.98E+7 5.38E+7 Fe-59 1.81 E+8 4.22E+8 - - 1.33E+8 9.98E+8 1.63E+8 Co-57 1.79E+7 - - 3.34E+8 3.OOE+7 Co-58 4.38E+7 - - - 6.04E+8 1.01 E+8 Co-60 2.49E+8 - - - 3.24E+9 5.60E+8 Ni-63 1.61E+10 1.13E+9 - - - 1.81E+8 5.45E+8 Ni-65 5.73E+1 7.32E+O - - - 3.97E+2 3.33E+0 Cu-64 8.40E+3 - 2.12E+4 - 6.51E+5 3.95E+3 Zn-65 4.24E+8 1.47E+9 - 9.41 E+8 - 6.23E+8 6.86E+8 Zn-69 8.19E-6 1.56E-5 - 1.02E-5 - 2.88E-5 1.09E-6 Br-82 - - - 1.33E+6 Br-83 - - - 3.01E+O Br-84 - - -

Br-85 - -

Rb-86 - 2.73E+8 4.05E+7 1.28E+8 Rb-88 - -

Rb-89 - - - - -

Sr-89 1.51 E+1I - - - - 1.80E+9 4.33E+8 Sr-90 7.51E+11 - - - - 2.11E+10 1.85E+11 Sr-91 2.99E+5 - - - - 1.36E+6 1.19E+4 Sr-92 3.97E+2 - - - 1.01 E+4 1.69E+1 Y-90 1.24E+4 - - - - 1.02E+8 3.34E+2 Y-91m 5.43E-9 - - - - 2.56E-7 Y-91 7.87E+6 - - - - 3.23E+9 2.11E+5 Y-92 8.47E-1 - - - - 2.32E+4 2.45E-2 Y-93 1.63E+2 - - - - 4.98E+6 4.47E+0 Zr-95 1.74E+6 5.49E+5 - 8.07E+5 - 1.27E+9 3.78E+5 Zr-97 3.09E+2 6.11E+1 - 9.26E+1 - 1.65E+7 2.81 E+1 Nb-95 1.92E+5 1.06E+5 - 1.03E+5 - 4.55E+8 5.86E+4 Nb-97 2.69E-6 6.67E-7 - 7.80E-7 - 1.59E-2 2.44E-7 Mo-99 5.74E+6 - 1.31 E+7 - 1.03E+7 1.09E+6 Tc-99m 2.70E+0 7.54E+0 - 1.12E+2 4.19E+0 4.95E+3 9.77E+1 Tc-101 2-27 REV. 11 02/22/2007

Table 2.9 RI Vegetation Pathway Dose Factors - TEEN (mrem/yr per gCi/m 3 ) for H-3 and C-14 (M 2 x mrem/yr gCi/sec) for others Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body Ru-103 6.87E+6 2.42E+7 5.74E+8 2.94E+6 Ru-105 5.OOE+1 - 6.31E+2 4.04E+4 1.94E+1 Ru-106 3.09E+8 5.97E+8 1.48E+1 0 3.90E+7 Rh-103m Rh-106 Ag-110m 1.52E+7 1.44E+7 - 2.74E+7 4.04E+9 8.74E+6 Sb-124 1.55E+8 2.85E+6 3.51E+5 1.35E+8 3.11 E+9 6.03E+7 Sb-125 2.14E+8 2.34E+6 2.04E+5 1.88E+8 1.66E+9 5.OOE+7 Te-125m 1.48E+8 5.34E+7 4.14E+7 4.37E+8 1.98E+7 Te-127m 5.51E+8 1.96E+8 1.31 E+8 2.24E+9 1.37E+9 6.56E+7 Te-127 5.43E+3 1.92E+3 3.74E+3 2.20E+4 4.19E+5 1.17E+3 Te-129m 3.67E+8 1.36E+8 1.18E+8 1.54E+9 1.38E+9 5.81E+7 Te-129 6.22E-4 2.32E-4 4.45E-4 2.61E-3 3.40E-3 1.51 E-4 Te-131m 8.44E+5 4.05E+5 6.09E+5 4.22E+6 3.25E+7 3.38E+5 Te-131 Te-132 3.90E+6 2.47E+6 2.60E+6 2.37E+7 7.82E+7 2.32E+6 1-130 3.54E+5 1.02E+6 8.35E+7 1.58E+6 - 7.87E+5 4.09E+5 1-131 7.70E+7 1.08E+8 3.14E+10 1.85E+8 - 2.13E+7 5.79E+7 1-132 5.18E+1 1.36E+2 4.57E+3 2.14E+2 - 5.91E+1 4.87E+1 1-133 1.97E+6 3.34E+6 4.66E+8 5.86E+6 - 2.53E+6 1.02E+6 1-134 9.59E-5 2.54E-4 4.24E-3 4.01 E-4 - 3.35E-6 9.13E-5 1-135 3.68E+4 9.48E+4 6.10E+6 1.50E+5 - 1.05E+5 3.52E+4 Cs-134 7.09E+9 1.67E+10 5.30E+9 2.02E+9 2.08E+8 7.74E+9 Cs-136 4.29E+7 1.69E+8 - 9.19E+7 1.45E+7 1.36E+7 1.13E+8 Cs-137 1.01E+10 1.35E+1 0 4.59E+9 1.78E+9 1.92E+8 4.69E+9 Cs-138 Ba-139 2.77E-2 1.95E-5 1.84E-5 1.34E-5 2.47E-1 8.08E-4 Ba-140 1.38E+8 1.69E+5. 5.75E+4 1.14E+5 2.13E+8 8.91E+6 Ba-141 Ba-142 La-140 1.80E+3 8.84E+2 5.08E+7 2.35E+2 La-142 1.28E-4 5.69E-5 - 1.73E+0 1.42E-5 Ce-141 2.82E+5 1.88E+5 8.86E+4 - 5.38E+8 2.16E+4 Ce-143 9.37E+2 6.82E+5 3.06E+2 - 2.05E+7 7.62E+1 Ce-144 5.27E+7 2.18E+7 1.30E+7 - 1.33E+10 2.83E+6 Pr-143 7.12E+4 2.84E+4 1.65E+4 - 2.34E+8 3.55E+3 Pr-144 Nd-147 3.63E+4 3.94E+4 2.32E+4 1.42E+8 2.36E+3 W-187 3.55E+4 2.90E+4 7.84E+6 1.02E+4 Np-239 1.38E+3 1.30E+2 4.09E+2 2.1OE+7 7.24E+1 2-28 REV. 11 02/22/2007

Table 2.10 R1 Vegetation Pathway Dose Factors - CHILD (mrem/yr per pCi/m 3) for H-3 and C-14 (M 2 x mrem/yr gCi/sec) for others Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body H-3 4.01E+3 4.01E+3 4.01E+3 4.01E+3 4.01E+3 4.01E+3 C-14 3.50E+6 7.01E+5 7.01E+5 7.01E+5 7.01E+5 7.01E+5 7.01E+5 Na-24 3.83E+5 3.83E+5 3.83E+5 3.83E+5 3.83E+5 3.83E+5 3.83E+5 P-32 3.37E+9 1.58E+8 9.30E+7 1.30E+8 Cr-51 6.54E+4 1.79E+4 1.19E+5 6.25E+6 1.18E+5 Mn-54 - 6.61E+8 1.85E+8 5.55E+8 1.76E+8 Mn-56 1.90E+1 2.29E+1 2.75E+3 4.28E+0 Fe-55 8.00E+8 4.24E+8 2.40E+8 7.86E+7 1.31 E+8 Fe-59 4.01 E+8 6.49E+8 - 1.88E+8 6.76E+8 3.23E+8 Co-57 2.99E+7 - 2.45E+8 6.04E+7 Co058 . 6.47E+7 - - 3.77E+8 1.98E+8 Co-60 3.78E+8 - - 2.10E+9 1.12E+9 Ni-63 3.95E+ 10 2.11E+9 - - 1.42E+8 1.34E+9 Ni-65 1.05E+2 9.89E+0 - - 1.21 E+3 5.77E+0 Cu-64 1.11E+4 2.68E+4 - 5.20E+5 6.69E+3 Zn-65 8.12E+8 2.16E+9 1.36E+9 - 3.80E+8 1.35E+9 Zn-69 1.51 E-5 2.18E-5 1.32E-5 - 1.38E-3 2.02E-6 Br-82 - 2.04E+6 Br-83 - 5.55E+0 Br-84 -

Br-85 -

Rb-86 - 4.52E+8 2.91 E+7 2.78E+8 Rb-88 - - -

Rb-89 - - -

Sr-89 3.59E+10 - - 1.39E+9 1.03E+9 Sr-90 1.24E+12 - - 1.67E+10 3.15E+11 Sr-91 5.50E+5 - - - 1.21 E+6 2.08E+4 Sr-92 7.28E+2 - - - - 1.38E+4 2.92E+1 Y-90 2.30E+4 - - - - 6.56E+7 6.17E+2 Y-91 m 9.94E-9 - - - - 1.95E-5 Y-91 1.87E+7 - - - - 2.49E+9 5.01 E+5 Y-92 1.56E+0 - - - - 4.51 E+4 4.46E-2 Y-93 3.01 E+2 - - - - 4.48E+6 8.25E+0 Zr-95 3.90E+6 8.58E+5 - 1.23E+6 - 8.95E+8 7.64E+5 Zr-97 5.64E+2 8.15E+1 - 1.17E+2 - 1.23E+7 4.81E+1 Nb795 4.10E+5 1.59E+5 - 1.50E+5 - 2.95E+8 1.14E+5 Nb-97 4.90E-6 8.85E-7 - 9.82E-7 - 2.73E-1 4.13E-7 Mo-99 7.83E+6 - 1.67E+7 - 6.48E+6 1.94E+6 Tc-99m 4.65E+0 9.12E+0 - 1.33E+2 4.63E+0 5.19E+3 1.51 E+2 Tc-101 2-29 REV. 11 02/22/2007

Table 2.10 Ri Vegetation Pathway Dose Factors - CHILD (mrem/yr per pCi/m 3) for H-3 and C-14 (m2 x mrem/yr gCi/sec) for others Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body Ru-103 1.55E+7 3.89E+7 3.99E+8 5.94E+6 Ru-105 9.17E+1 8.06E+2 5.98E+4 3.33E+1 Ru-106 7.45E+8 1.01 E+9 1.16E+10 9.30E+7 Rh-103m Rh-106 Ag-110m 3.22E+7 2.17E+7 4.05E+7 2.58E+9 1.74E+7 Sb-124 3.52E+8 4.57E+6 7.78E+5 1.96E+8 2.20E+9 1.23E+8 Sb-125 4.99E+8 3.85E+6 4.62E+5 2.78E+8 1.19E+9 1.05E+8 Te-125m 3.51 E+8 9.50E+7 9.84E+7 3.38E+8 4.67E+7 Te-127m 1.32E+9 3.56E+8 3.16E+8 3.77E+9 1.07E+9 1.57E+8 Te-127 1.OOE+4 2.70E+3 6.93E+3 2.85E+4 3.91E+5 2.15E+3 Te-129m 8.54E+8 2.39E+8 2.75E+8 2.51E+9 1.04E+9 1.33E+8 Te-129 1.15E-3 3.22E-4 8.22E-4 3.37E-3 7.17E-2 2.74E-4 Te-131m 1.54E+6 5.33E+5 1.10E+6 5.16E+6 2.16E+7 5.68E+5 Te-131 Te-132 6.98E+6 3.09E+6 4.50E+6 2.87E+7 - 3.11E+7 3.73E+6 1-130 6.21 E+5 1.26E+6 1.38E+8 1.88E+6 - 5.87E+5 6.47E+5 1-131 1.43E+8 1.44E+8 4.76E+10 2.36E+8 - 1.28E+7 8.18E+7 1-132 9.20E+1 1.69E+2 7.84E+3 2.59E+2 - 1.99E+2 7.77E+1 1-133 3.59E+6 4.44E+6 8.25E+8 7.40E+6 - 1.79E+6 1.68E+6 1-134 1.70E-4 3.16E-4 7.28E-3 4.84E-4 - 2.1OE-4 1.46E-4 1-135 6.54E+4 1.18E+5 1.04E+7 1.81 E+5 - 8.98E+4 5.57E+4 Cs-134 1.60E+10 2.63E+10 8.14E+9 2.92E+9 1.42E+8 5.54E+9 Cs-136 8.06E+7 2.22E+8 1.18E+8 1.76E+7 7.79E+6 1.43E+8 Cs-137 2.39E+10 2.29E+10 7;46E+9 2.68E+9 1.43E+8 3.38E+9 Cs-138 - -

Ba-139 5.11E-2 2.73E-5 2.38E-5 1.61 E-5 2.95E+O 1.48E-3 Ba-140 2.77E+8 2.43E+5 7.90E+4 1.45E+5 1.40E+8 1.62E+7 Ba-141 Ba-142 La-140 3.23E+3 1.13E+3 - 3.15E+7 3.81E+2 La-142 2.32E-4 7.40E-5 - - 1.47E+1 2.32E-5 Ce-141 6.35E+5 3.26E+5 - 1.43E+5 - 4.07E+8 4.84E+4 Ce-143 1.73E+3 9.36E+5 - 3.93E+2 - 1.37E+7 1.36E+2 Ce-144 1.27E+8 3.98E+7 - 2.21 E+7 - 1.04E+10 6.78E+6 Pr-143 1.48E+5 4.46E+4 - 2.41E+4 - 1.60E+8 7.37E+3 Pr-144 Nd-147 7.16E+4 5.80E+4 3.18E+4 9.18E+7 4.49E+3 W-187 6.47E+4 3.83E+4 5.38E+6 1.72E+4 Np-239 2.55E+3 1.83E+2 5.30E+2 1.36E+7 1.29E+2 2-30 REV. 1I 02/22/2007

Table 2.11 Ri Grass-Cow-Milk Pathway Dose Factors - ADULT (mrem/yr per RCi/m 3) for H-3 and C-14 (M 2 x mrem/yr RCi/sec) for others Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body H-3 7.63E+2 7.63E+2 7.63E+2 7.63E+2 7.63E+2 7.63E+2 C-14 3.63E+5 7.26E+4 7.26E+4 7.26E+4 7.26E+4 7.26E+4 7.26E+4 Na-24 2.54E+6 2.54E+6 2.54E+6 2.54E+6 2.54E+6 2.54E+6 2.54E+6 P-32 1.71 E+1 0 1.06E+9 - 1.92E+9 6.60E+8 Cr-51 1.71 E+4 6.30E+3 3.80E+4 7.20E+6 2.86E+4 Mn-54 8.40E+6 - 2.50E+6 2.57E+7 1.60E+6 Mn-56 4.23E-3 - 5.38E-3 1.35E-1 7.51E-4 Fe-55 2.51 E+7 1.73E+7 - - 9.67E+6 9.95E+6 4.04E+6 Fe-59 2.98E+7 7.OOE+7 - - 1.95E+7 2.33E+8 2.68E+7 Co-57 1.28E+6 - - 3.25E+7 2.13E+6 Co-58 4.72E+6 - - 9.57E+7 1.06E+7 Co-60 1.64E+7 - - 3.08E+8 3.62E+7 Ni-63 6.73E+9 4.66E+8 - - - 9.73E+7 2.26E+8 Ni-65 3.70E-1 4.81E-2 - - - 1.22E+O 2.19E-2 Cu-64 2.41 E+4 - 6.08E+4 - 2.05E+6 1.13E+4 Zn-65 1.37E+9 4.36E+9 - 2.92E+9 - 2.75E+9 1.97E+9 Zn-69 Br-82 - - 3.72E+7 3.25E+7 Br-83 - 1.49E-1 1.03E-1 Br-84 Br-85 Rb-86 2.59E+9 5.11E+8 1.21 E+9 Rb-88 Rb-89 Sr-89 1.45E+9 2.33E+8 4.16E+7 Sr-90 4.68E+10 1.35E+9 1.15E+10 Sr-91 3.13E+4 1.49E+5 1.27E+3 Sr-92 4.89E-1 9.68E+O 2.11 E-2 Y-90 7.07E+1 7.50E+5 1.90E+O Y-91m -

Y-91 8.60E+3 - 4.73E+6 2.30E+2 Y-92 5.42E-5 - 9.49E-1 1.58E-6 Y-93 2.33E-1 - 7.39E+3 6.43E-3 Zr-95 9.46E+2 3.03E+2 4.76E+2 - 9.62E+5 2.05E+2 Zr-97 4.26E-1 8.59E-2 1.30E-1 - 2.66E+4 3.93E-2 Nb-95 8.25E+4 4.59E+4 4.54E+4 - 2.79E+8 2.47E+4 Nb-97 - 5.47E-9 Mo-99 2.52E+7 5.72E+7 - 5.85E+7 4.80E+6 Tc-99m 3.25E+O 9.19E+O 1.40E+2 4.50E+O 5.44E+3 1.17E+2 Tc-101 2-31 REV. 11 02/22/2007

Table 2.11 Ri Grass-Cow-Milk Pathway Dose Factors - ADULT (mrem/yr per RCi/m 3 ) for H-3 and C-14 (M 2 x mrem/yr gCi/sec) for others Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body Ru-103 1.02E+3 3.89E+3 1.19E+5 4.39E+2 Ru-105 8.57E-4 1.11E-2 5.24E-1 3.38E-4 Ru-106 2.04E+4 3.94E+4 1.32E+6 .2.58E+3 Rh-103m Rh-106 Ag-110m 5.83E+7 5.39E+7 1.06E+8 2.20E+10 3.20E+7 Sb-124 2.57E+7 4.86E+5 6.24E+4 2.OOE+7 7.31E+8 1.02E+7 Sb-125 2.04E+7 2.28E+5 2.08E+4 1.58E+7 2.25E+8 4.86E+6 Te-125m 1.63E+7 5.90E+6 4.90E+6 6.63E+7 6.50E+7 2.18E+6 Te-127m 4.58E+7 1.64E+7 1.17E+7 1.86E+8 1.54E+8 5.58E+6 Te-127 6.72E+2 2.41E+2 4.98E+2 2.74E+3 5.30E+4 1.45E+2 Te-129m 6.04E+7 2.25E+7 2.08E+7 2.52E+8 3.04E+8 9.57E+6 Te-129 Te-131m 3.61E+5 1.77E+5 2.80E+5 1.79E+6 1.75E+7 1.47E+5 Te-131 Te-132 2.39E+6 1.55E+6 1.71 E+6 1.49E+7 7.32E+7 1.45E+6 1-130 4.26E+5 1.26E+6 1.07E+8 1.96E+6 1.08E+6 4.96E+5 1-131 2.96E+8 4.24E+8 1.39E+ 11 7.27E+8 1.12E+8 2.43E+8 1-132 1.64E-1 4.37E-1 1.53E+1 6.97E-1 8.22E-2 1.53E-1 1-133 3.97E+6 6.90E+6 1.01 E+9 1.20E+7 6.20E+6 2.1OE+6 1-134 -

1-135 1.39E+4 3.63E+4 2.40E+6 5.83E+4 4.10E+4 1.34E+4 Cs-134 5.65E+9 1.34E+1O0 4.35E+9 1.44E+9 2.35E+8 1.10E+10 Cs-136 2.61E+8 1.03E+9 5.74E+8 7.87E+7 1.17E+8 7.42E+8 Cs-137 7.38E+9 1.01 E+1 0 3.43E+9 1.14E+9 1.95E+8 6.61E+9 Cs-138 -

Ba-139 4.70E-8 - 8.34E-8 1.38E-9 Ba-140 2.69E+7 3.38E+4 1.15E+4 1.93E+4 5.54E+7 1.76E+6 Ba-141 Ba-142 -

La-140 4.49E+0 2.26E+0 1.66E+5 5.97E-1 La-142 - 3.03E-8 -

Ce-141 4.84E+3 3.27E+3 - 1.52E+3 1.25E+7 3.71E+2 Ce-143 4.19E+1 3.09E+4 - 1.36E+1 1.16E+6 3.42E+O Ce-144 3.58E+5 1.50E+5 - 8.87E+4 1.21 E+8 1.92E+4 Pr-143 1.59E+2 6.37E+1 - 3.68E+1 6.96E+5 7.88E+0 Pr-144 Nd-147 9.42E+1 1.09E+2 6.37E+1 5.23E+5 6.52E+0 W-187 6.56E+3 5.48E+3 1.80E+6 1.92E+3 Np-239 3.66E+0 3.60E-1 1.12E+0 7.39E+4 1.98E-1 2-32 REV. 11 02/22/2007

Table 2.12 Ri Grass-Cow-Milk Pathway Dose Factors - TEEN (mrem/yr per gCi/m 3) for H-3 and C-14 (M 2 x mrem/yr gCi/sec) for others Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body H-3 9.94E+2 9.94E+2 9.94E+2 9.94E+2 9.94E+2 9.94E+2 C-14 6.70E+5 1.34E+5 1.34E+5 1.34E+5 1.34E+5 1.34E+5 1.34E+5 Na-24 4.44E+6 4.44E+6 4.44E+6 4.44E+6 4.44E+6 4.44E+6 4.44E+6 P-32 3.15E+10 1.95E+9 2.65E+9 1.22E+9 Cr-51 2.78E+4 1.10E+4 7.13E+4 8.40E+6 5.OOE+4 Mn-54 1.40E+7 4.17E+6 2.87E+7 2.78E+6 Mn-56 7.51E-3 9.50E-3 4.94E-1 1.33E-3 Fe-55 4.45E+7 3.16E+7 - 2.OOE+7 1.37E+7 7.36E+6 Fe-59 5.20E+7 1.21 E+8 - 3.82E+7 2.87E+8 4.68E+7 Co-57 2.25E+6 - 4.19E+7 3.76E+6 Co-58 7.95E+6 - 1.10E+8 1.83E+7 Co-60 2.78E+7 - 3.62E+8 6.26E+7 Ni-63 1.18E+10 8.35E+8 - - 1.33E+8 4.01 E+8 Ni-65 6.78E-1 8.66E-2 - - 4.70E+O 3.94E-2 Cu-64 - 4.29E+4 - 1.09E+5 - 3.33E+6 2.02E+4 Zn-65 2.11E+9 7.31E+9 - 4.68E+9 - 3.10E+9 3.41E+9 Zn-69 -

Br-82 - 5.64E+7 Br-83 - 1.91 E-1 Br-84 - -

Br-85 -

Rb-86 - 4.73E+9 7.OOE+8 2.22E+9 Rb-88 -

Rb-89 -

Sr-89 2.67E+9 3.18E+8 7.66E+7 Sr-90 6.61E+10 1.86E+9 1.63E+10 Sr-91 5.75E+4 2.61 E+5 2.29E+3 Sr-92 8.95E-1 2.28E+1 3.81 E-2 Y-90 1.30E+2 1.07E+6 3.50E+O Y-91m Y-91 1.58E+4 - 6.48E+6 4.24E+2 Y-92 1.OOE-4 - 2.75E+0 2.90E-6 Y-93 4.30E-1 - 1.31 E+4 1.18E-2 Zr-95 1.65E+3 5.22E+2 7.67E+2 - 1.20E+6 3.59E+2 Zr-97 7.75E-1 1.53E-1 2.32E-1 - 4.15E+4 7.06E-2 Nb-95 1.41 E+5 7.80E+4 7.57E+4 - 3.34E+8 4.30E+4 Nb-97 - 6.34E-8 Mo-99 4.56E+7 1.04E+8 - 8.16E+7 8.69E+6 Tc-99m 5.64E+0 1.57E+1 2.34E+2 8.73E+O 1.03E+4 2.04E+2 Tc-101 2-33 REV. 11 02/22/2007

Table 2.12 Ri Grass-Cow-Milk Pathway Dose Factors - TEEN (mrem/yr per gCi/m 3) for H-3 and C-14 (M 2 x mrem/yr gCi/sec) for others Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body Ru-103 1.81 E+3 6.40E+3 1.52E+5 7.75E+2 Ru-105 1.57E-3 - 1.97E-2 1.26E+0 6.08E-4 Ru-106 3.75E+4 7.23E+4 t1.80E+6 4.73E+3 Rh-103m Rh-106 Ag-110m 9.63E+7 9.11E+7 - 1.74E+8 2.56E+ 10 5.54E+7 Sb-124 4.59E+7 8.46E+5 1.04E+5 4.01E+7 9.25E+8 1.79E+7 Sb-125 3.65E+7 3.99E+5 3.49E+4 3.21 E+7 2.84E+8 8.54E+6 Te-125m 3.OOE+7 1.08E+7 8.39E+6 8.86E+7 4.02E+6 Te-127m 8.44E+7 2.99E+7 2.01E+7 3.42E+8 2.10E+8 1.OOE+7 Te-127 1.24E+3 4.41 E+2 8.59E+2 5.04E+3 - 9.61 E+4 2.68E+2 Te-129m 1.11E+8 4.10E+7 3.57E+7 4.62E+8 - 4.15E+8 1.75E+7 Te-129 1.67E-9 - 2.18E-9 Te-131m 6.57E+5 3.15E+5 4.74E+5 3.29E+6 - 2.53E+7 2.63E+5 Te-131 Te-132 4.28E+6 2.71 E+6 2.86E+6 2.60E+7 - 8.58E+7 2.55E+6 1-130 7.49E+5 2.17E+6 1.77E+8 3.34E+6 - 1.67E+6 8.66E+5 1-131 5.38E+8 7.53E+8 2.20E+ 11 1.30E+9 - 1.49E+8 4.04E+8 1-132 2.90E-1 7.59E-1 2.56E+1 1.20E+O - 3.31 E-1 2.72E-1 1-133 7.24E+6 1.23E+7 1.72E+9 2.15E+7 - 9.30E+6 3.75E+6 1-134 1-135 2.47E+4 6.35E+4 4.08E+6 1.OOE+5 7.03E+4 2.35E+4 Cs-134 9.81E+9 2.31E+I 0 7.34E+9 2.80E+9 2.87E+8 1.07E+ 10 Cs-136 4.45E+8 1.75E+9 9.53E+8 1.50E+8 1.41 E+8 1.18E+9 Cs-137 1.34E+10 1.78E+10 6.06E+9 2.35E+9 2.53E+8 6.20E+9 Cs-138 -

Ba-139 8.69E-8 7.75E-7 2.53E-9 Ba-140 4.85E+7 5.95E+4 2.02E+4 4.OOE+4 7.49E+7 3.13E+6 Ba-141 -

Ba-142 La-140 8.06E+0 3.96E+0 - 2.27E+5 1.05E+O La-142 - 2.23E-7 Ce-141 8.87E+3 5.92E+3 - 2.79E+3 - 1.69E+7 6.81E+2 Ce-143 7.69E+1 5.60E+4 - *2.51 E+1 - 1.68E+6 6.25E+0 Ce-144 6.58E+5 2.72E+5 - 1.63E+5 - 1.66E+8 3.54E+4 Pr-143 2.92E+2 1.17E+2 - 6.77E+1 - 9.61 E+5 1.45E+1 Pr-144 Nd-147 1.81E+2 1.97E+2 1.16E+2 7.11E+5 1.18E+1 W-187 1.20E+4 9.78E+3 - 2.65E+6 3.43E+3 Np-239 6.99E+0 6.59E-1 2.07E+0 1.06E+5 3.66E-1 2-34 REV. 11 02/22/2007

Table 2.13 Ri Grass-Cow-Milk Pathway Dose Factors - CHILD (mrem/yr per gCi/m 3 ) for H-3 and C-14 (m 2 x mrem/yr gCi/sec) for others Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body H-3 1.57E+3 1.57E+3 1.57E+3 1.57E+3 1.57E+3 1.57E+3 C-14 1.65E+6 3.29E+5 3.29E+5 3.29E+5 3.29E+5 3.29E+5 3.29E+5 Na-24 9.23E+6 9.23E+6 9.23E+6 9.23E+6 9.23E+6 9.23E+6 9.23E+6 P-32 7.77E+10 3.64E+9 2.15E+9 3.OOE+9 Cr-51 5.66E+4 1.55E+4 1.03E+5 5.41E+6 1.02E+5 Mn-54 2.09E+7 5.87E+6 1.76E+7 5.58E+6 Mn-56 1.31 E-2 1.58E-2 1.90E+O 2.95E-3 Fe-55 1.12E+8 5.93E+7 3.35E+7 1.10E+7 1.84E+7 Fe-59 1.20E+8 1.95E+8 - 5.65E+7 2.03E+8 9.71 E+7 Co-57 3.84E+6 - - - 3.14E+7 7.77E+6 Co-58 1.21 E+7 - - - 7.08E+7 3.72E+7 Co-60 4.32E+7 - - - 2.39E+8 1.27E+8 Ni-63 2.96E+ 10 1.59E+9 - - - 1.07E+8 1.01 E+9 Ni-65 1.66E+O 1.56E-1 - - - 1.91 E+1 9.11E-2 Cu-64 7.55E+4 - 1.82E+5 - 3.54E+6 4.56E+4 Zn-65 4.13E+9 1.10E+10 - 6.94E+9 - 1.93E+9 6.85E+9 Zn-69 - - 2.14E-9 Br-82 - - 1.15E+8 Br-83 - - - 4.69E-1 Br-84 - - -

Br-85 - - -

Rb-86 - 8.77E+9 - 5.64E+8 5.39E+9 Rb-88 - - - - -

Rb-89 - - - - -

Sr-89 6.62E+9 - - - - 2.56E+8 1.89E+8 Sr-90 1.12E+11 - - - - 1.51E+9 2.83E+10 Sr-91 1.41 E+5 - - - - 3.12E+5 5.33E+3 Sr-92 2.19E+O - - - - 4.14E+1 8.76E-2 Y-90 3.22E+2 - - - - 9.15E+5 8.61E+O Y-91m Y-91 3.91 E+4 - 5.21 E+6 1.04E+3 Y-92 2.46E-4 - 7.1OE+O 7.03E-6 Y-93 1.06E+O - 1.57E+4 2.90E-2 Zr-95 3.84E+3 8.45E+2 1.21 E+3 - 8.81E+5 7.52E+2 Zr-97 1.89E+O 2.72E-1 3.91E-1 - 4.13E+4 1.61 E-1 Nb-95 3.18E+5 1.24E+5 1.16E+5 - 2.29E+8 8.84E+4 Nb-97 - 1.45E-6 Mo-99 8.29E+7 1.77E+8 - 6.86E+7 2.05E+7 Tc-99m 1.29E+1 2.54E+1 3.68E+2 1.29E+1 1.44E+4 4.20E+2 Tc-101 -

2-35 REV. 11 02/22/2007

Table 2.13 R, Grass-Cow-Milk Pathway Dose Factors - CHILD (mrem/yr per RCi/m 3 ) for H-3 and C-14 (M 2 x mrem/yr gCi/sec) for others Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body Ru-103 4.29E+3 - 1.08E+4 1.11E+5 1.65E+3 Ru-105 3.82E-3 - 3.36E-2 2.49E+O 1.39E-3 Ru-106 9.24E+4 - 1.25E+5 1.44E+6 1.15E+4 Rh-103m Rh-106 Ag-11Om 2.09E+8 1.41 E+8 - 2.63E+8 1.68E+10 1.13E+8 Sb-124 1.09E+8 1.41 E+8 2.40E+5 6.03E+7 6.79E+8 3.81 E+7 Sb-125 8.70E+7 1.41 E+6 8.06E+4 4.85E+7 2.08E+8 1.82E+7 Te-125m 7.38E+7 2.OOE+7 2.07E+7 7.12E+7 9.84E+6 Te-127m 2.08E+8 5.60E+7 4.97E+7 5.93E+8 1.68E+8 2.47E+7 Te-127 3.06E+3 8.25E+2 2.12E+3 8.71E+3 1.20E+5 6.56E+2 Te-129m 2.72E+8 7.61E+7 8.78E+7 8.OOE+8 3.32E+8 4.23E+7 Te-129 2.87E-9 6.12E-8 Te-131m 1.60E+6 5.53E+5 1.14E+6 5.35E+6 2.24E+7 5.89E+5 Te-131 Te-132 1.02E+7 4.52E+6 6.58E+6 4.20E+7 4.55E+7 5.46E+6 1-130 1.75E+6 3.54E+6 3.90E+8 5.29E+6 1.66E+6 1.82E+6 1-131 1.30E+9 1.31 E+9 4.34E+ 11 2.15E+9 1.17E+8 7.46E+8 1-132 6.86E-1 1.26E+O 5.85E+1 1.93E+O 1.48E+O 5.80E-1 1-133 1.76E+7 2.18E+7 4.04E+9 3.63E+7 8.77E+6 8.23E+6 1-134 1-135 5.84E+4 1.05E+5 9.30E+6 1.61 E+5 8.OOE+4 4.97E+4 Cs-134 2.26E+10 3.71E+1O0 1.15E+10 4.13E+9 2.OOE+8 7.83E+9 Cs-136 1.OOE+9 2.76E+9 1.47E+9 2.19E+8 9.70E+7 1.79E+9 Cs-137 3.22E+10 3.09E+10 1.01 E+1 0 3.62E+9 1.93E+8 4.55E+9 Cs-138 Ba-139 2.14E-7 1.23E-5 6.19E-9 Ba-140 1.17E+8 1.03E+5 3.34E+4 6.12E+4 5.94E+7 6.84E+6 Ba-141 Ba-142 La-140 1.93E+1 6.74E+O 1.88E+5 2.27E+O La-142 - 2.51 E-6 Ce-141 2.19E+4 1.09E+4 - 4.78E+3 - 1.36E+7 1.62E+3 Ce-143 1.89E+2 1.02E+5 - 4.29E+1 - 1.50E+6 1.48E+1 Ce-144 1.62E+6 5.09E+5 - 2.82E+5 - 1.33E+8 8.66E+4 Pr-143 7.23E+2 2.17E+2 - 1.17E+2 - 7.80E+5 3.59E+1 Pr-144 Nd-147 4.45E+2 3.60E+2 1.98E+2 5.71 E+5 2.79E+1 W-187 2.91 E+4 1.72E+4 2.42E+6 7.73E+3 Np-239 1.72E+1 1.23E+O 3.57E+O 9.14E+4 8.68E-1 2-36 REV. 11 02/22/2007

Table 2.14 Ri Grass-Cow-Milk Pathway Dose Factors - INFANT (mrem/yr per gCi/m 3 ) for H-3 and C-14 (m 2 x mrem/yr gCi/sec) for others Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body H-3 2.38E+3 2.38E+3 2.38E+3 2.38E+3 2.38E+3 2.38E+3 C-14 3.23E+6 6.89E+5 6.89E+5 6.89E+5 6.89E+5 6.89E+5 6.89E+5 Na-24 1.61 E+7 1.61 E+7 1.61 E+7 1.61 E+7 1.61 E+7 1.61 E+7 1.61 E+7 P-32 1.60E+11 9.42E+9 2.17E+9 6.21E+9 Cr-51 1.05E+5 2.30E+4 2.05E+5 4.71E+6 1.61 E+5 Mn-54 3.89E+7 8.63E+6 1.43E+7 8.83E+6 Mn-56 3.21 E-2 2.76E-2 2.91 E+O 5.53E-3 Fe-55 1.35E+8 8.72E+7 4.27E+7 1.11 E+7 2.33E+7 Fe-59 2.25E+8 3.93E+8 1.1 6E+8 1.88E+8 1.55E+8 Co-57 8.95E+6 - 3.05E+7 1.46E+7 Co-58 2.43E+7 - - 6.05E+7 6.06E+7 Co-60 8.81E+7 - - 2.10E+8 2.08E+8 Ni-63 3.49E+10 2.16E+9 - - 1.07E+8 1.21E+9 Ni-65 3.51E+O 3.97E-1 - - 3.02E+1 1.81 E-1 Cu-64 1.88E+5 .3.17E+5 - 3.85E+6 8.69E+4 Zn-65 5.55E+9 1.90E+10 9.23E+9 - 1.61 E+1 0 8.78E+9 Zn-69 - - - 7.36E-9 Br-82 - - 1.94E+8 Br-83 - - 9.95E-1 Br-84 - -

Br-85 - -

Rb-86 - 2.22E+10 5.69E+8 1.10E+10 Rb-88 -

Rb-89 -

Sr-89 1.26E+10 - 2.59E+8 3.61E+8 Sr-90 1.22E+11 - - - 1.52E+9 3.1OE+10 Sr-91 2.94E+5 - - - 3.48E+5 1.06E+4 Sr-92 4.65E+O - - - 5.01E+1 1.73E-1 Y-90 6.80E+2 - - - 9.39E+5 1.82E+1 Y-91m Y-91 7.33E+4 - 5.26E+6 1.95E+3 Y-92 5.22E-4 - 9.97E+O 1.47E-5 Y-93 2.25E+O - 1.78E+4 6.13E-2 Zr-95 6.83E+3 1.66E+3 1.79E+3 8.28E+5 1.18E+3 Zr-97 3.99E+O 6.85E-1 6.91 E-1 4.37E+4 3.13E-1 Nb-95 5.93E+5 2.44E+5 1.75E+5 2.06E+8 1.41 E+5 Nb-97 3.70E-6 Mo-99 2.12E+8 3.17E+8 6.98E+7 4.13E+7 Tc-99m 2.69E+1 5.55E+1 5.97E+2 2.90E+1 1.61 E+4 7.15E+2 Tc-1 01 2-37 REV. 11 02/22/2007

Table 2.14 Ri Grass-Cow-Milk Pathway Dose Factors - INFANT (mrem/yr per gCi/m 3) for H-3 and C-14 (m 2 x mrem/yr gCi/sec) for others Nuclide Bone Liver Thyroid Kidney Lung GI-LLI T.Body Ru-103 8.69E+3 1.81 E+4 1.06E+5 2.91E+3 Ru-105 8.06E-3 5.92E-2 3.21E+O 2.71E-3 Ru-106 1.90E+5 2.25E+5 1.44E+6 2.38E+4 Rh-103m Rh-106 Ag-110m 3.86E+8 2.82E+8 4.03E+8 1.46E+10 1.86E+8 Sb-124 2.09E+8 3.08E+6 5.56E+5 1.31 E+8 6.46E+8 6.49E+7 Sb-125 1.49E+8 1.45E+6 1.87E+5 9.38E+7 1.99E+8 3.07E+7 Te-125m 1.51 E+8 5.04E+7 5.07E+7 - 7.18E+7 2.04E+7 Te-127m 4.21E+8 1.40E+8 1.22E+8 1.04E+9 - 1.70E+8 5.10E+7 Te-127 6.50E+3 2.18E+3 5.29E+3 1.59E+4 - 1.36E+5 1.40E+3 Te-129m 5.59E+8 1.92E+8 2.15E+8 1.40E+9 - 3.34E+8 8.62E+7 Te-129 2.08E-9 1.75E-9 5.18E-9 - 1.66E-7 Te-131m 3.38E+6 1.36E+6 2.76E+6 9.35E+6 - 2.29E+7 1.12E+6 Te-131 Te-132 2.10E+7 1.04E+7 1.54E+7 6.51E+7 3.85E+7 9.72E+6 1-130 3.60E+6 7.92E+6 8.88E+8 8.70E+6 1.70E+6 3.18E+6 1-131 2.72E+9 3.21E+9 1.05E+12 3.75E+9 1.15E+8 1.41 E+9 1-132 1.42E+0 2.89E+0 1.35E+2 3.22E+0 2.34E+0 1.03E+0 1-133 3.72E+7 5.41E+7 9.84E+9 6.36E+7 9.16E+6 1.58E+7 1-134 1.01 E-9 -

1-135 1.21 E+5 2.41E+5 2.16E+7 2.69E+5 8.74E+4 8.80E+4 Cs-134 3.65E+10 6.80E+10 1.75E+10 7.18E+9 1.85E+8 6.87E+9 Cs-136 1.96E+9 5.77E+9 2.30E+9 4.70E+8 8.76E+7 2.15E+9 Cs-137 5.15E+10 6.02E+10 1.62E+10 6.55E+9 1.88E+8 4.27E+9 Cs-138 Ba-139 4.55E-7 2.88E-5 1.32E-8 Ba-140 2.41 E+8 2.41E+5 5.73E+4 1.48E+5 5.92E+7 1.24E+7 Ba-141 Ba-142 La-140 4.03E+1 1.59E+1 - 1.87E+5 4.09E+0 La-142 - 5.21 E-6 Ce-141 4.33E+4 2.64E+4 8.15E+3 - 1.37E+7 3.11E+3 Ce-143 4.OOE+2 2.65E+5 7.72E+1 - 1.55E+6 3.02E+1 Ce-144 2.33E+6 9.52E+5 3.85E+5 - 1.33E+8 1.30E+5 Pr-143 1.49E+3 5.59E+2 2.08E+2 - 7.89E+5 7.41 E+1 Pr-144 Nd-147 8.82E+2 9.06E+2 3.49E+2 5.74E+5 5.55E+1 W-187 6.12E+4 4.26E+4 2.50E+6 1.47E+4 Np-239 3.64E+1 3.25E+O 6.49E+0 9.40E+4 1.84E+0 2-38 REV. 11 02/22/2007

Table 2.15 R, Ground Plane Pathway Dose Factors (m2 x mrem/yr per gCi/sec)

Nuclide Any Organ H-3 C-14 Na-24 1.21 E+7 P-32 Cr-51 4.68E+6 Mn-54 1.34E+9 Mn-56 9.05E+5 Fe-55 Fe-59 2.75E+8 Co-57 4.37E+8 Co-58 3.82E+8 Co-60 2.16E+10 Ni-63 Ni-65 2.97E+5 Cu-64 6.09E+5 Zn-65 7.45E+8 Zn-69 Br-82 4.57E+7 Br-83 4.89E+3 Br-84 2.03E+5 Br-85 Rb-86 8.98E+6 Rb-88 3.29E+4 Rb-89 1.21 E+5 Sr-89 2.16E+4 Sr-90 Sr-91 2.19E+6 Sr-92 7.77E+5 Y-90 4.48E+3 Y-91m 1.01 E+5 Y-91 1.08E+6 Y-92 1.80E+5 Y-93 1.85E+5 Zr-95 2.48E+8 Zr-97 2.94E+6 Nb-95 1.36E+8 Nb-97 2.28E+6 Mo-99 4.05E+6 Tc-99m 1.83E+5 Tc-101 2.04E+4 Ru-103 1.09E+8 2-39 REV. 11 02/22/2007

Table 2.15 Ri Ground Plane Pathway Dose Factors (m2 x mrem/yr per gCi/sec)

Nuclide Any Organ Ru-105 6.36E+5 Ru-106 4.21 E+8 Rh-1 03m Rh-106 Ag-110m 3.47E+9 Sb-124 2.87E+9 Sb-125 6.49E+9 Te-125m 1.55E+6 Te-127m 9.17E+4 Te-127 3.OOE+3 Te-129m 2.OOE+7 Te-129 2.60E+4 Te-131m 8.03E+6 Te-131 2.93E+4 Te-132 4.22E+6 1-130 5.53E+6 1-131 1.72E+7 1-132 1.24E+6 1-133 2.47E+6 1-134 4.49E+5 1-135 2.56E+6 Cs-134 6.75E+9 Cs-136 1.49E+8 Cs-137 1.04E+10 Cs-138 3.59E+5 Ba-139 1.06E+5 Ba-140 2.05E+7 Ba-141 4.18E+4 Ba-142 4.49E+4 La-140 1.91 E+7 La-142 7.36E+5 Ce-141 1.36E+7 Ce-143 2.32E+6 Ce-144 6.95E+7 Pr-1 43 Pr-144 1.83E+3 Nd-147 8.40E+6 W-187 2.36E+6 Np-239 1.71 E+6 2 -40 REV. 11 02/22/2007

3/4 RADIOLOGICAL EFFLUENT SPECIFICATIONS AND SURVEILLANCE REQUIREMENTS 3/4.0 APPLICABILITY AND SURVEILLANCE REQUIREMENTS SPECIFICATIONS 3.0.1 Compliance with the specifications contained in the succeeding text is required during the conditions specified therein; except that upon failure to meet the specifications, the associated ACTION requirements shall be met.

3.0.2 Noncompliance with a Specification shall exist when its requirements and associated ACTION requirements are not met within the specified time intervals. If the Specification is restored prior to expiration of the specified time intervals,' completion of the Action requirements is not required.

3.0.3 When a Specification is not met, except as provided in the associated ACTION requirements, reporting as directed in the ACTION requirement will be initiated.

SURVEILLANCE REQUIREMENTS 4.0.1 Surveillance Requirements shall be met during the conditions specified for individual Specifications unless otherwise stated in an individual Surveillance Requirement.

4.0.2 Each. Surveillance Requirement shall be performed. within the specified time interval with a maximum allowable extension not to exceed 25% of the surveillance interval.

4.0.3 Failure to perform a Surveillance Requirement within the specified time interval shall constitute a failure to meet the OPERABILITY requirements for a Specification. Exceptions to these requirements are stated in the individual Specification. Surveillance Requirements do not have to be performed on inoperable equipment.

3-1 REV. 11 02/22/2007

3/4.1 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION SPECIFICATIONS 3.1 The radioactive liquid effluent monitoring instrumentation channels shown in Table 3.1 shall be OPERABLE with their alarm/trip setpoints set to ensure that the limits of ODCM Specification 3.3.1 are not exceeded. The alarm/trip setpoints of these channels shall be determined in accordance with the methodology in Section 1.0 of the OFF-SITE DOSE CALCULATION MANUAL (ODCM).

APPLICABILITY During release via the monitored pathway.

ACTION

a. With a radioactive liquid effluent monitoring instrumentation channel alarm/trip setpoint less conservative than required by the above specification, without delay suspend the release of radioactive liquid effluents monitored by the affected channel, or declare the channel inoperable, or change the setpoint so it is acceptably conservative. Non-compliance with, or a delay in initiation of this action item requires the initiation of a CAP AND an explanation of the incident included in the next Radioactive Effluent Release Report.

b. With less than the minimum number of radioactive liquid effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table 3.1.

Exert best efforts to return the instruments to OPERABLE status within 30 days and, if unsuccessful, explain in the next Radioactive Effluent Release Report why the inoperability was not corrected in a timely manner.

SURVEILLANCE REQUIREMENTS 4.1 Each radioactive liquid effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION and CHANNEL FUNCTIONAL TEST operations at the frequencies shown in Table 4.1.

BASIS Radioactive Liquid Effluent Monitoring Instrumentation - The radioactive liquid effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of liquid effluents. The alarm/trip setpoints for these instruments shall be calculated and adjusted in accordance with the methodology and parameters in the ODCM to ensure that the alarm/trip will occur prior to exceeding ten (10) times the values of 10 CFR Part 20, Appendix B, Table 2, Column 2. The operability and use of this instrumentation is consistent with the appropriate requirements of General Design Criteria 60, 63 and 64 of Appendix A to 10 CFR Part 50.

3-2 REV. 11 02/22/2007

3/4.2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION SPECIFICATIONS 3.2 The radioactive gaseous effluent monitoring instrumentation channels shown in Table 3.2 shall be OPERABLE with their alarm/trip setpoints set to ensure that the limits of ODCM Specification 3.4.1 are not exceeded. The alarm/trip setpoints of these channels shall be determined in accordance with the methodology in section 2.0 of the ODCM.

APPLICABILITY As shown in Table 3.2.

ACTION

a. With a radioactive gaseous effluent monitoring instrumentation channel alarm/trip setpoint less conservative than required by the above Specification, without delay suspend the release of radioactive gaseous effluents monitored by the affected channel, or declare the channel inoperable, or change the setpoint so it is acceptably conservative. Non-compliance with, or a delay in initiation of this action item requires the initiation of a CAP AND an explanation of the incident included in the next Radioactive Effluent Release Report.

b. With less than the minimum number of radioactive gaseous effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table 3.2.

Exert best efforts to return the instruments to OPERABLE status within 30 days and, if unsuccessful, explain in the next Radioactive Effluent Release Report why the inoperability was not corrected in a timely manner.

SURVEILLANCE REQUIREMENTS 4.2 Each radioactive gaseous effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION and CHANNEL FUNCTIONAL TEST operations at the frequencies shown in Table 4.2.

BASIS Radioactive Gaseous Effluent Monitoring Instrumentation - The radioactive gaseous effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in gaseous effluents during actual or potential releases of gaseous effluents. The alarm/trip will occur prior to exceeding the dose rate limits of ODCM Specification 3.4.1. The operability and use of this instrumentation is consistent with the appropriate requirements of General Design Criteria 60, 63 and 64 of Appendix A to 10 CFR Part 50.

3-3 REV. 11 02/22/2007

3/4.3 LIQUID EFFLUENTS CONCENTRATION SPECIFICATIONS 3.3.1 The concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS shall be limited to ten times the concentrations specified in 10 CFR Part 20, Appendix B, Table 2, Column 2 for radionuclides other than dissolved or entrained noble gases. For dissolved or entrained noble gases, the concentration shall be limited to 2 x 10-4 pCi/mIl total activity.

APPLICABILITY During release via the monitored pathway.

ACTION

a. With the concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS exceeding the above limits, without delay restore the concentration to within the above limits. Non-compliance with, or a delay in initiation of this action item requires the initiation of a CAP AND an explanation of the incident included in the next Radioactive Effluent Release Report.

SURVEILLANCE REQUIREMENTS 4.3.1.1 Radioactive liquid wastes shall be sampled and analyzed according to the sampling and analysis program of Table 4.3.

4.3.1.2 The results of the radioactivity analyses shall be used in accordance with the methodology and parameters in the ODCM to assure that the concentrations at the point of release are maintained within the limits of ODCM Specification 3.3.1.

BASIS Concentration - This specification is provided to ensure that the concentration of radioactive materials released in liquid waste effluents to UNRESTRICTED AREAS will be less than ten times the concentration levels specified in 10 CFR Part 20, Appendix B, Table 2, Column 2. This limitation provides additional assurance that the levels of radioactive materials in bodies of water in UNRESTRICTED AREAS will result in exposures within (1) the Section II.A design objectives of Appendix I, 10 CFR Part 50, to a MEMBER OF THE PUBLIC and (2) the limits of 10 CFR Part 20.1301 to the population. The concentration limit for dissolved or entrained noble gases is based upon the assumption that Xe-135 is the controlling radioisotope and its concentration limit in air (submersion) was converted to an equivalent concentration in water using the methods described in International Commission on Radiological Protection (ICRP)

Publication 2.

The required detection capabilities for radioactive materials in liquid waste samples are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD, and other detection limits can be found in HASL Procedures Manual, HASL-300 (revised annually), Currie, L.A., "Limits for Qualitative Detection and Quantitative Determination - Application to Radiochemistry," Anal. Chem. 40, 586-93 (1968), and Hartwell, J.K., "Detection Limits for Radioanalytical Counting Techniques," Atlantic Richfield Hanford Company Report ARH-SA-215 (June 1975).

3-4 REV. 11 02/22/2007

DOSE SPECIFICATIONS 3.3.2 The dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials in liquid effluents released to UNRESTRICTED AREAS shall be limited:

a. During any calendar quarter to less than or equal to 1.5 mrem to the total body and to less than or equal to 5 mrem to any organ, and

b. During any calendar year to less than or equal to 3 mrem to the total body and to less than or equal to 10 mrem to any organ.

APPLICABILITY At all times.

ACTION

a. With the calculated dose from the release of radioactive materials in liquid effluents exceeding any of the above limits, in lieu of a Licensee Event Report, prepare and submit to the Commission within 30 days, pursuant to Technical Specification (TS) 6.9.b.3, a Special Report that identifies the cause(s) for exceeding the limit(s) and defines the corrective actions that have been taken to reduce the release and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits.

SURVEILLANCE REQUIREMENTS 4.3.2 Cumulative dose contributions from liquid effluents for the current calendar quarter and the current calendar year shall be determined in accordance with the methodology and parameters in the ODCM once per 31 days.

BASIS Dose - This specification is provided to implement the requirements of Sections II.A, III.A and IV.A of Appendix I, 10 CFR 50. The Limiting Condition for Operation implements the guides set forth in Section II.A of Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in liquid effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably achievable." The dose calculation methodology and parameters in the ODCM implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The equations specified in the ODCM for calculating the doses due to the actual release rates of radioactive materials in liquid effluents are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.113, "Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," April 1977.

3-5 REV. 11 02/22/2007

LIQUID RADWASTE TREATMENT SYSTEM SPECIFICATIONS 3.3.3 The liquid radwaste treatment system as described in the ODCM shall be used to reduce the radioactive materials in liquid wastes prior to their discharge when the projected doses, due to the liquid effluent, to UNRESTRICTED AREAS would exceed 0.18 mrem to the total body or 0.62 mrem to any organ in a calendar quarter.

APPLICABILITY At all times.

ACTION

a. With radioactive liquid waste being discharged without treatment and in excess of the above limits, in lieu of a Licensee Event Report, prepare and submit to the Commission within 30 days pursuant to TS 6.9.b.3, a Special Report that includes the following information:

1. Explanation of why liquid radwaste was being discharged without treatment, identification of any inoperable equipment or subsystems, and the reason for the inoperability,

2. Action(s) taken to restore the inoperable equipment to OPERABLE status, and

3. Summary description of action(s) taken to prevent a recurrence.

SURVEILLANCE REQUIREMENTS 4.3.3 Doses due to liquid releases from the unit to UNRESTRICTED AREAS shall be projected once per 31 days in accordance with the methodology and parameters in the ODCM.

BASIS Liquid Radwaste Treatment System - The requirement that the appropriate portions of this system be used, when specified, provides assurance that the releases of radioactive materials in liquid effluents will be kept "as low as is reasonably achievable." This specification implements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50 and the design objective given in Section II.D of Appendix I to 10 CFR Part 50. The specified limits governing the use of appropriate portions of the liquid radwaste treatment system were specified as a suitable fraction of the dose design objectives set forth in Section II.A of Appendix I, 10 CFR Part 50, for liquid effluents.

3-6 REV. 11 02/22/2007

3/4.4 GASEOUS EFFLUENTS DOSE RATE SPECIFICATIONS 3.4.1 The dose rate due to radioactive materials released in gaseous effluents from the site to areas at and beyond the SITE BOUNDARY shall be limited to the following:

a. For noble gases: Less than or equal to 500 mrem/yr to the total body and less than or equal to 3000 mrem/yr to the skin, and

b. For iodine-131, iodine-133, tritium, and for all radionuclides in particulate form with half lives greater than 8 days: Less than or equal to 1500 mrem/yr to any organ.

APPLICABILITY At all times.

ACTION

a. With the dose rate(s) exceeding the above limits, without delay restore the release rate to within the above limit(s). Non-compliance with, or a delay in initiation of this action item requires the initiation of a CAP AND an explanation of the incident included in the next Radioactive Effluent Release Report.

SURVEILLANCE REQUIREMENTS 4.4.1.1 The dose rate due to noble gases in gaseous effluents shall be determined to be within the above limits in accordance with the methodology and parameters in the ODCM.

4.4.1.2 The dose rate due to iodine-131, iodine-133, tritium, and all radionuclides in particulate form with half lives greater than 8 days in gaseous effluents shall be determined to be within the above limits in accordance with the methodology and parameters in the ODCM by obtaining representative samples and performing analyses in accordance with the sampling and analysis program specified in Table 4.4.

3-7 REV. 11 02/22/2007

BASIS Dose Rate - This specification is provided to ensure that the dose rates at any time to a MEMBER OF THE PUBLIC at or beyond the SITE BOUNDARY are less than or equal to 500 mrem/yr to the total body and less than or equal to 3000 mrem/yr to the skin. This also restricts releases, at all times, for the corresponding thyroid dose rate above background to a child via the inhalation pathway to less than or equal to 1500 mrem/yr.

These dose rate limits provide additional assurance that radioactive material discharged in gaseous effluents will be maintained ALARA, and coupled with the requirements of ODCM Specification 3.4.2, ensure that the exposures of MEMBERS OF THE PUBLIC in an UNRESTRICTED AREA, either within or outside the SITE BOUNDARY, will not exceed the annual average concentrations specified in Appendix B, Table 2, Column I of 10 CFR 20. For MEMBERS OF THE PUBLIC who may at times be within the SITE BOUNDARY, the occupancy of that MEMBER OF THE PUBLIC will usually be sufficiently low to compensate for any increase in the atmospheric diffusion factor above that for the SITE BOUNDARY.

The required detection capabilities for radioactive materials in gaseous waste samples are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD, and other detection limits can be found in HASL Procedures Manual, HASL-300 (revised annually), Currie, L.A., "Limits for Qualitative Detection and Quantitative Determination - Application to Radiochemistry," Anal. Chem. 40, 586-93 (1968), and Hartwell, J.K., "Detection Limits for Radioanalytical Counting Techniques," Atlantic Richfield Hanford Company Report ARH-SA-215 (June 1975).

3-8 REV. 11 02/22/2007

DOSE - NOBLE GASES SPECIFICATIONS 3.4.2 The air dose due to noble gases released in gaseous effluents, to areas at and beyond the SITE BOUNDARY shall be limited to the following:

a. During any calendar quarter: Less than or equal to 5 mrad for gamma radiation and less than or equal to 10 mrad for beta radiation and,

b. During any calendar year: Less than or equal to 10 mrad for gamma radiation and less than or equal to 20 mrad for beta radiation.

APPLICABILITY At all times.

ACTION

a. With the calculated air dose from radioactive noble gases in gaseous effluents exceeding any of the above limits, in lieu of a Licensee Event Report, prepare and submit to the Commission within 30 days, pursuant to TS 6.9.b.3, a Special Report that identifies the cause(s) for exceeding the limit(s) and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits.

SURVEILLANCE REQUIREMENTS 4.4.2 Cumulative dose contributions for the current calendar quarter and current calendar year for noble gases shall be determined in accordance with the methodology and parameters in the ODCM once per 31 days.

BASIS Dose - Noble Gases - This specification is provided to implement the requirements of Sections II.B, III.A and IV.A of Appendix I, 10 CFR Part 50. The Limiting Condition for Operation implements the guides set forth in Section II.B of Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in gaseous effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably achievable." The Surveillance Requirements implement the requirements in Section Ill.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The dose calculation methodology and parameters established in the ODCM for calculating the doses due to the actual release rates of radioactive noble gases in gaseous effluents are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.111, "Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water Cooled Reactors,"

Revision 1, July 1977. The ODCM equations provided for determining the air doses at and beyond the SITE BOUNDARY are based upon the historical average atmospheric conditions.

3-9 REV. 11 02/22/2007

DOSE - IODINE-131, IODINE-133, TRITIUM AND RADIONUCLIDES IN PARTICULATE FORM SPECIFICATIONS 3.4.3 The dose to a MEMBER OF THE PUBLIC from iodine-131, iodine-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released to areas at and beyond the SITE BOUNDARY shall be limited to the following:

a. During any calendar quarter: Less than or equal to 7.5 mrem to any organ and,

b. During any calendar year: Less than or equal to 15 mrem to any organ.

APPLICABILITY At all times.

ACTION

a. With the calculated dose from the release of iodine-131, iodine-133, tritium, and radionuclides in particulate form with half lives greater than 8 days, in gaseous effluents exceeding any of the above limits, in lieu of a Licensee Event Report, prepare and submit to the Commission within 30 days, pursuant to TS 6.9.b.3, a Special Report that identifies the cause(s) for exceeding the limit and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits.

SURVEILLANCE REQUIREMENTS 4.4.3 Cumulative dose contributions for the current calendar quarter and current calendar year for iodine-131, iodine-133, tritium, and radionuclides in particulate form with half lives greater than 8 days shall be determined in accordance with the methodology and parameters in the ODCM once per 31 days.

BASIS Dose - Iodine-131, Iodine-133, Tritium, and Radionuclides in Particulate Form -

This specification is provided to implement the requirements of Sections II.C, III.A and IV.A of Appendix I, 10 CFR Part 50. The Limiting Conditions for Operation are the guides set forth in Section II.C of Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive materials in gaseous effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably achievable."

3-10 REV. 11 02/22/2007

The ODCM calculational methods specified in the Surveillance Requirements implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The ODCM calculational methodology and parameters for calculating the doses due to the actual release rates of the subject materials are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.111, "Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, July 1977. These equations also provide for determining the actual doses based upon the historical average atmospheric conditions. The release rate specifications for iodine-131, iodine-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days are dependent upon the existing radionuclide pathways to man, in areas at and beyond the SITE BOUNDARY. The pathways that were examined in the development of these calculations were: 1) individual inhalation of airborne radionuclides, 2) deposition of radionuclides onto green leafy vegetation with subsequent consumption by man, 3) deposition onto grassy areas where milk animals and meat producing animals graze with consumption of the milk and meat by man, and 4) deposition on the ground with subsequent exposure of man.

3-11 REV. 11 02/22/2007

GASEOUS RADWASTE TREATMENT SYSTEM SPECIFICATIONS 3.4.4 The GASEOUS RADWASTE TREATMENT SYSTEM and the VENTILATION EXHAUST TREATMENT SYSTEM shall be used to reduce radioactive materials in gaseous waste prior to their discharge when the projected gaseous effluent air doses due to gaseous effluent releases to areas at and beyond the SITE BOUNDARY would exceed 0.62 mrad for gamma radiation and 1.25 mrad for beta radiation in a calendar quarter. The VENTILATION EXHAUST TREATMENT SYSTEM shall be used to reduce radioactive materials in gaseous waste prior to their discharge when the projected doses due to gaseous effluent releases, to areas at and beyond the SITE BOUNDARY would exceed 0.94 mrem to any organ in a calendar quarter.

APPLICABILITY At all times.

ACTION

a. With gaseous waste being discharged without treatment and in excess of the above limits, in lieu of a Licensee Event Report, prepare and submit to the Commission within 30 days, pursuant to TS 6.9.b.3, a Special Report that includes the following information:

I. Explanation of why gaseous radwaste was being discharged without treatment, identification of any inoperable equipment or subsystems, and the reason for the inoperability,

2. Action(s) taken to restore the inoperable equipment to OPERABLE status, and

3. Summary description of action(s) taken to prevent a recurrence.

SURVEILLANCE REQUIREMENTS 4.4.4 Doses due to gaseous releases from areas at and beyond the SITE BOUNDARY shall be projected once per 31 days in accordance with the methodology and parameters in the ODCM.

3-12 REV. 11 02/22/2007

BASIS Gaseous Radwaste Treatment System - The requirement that the appropriate portions of these systems be used, when specified, provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable."

This specification implements the requirements of 10 CFR 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50, and the design objectives given in Section I.D of Appendix I to 10 CFR Part 50. The specified limits governing the use of appropriate portions of the systems were specified as a suitable fraction of the dose design objectives set forth in Sections II.B and II.C of Appendix I, 10 CFR Part 50, for gaseous effluents.

3-13 REV. 11 02/22/2007

3/4.5 TOTAL DOSE SPECIFICATIONS 3.5 The annual (calendar year) dose or dose commitment to any MEMBER OF THE PUBLIC due to releases of radioactivity and to radiation from uranium fuel cycle sources shall be limited to less than or equal to 25 mrem to the total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrem.

APPLICABILITY At all times.

ACTION

a. With the calculated doses from the release of radioactive materials in liquid or gaseous effluents exceeding twice the limits of ODCM Specification 3.3.2.a, 3.3.2.b, 3.4.2.a, 3.4.2.b, 3.4.3.a, or 3.4.3.b, calculations should be made including direct radiation contributions from the reactor unit to determine whether the above limits have been exceeded. If such is the case in lieu of a Licensee Event Report, prepare and submit to the Commission within 30 days, pursuant to TS 6.9.b.3, a special report that defines the corrective action to be taken to reduce subsequent releases to prevent recurrence of exceeding the above limits and includes the schedule for achieving conformance with the above limits. This special report as defined in 10 CFR 20.2203, shall include an analysis that estimates the radiation exposure (dose) to a MEMBER OF THE PUBLIC from uranium fuel cycle sources, including all effluent pathways and direct radiation, for the calendar year that includes the release(s) covered by this report. It shall also describe levels of radiation and concentrations of radioactive material involved, and the cause of the exposure levels or concentrations. If the estimated dose(s) exceeds the above limits, and if the release condition resulting in violation of 40 CFR Part 190 has not already been corrected, the special report shall include a request for a variance in accordance with the provisions of 40 CFR Part 190. Submittal of the report is considered a timely request, and a variance is granted until staff action on the request is complete.

SURVEILLANCE REQUIREMENTS 4.5.1 Cumulative dose contributions from liquid and gaseous effluents shall be determined in accordance with Surveillance Requirements 4.3.2, 4.4.2, and 4.4.3 in accordance with the methodology and parameters in the ODCM.

4.5.2 Cumulative dose contributions from direct radiation from the reactor unit shall be determined in accordance with the methodology and parameters in the ODCM.

This requirement is applicable only under conditions set forth in ODCM Specification 3.5.a.

3-14 REV. 11 02/22/2007

BASIS Total Dose - This specification is provided to meet the dose limitations of 40 CFR Part 190 that have been incorporated into 10 CFR Part 20 by 46 FR 18525. The specification requires the preparation and submittal of a Special Report whenever the calculated doses from plant generated radioactive effluents and direct radiation exceed 25 mrem to the total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrem. It is highly unlikely that the resultant dose to a MEMBER OF THE PUBLIC will exceed the dose limits of 40 CFR Part 190 if the reactor remains within twice the dose design objectives of Appendix I, and if direct radiation doses from the reactor are kept small. The Special Report will describe a course of action that should result in the limitation of the annual dose to a MEMBER OF THE PUBLIC to within the 40 CFR Part 190 limits. For the purposes of the Special Report, it may be assumed that the dose commitment to the MEMBER OF THE PUBLIC from other uranium fuel cycle sources is negligible. If the dose to any MEMBER OF THE PUBLIC is estimated to exceed the requirements of 40 CFR Part 190, the Special Report with a request for a variance (provided the release conditions resulting in violation of 40 CFR Part 190 have not already been corrected), in accordance with the provisions of 40 CFR 190.11 and 10 CFR 20.2203, is considered to be a timely request and fulfills the requirements of 40 CFR Part 190 until NRC staff action is completed. The variance only relates to the limits of 40 CFR Part 190, and does not apply in any way to the other requirements for dose limitation of 10 CFR Part 20, as addressed in ODCM Specifications 3.3.1 and 3.4.1. An individual is not considered a MEMBER OF THE PUBLIC during any period in which he/she is engaged in carrying out any operation that is part of the nuclear fuel cycle.

3-15 REV. 11 02/22/2007

3/4.6 REPORTING REQUIREMENTS 3/4.6.1 Radioactive Effluent Release Report The Radioactive Effluent Release Report shall include the following:

a. A summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the unit following the format of Regulatory Guide 1.21, "Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants," Revision 1, June 1974.

b. An annual summary of hourly meteorological data collected over the previous year. This annual summary may be either in the form of an hour-by-hour listing on magnetic tape of wind speed, wind direction, atmospheric stability, and precipitation (if measured), or in the form of joint frequency distributions of wind speed, wind direction, and atmospheric stability 4 . This same report shall include an assessment of the radiation doses due to the radioactive liquid and gaseous effluents released from the unit during the previous calendar year. The assumptions used in making these assessment, i.e., specific activity, exposure time and location shall be included in these reports. The assessment-of radiation doses shall be performed based on the calculational guidance, as presented in the ODCM.

c. An assessment of radiation doses to the likely most exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources, including doses from primary effluent pathways and direct radiation, the previous calendar year to show conformance with 40 CFR Part 190, Environmental Radiation Protection Standards for Nuclear Power Operation.

d. A list and description of unplanned releases from the site to UNRESTRICTED AREAS of radioactive materials in gaseous and liquid effluents made during the reporting period.

e. Any changes made during the reporting period to the ODCM.

4 In lieu of submission with the annual Radioactive Effluent Release Report, the licensee has the option of retaining this summary of required meteorological data on site in a file that shall be provided to the NRC upon request.

3-16 REV. 11 02/22/2007

TABLE 3.1 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION Minimum Instrument Channels Action Operable

1. Gross Radioactivity Monitors Providing Alarm and Automatic Termination of Release

a. Liquid Radwaste Effluent Line (R-18) 1

b. Steam Generator Blowdown Effluent Line (R-19) 1 2

2. Gross Beta or Gamma Radioactivity Monitors Providing Alarm But Not Providing Automatic Termination of Release

a. Service Water System Effluent Line (Component cooling, R-20) 1 3

b. Service Water System Effluent Line (Containment fan cooling, R-16) 1 3 Action I - With the number ot channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases may continue provided that prior to initiating a release:

a. At least two independent samples are analyzed in accordance with Surveillance Requirement 4.3.1.1 and

b. At least two technically qualified members of the Facility Staff independently verify the release rate calculations and discharge line valving; Otherwise, suspend release of radioactive effluents via this pathway.

Action 2 - With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue provided grab samples are analyzed for gross radioactivity (beta or gamma) at a lower limit of detection of 1.OE-6 uCi/ml:

a. At least once per week with no indication of primary-to-secondary leakage; or

b. At least once per 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br /> with identified primary-to-secondary leakage (with secondary side activity > 1.OE-05 uCi/ml)

Action 3 - With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue provided that, at least once per 12 hours1.388889e-4 days <br />0.00333 hours <br />1.984127e-5 weeks <br />4.566e-6 months <br />, grab samples are collected and analyzed for gross radioactivity (beta or gamma) at a lower limit of detection of 1.OE-6 uCi/ml. (Note: Failure to complete sampling and analysis prior to 12 hours1.388889e-4 days <br />0.00333 hours <br />1.984127e-5 weeks <br />4.566e-6 months <br /> after the monitor is declared O.O.S. is a violation of this specification).

3-17 REV. 11 02/22/2007

TABLE 3.2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION (Page 1 of 2)

Minimum Instrument Channels Applicability Action Operable Noble Gas Activity Monitor

a. R-13 or R-14

- Waste Gas Holdup System (auto-isolation)

- Auxiliary Building Ventilation System

- Containment Purge 2" line 4 (auto-isolation) 5

b. R-12 or R-21 6

- Containment purge 36" duct (auto-isolation) 6

c. R-15

- Condenser Evacuation System 5

2. Radioiodine & Particulate Samplers

a. Containment Building Vent (R-21)

b. Auxiliary Building Vent (R-13 or 1

• 7 R-14) 1

• 7

3. Sampler Flow Rate Measuring Devices

a. Containment Building Vent Sampler (R-21)

b. Auxiliary Building Vent Sampler 1

• 8 (R-13 or R-14) 1

• 8

• At all times 3-18 REV. 11 02/22/2007

TABLE 3.2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION (Page 2 of 2)

TABLE NOTATIONS Action 4 - With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, the contents of the tank(s) may be released to the environment provided that prior to initiating the release:

a. At least two independent samples of the tank's contents are analyzed, and

b. At least two technically qualified members of the Facility Staff independently verify the release rate calculations and discharge valve lineup; Otherwise, suspend release of radioactive effluents via this pathway.

Action 5 - With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue provided grab samples are taken at least once per 12 hours1.388889e-4 days <br />0.00333 hours <br />1.984127e-5 weeks <br />4.566e-6 months <br /> and these samples are analyzed for gross activity within 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br />.

Action 6 - With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, immediately suspend PURGING of radioactive effluents via this pathway.

Action 7 - With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via the affected pathway may continue provided samples are continuously collected with auxiliary sampling equipment as required in Table 4.4.

Action 8 - With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue provided the flow rate is estimated at least once per 4 hours4.62963e-5 days <br />0.00111 hours <br />6.613757e-6 weeks <br />1.522e-6 months <br />.

3-19 REV. 11 02/22/2007

TABLE 4.0 FREQUENCY NOTATION Notation Frequency5 S Once per shift St Once per 12 hours1.388889e-4 days <br />0.00333 hours <br />1.984127e-5 weeks <br />4.566e-6 months <br /> D Once per 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br /> W Once per 7 days M Once per 31 days Q Once per 92 days SA Once per 184 days R Once per refueling cycle, not to exceed 18 months P Prior to each reactor startup if not done previous week PR Completed prior to each release NA Not applicable 5 A maximum extension not to exceed 25% of the surveillance interval.

3-20 REV. 11 02/22/2007

TABLE 4.1 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REQUIREMENTS Channel Channel Source Channel Functional Instrument Check Check Calibration Test Gross Radioactivity Monitors Providing Alarm and Automatic Termination of Release

a. Liquid Radwaste Effluent Line (R-18) D PR R Q

b. Steam Generator Blowdown Effluent D M R Q Line (R- 19)

2. Gross Beta or Gamma Radioactivity Monitors Providing Alarm But Not Providing Automatic Termination of Release

a. Service Water System Effluent Line D M R Q (Component cooling, R-20)

b. Service Water System Effluent Line D M R Q (Containment fan cooling, R-16) 3-21 REV. 11 02/22/2007

TABLE 4.2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REQUIREMENTS Channel Modes In Which Channel Source Channel Functional Surveillance Instrument Check Check Calibration Test Required

1. Noble Gas Activity Monitor

a. R-13 or R-14 Waste Gas Holdup System PR PR R Q (auto-isolation)

Auxiliary Building Ventilation' D M R Q System Containment Purge 2" line D M R Q (auto-isolation)

b. R-12 or R-21 Containment purge 36" duct D PR R Q (auto-isolation)

c. R-15 Condenser Evacuation System D M R Q

2. Radioiodine Particulate Samplers

a. Containment Building vent W NA NA NA (R-21)

b. Auxiliary Building vent (R-13 W NA NA NA or R-14)

3. Sampler Flow Rate Measuring Devices

a. Containment Building vent D NA R Q sampler (R-21)

b. Auxiliary Building vent sampler D NA R Q (R-13 or R-14)

At all times other than when the line is valved out and tagged.

3-22 REV. 11 02/22/2007

TABLE 4.3 RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM Page 1 of 2 Minimum Lower Limit of Sampling Analysis Type of Activity Detection (LLD)a Liquid Release Type Frequency Frequency Analysis (RCi/ml)

A. Batch Waste Release PR PR Principal Gamma lx10-6 Tanksb Each Batch Each Batch Emittersc 1-131 1xl0-6 PR M H-3 1x1O05 Each Batch Composited Gross Alpha 5x10-7 PR Q Sr-89, Sr-90 5x10 8-6 Each Batch Composited Fe-55 1xl0 B. Continuous Releasese W W Principal Gamma (SG Blowdown) Grab Sample Grab Sample .Emitters' 5x10 7 (TB Sump')

1-131 lxl0-6 W M H-3 1xl0-5 Grab Sample Compositef Gross Alpha 5x10-7 W Q Sr-89, Sr-90 5x10-86 Grab Sample Compositef Fe-55 1x10 3-23 REV. 11 02/22/2007

TABLE 4.3 RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM Page 2 of 2 Table Notations a The LLD is defined, for purposes of these specifications, as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal.

For a particular measurement system, which may include radiochemical separation:

LLD 4.66

• sb E'V* 2.22 x 106*Y* exp-lDt)

Where:

• LLD is the a priori lower limit of detection as defined above, as gCi per unit mass or volume,

" Sb is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate, as counts per minute,

" E is the counting efficiency, as counts per disintegration,

• V is the sample size in units of mass or volume,

" 2.22 x 106 is the number of disintegrations per minute per microcurie,

" Y is the fractional radiochemical yield, when applicable,

?, is the radioactive decay constant for the particular radionuclide, and

• At for plant effluents is the elapsed time between the midpoint of sample collection and time of counting.

• Typical values of E, V, Y and At should be used in the calculation.

It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a measurement system and not as an a posteriori (after the fact) limit for a particular measurement.

b A batch release is the discharge of liquid wastes of a discrete volume. Prior to sampling for analysis, each batch shall be located, and then thoroughly mixed to ensure representative sampling.

c The principal gamma emitters for which the LLD specification applies exclusively are the following radionuclides: Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, Ce-141, and Ce-144. This list does not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the Radioactive Effluent Release Report pursuant to TS 6.9.b.2.

d A composite sample is one in which the quantity of liquid sampled is proportional to the quantity of liquid waste discharged and in which the method of sampling employed results in a specimen that is representative of the liquids released.

e A continuous release is the discharge of liquid wastes of a nondiscrete volume, e.g., from a volume of a system that has an input flow during the continuous release.

f As a minimum, the monthly and quarterly composite samples shall be comprised of weekly grab samples.

g During periods of identified primary-to-secondary leakage (with the secondary activity > 1.OE-05 jtCi/ml),

grab samples are collected daily and analyzed by gamma spectroscopy.

3-24 REV. 11 02/22/2007

TABLE 4.4 RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM Page 1 of 2 Lower Limit of Minimum Detection Sampling Analysis Type of Activity (LLD)'

Gaseous Release Type Frequency Frequency Analysis (p.Ci/ml)

A. Waste Gas Storage PR PR Principal Gamma Ix 10-4 Tank Each Tank Each Tank Emittersb Grab Sample B. Containment PURGE PR PR Principal Gamma lx 10-4 Each Each Purge Emittersb PURGE Grab Sample C. Auxiliary Building and M M Principal Gamma Containment Building Grab Emittersb I X10-4 Vent Sample W 1-131 3x1012 Continuousc Charcoal Sample W Principal Gamma 1x 10]

Continuousc Particulate Emitterb Sample (1-131, others)

M Gross Alpha 1 1xlO01 Continuousc Composite Particulate Sample Q SR-89, SR-90 1xl0j" Continuous' Composite Patriculate Sample lx 10.6 Noble Gas Noble Gases ContinuousC Monitor Gross Beta or Gamma 3-25 REV. 11 02/22/2007

TABLE 4.4 RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM Page 2 of 2 I. Table Notations a The LLD is defined, for purposes of these specifications, as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal.

For a particular measurement system, which may include radiochemical separation:

LLD 4. 6 6

• sb E

• V

• 2.22 x 106

• Y

• exp(- I Dt)

Where:

• LLD is the a priori lower limit of detection as defined above, as ýtCi per unit mass or volume,

• Sb is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate, as counts per minute,

• E is the counting efficiency, as counts per disintegration,

" V is the sample size in units of mass or volume,

" 2.22 x 106 is the number of disintegrations per minute per microcurie,

" Y is the fractional radiochemical yield, when applicable,

• X is the radioactive decay constant for the particular radionuclide, and

• At for plant effluents is the elapsed time between the midpoint of sample collection and time of counting.

• Typical values of E, V, Y, and At should be used in the calculation.

It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a measurement system and not as an a posteriori (after the fact) limit for a particular measurement.

b The principal gamma emitters for which the LLD specification applies exclusively are the following radionuclides: Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, and Xe-138 for gaseous emissions and Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, Ce-141, and Ce-144 for particulate emissions. This list does not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the Radioactive Effluent Release Report pursuant to TS 6.9.b.2.

c The ratio of the sample flow rate to the sampled flow stream flow rate shall be known (based on sampler and ventilation system flow measuring devices or periodic flow estimates) for the time period covered by each dose or dose rate calculation made in accordance with ODCM Specifications 3.4.1, 3.4.2, and 3.4.3.

3-26 REV. 11 02/22/2007

APPENDIX A TECHNICAL BASIS FOR EFFECTIVE DOSE FACTORS - LIQUID RADIOACTIVE EFFLUENTS A-1 REV. 11 02/22/2007

Technical Basis for Effective Dose Factors -

Liquid Effluent Releases To verify that the current approach to determining environmental doses using a simplified method has remained consistent since the previous analysis (performed using effluent data from 1981-1983), a similar evaluation was performed using the liquid effluent release data from 2000-2002. From the effluent data, the dose contribution of the radionuclide mixture can be obtained to provide a simplified method of determining compliance with the dose limits of ODCM Specification 3.3.2. For the radionuclide distribution of effluents from the Kewaunee Power Station, the controlling organ is either the GI-LLI or the liver. The calculated GI-LLI dose is almost exclusively dictated by the Nb-95 releases; the liver dose is mostly a function of the Cs-134 and Fe-55 releases. The radionuclides, Fe-55, Co-58, Co-60, Sr-90, and Cs-137 contribute essentially all of the calculated total body dose. The results of this evaluation are presented in Table A-1. The individual nuclide doses used in the dose comparisons of Table A-1 were calculated using the total curies released via batch and continuous releases as reported in the Annual Radioactive Effluent Release Report, weighted by the appropriate dose factors.

Tritium is not included in the limited analysis dose assessment for liquid releases, because the potential dose resulting from normal reactor releases is negligible. From 2000-2002, the maximum tritium release from the Kewaunee Nuclear Plant to Lake Michigan was 270 curies.

The calculated total body dose from such a release is 1.36E-02 mrem/yr via the fish ingestion and drinking water pathways. This amounts to 0.07% of the design objective dose of 3 mrem/yr.

Furthermore, the release of tritium is a function of operating time and power level and is essentially unrelated to radwaste system operation.

For purposes of simplifying the details of the dose calculational process, it is conservative to identify a controlling, dose significant radionuclide and limit the calculational process to the use of the dose conversion factor for this nuclide. Multiplication of the total release (i.e., cumulative activity for all radionuclides) by this dose conversion factor provides for a dose calculational method that is simplified while also being conservative.

While not present in the 2000-2002 liquid effluent releases, it still remains conservative to use the Cs-134 dose conversion factor (7.09E+05 mrem/hr per gCi/ml, liver) to evaluate the maximum organ dose. Only the reactor-generated radionuclide Nb-95 has a higher dose conversion factor (1.51 E+06 mrem/hr per paCi/ml, GI-LLI). However, since Nb-95 releases are typically less than 5% of the total releases, it is conservative to use the Cs-134 factor. By this approach, the maximum organ dose will be routinely overestimated. For 2000, using this simplified conservative method (CW value of 2.OOE+05 gpm) would overestimate the maximum organ dose as reported in the Annual Radioactive Effluent Release Report by a factor of 234; for 2001, the conservatism is a factor of 109; and for 2002, a factor of 730. This comparison is shown in Table A-2.

A-2 REV. 11 02/22/2007

For the total body calculation, the Cs-134 dose factor (5.79E+05 mrem/hr per gCi/ml, total body) is again used since it is higher than the identified dominant nuclides. For 2000, using this simplified conservative dose calculational method would overestimate the total body dose by a factor of 253; for 2001, the conservatism is a factor of 105; and for 2002, a factor of 601.

For evaluating compliance with the dose limits of ODCM Specification 3.3.2 the following simplified equations may be used:

Total Body Dtb = 1.67E -02x VOL x Acs - 134, TB X Y Ci (A. 1)

CW where:

Dtb = dose to the total body (mrem)

Acs_134,TB 5.79E+05, total body ingestion dose conversion factor for Cs-134 (mrem/hr per lpCi/ml)

VOL = volume of liquid effluent released (gal)

Y-Ci = total concentration of all radionuclides (gCi/ml)

CW = average circulating water discharge rate during release period (gal/min) 1.67E-02 = conversion factor (hr/min)

Substituting the value for the Cs-134 total body dose conversion factor, the equation simplifies to:

Dtb = 9.67E+03xVOL xZCG (A.2)

CW Maximum Organ Dniax '1.67E-02xVOLxAcs 134, L x ci (A.3)

Cw where:

Dmax = maximum organ dose (mrem)

Acs-134,L = 7.09E+05, liver ingestion dose conversion factor for Cs-134 (mrem/hr per

ýtCi/ml)

A-3 REV. 11 02/22/2007

Substituting the value for Acs.134,Liver the equation simplifies to:

Dmix =1.18E +04xVOL (A.4)

Dmx

ý CW X/,%, A4 Only the total body dose need be evaluated by this simplified method since it represents the more limiting (compared with the maximum organ dose) for demonstrating compliance with ODCM Specification 3.3.2.

A-4 REV. 11 02/22/2007

Table A-i Adult Dose Contributions Fish and Drinking Water Pathways 2000 2001 2002 Radio-nuclide Release (Ci) TB Dose GI-LLI Dose Dose Liver Release (Ci) TB Dose GI-LLI Dose Dose Liver Release (Ci) TB Dose GI-LLI Dose Dose Liver Frac. Frac. Frac. Frac. Frac. Frac. Frac. Frac. Frac.

0.03 20005E20013.69E- 20

-Fe-55 4.1E 0.02 0.10 0.04 0.03 0.13 0.19 0.02 0.84 02 02 02 00-58 8.07E- 0.01 0.03 *4.09E- 0.01 0.02 *4.94E- 0.05 0.02 0.02 03 03 03 Fe-59 2.77E- , , , 2.44E- , , , 1.65E- 0.01

• 0.02 04 04 04 Co-60 4.71E- 4.31EB- 2.07E-0.02 0.04 0.01 0.02 0.05 0.01 0.06 0.02 0.03 03 03 03 Br-82 4,941- 0.01 *

• 1.44E- * *

• N/D * *

• 04 04 Sr-90 2.25E- 0.18 0.01 2.50E-2 0.25 0.01 9.76E- 0.63 04 04 05 Nb-95 3.41E- , 0.89

• 2.39E- , 0.86

• 2.45E- , 0.91

• 04 04 04 Cs-137 3.70E- 2.74E- 3.04E-0.75 0.01 0.88 0.68 0.01 0.85 0.05 0.08 04 04 06

• Less than 0.01 N/D = not detected A-5 REV. 11 02/22/2007

Table A-2 Adult Liver and Total Body Dose Assessment Dose Via the Simplified Method Versus the Actual Calculated Dose 2000 2001 2002 Simplified Liver Dose (mRem)* 1.16E+00 9.87E-01 7.88E-01 Actual Liver Dose (mRem)** 4.97E-03 9.02E-03 1.08E-03 Simplified divided by Actual 234 109 730 Simplified Total Body Dose (mRem)

• 9.53E-01 8.09E-01 6.46E-01 Actual Total Body Dose (mRem)

• • 3.77E-03 7.73E-03 1.07E-03 Simplified divided by Actual 253 105 601

• Assuming 2.OOE+05' gpm circulating water flow

• • From the Annual Radioactive Effluent Release Report A-6 REV. 11 02/22/2007

APPENDIX B TECHNICAL BASIS FOR EFFECTIVE DOSE FACTORS -

GASEOUS RADIOACTIVE EFFLUENTS B-1 REV. 11 02/22/2007

APPENDIX B Technical Basis for Effective Dose Factors -

Gaseous Radioactive Effluents Overview The evaluation of doses due to releases of radioactive material to the atmosphere can be simplified by the use of effective dose transfer factors instead of using dose factors, which are radionuclide specific. These effective factors, which can be based on typical radionuclide distributions of releases, can be applied to the total radioactivity released to approximate the dose in the environment (i.e., instead of having to perform individual radionuclide dose analyses only a single multiplication (Keff, Meff or Neff) times the total quantity of radioactive material released would be needed). This approach provides a reasonable estimate of the actual dose while eliminating the need for a detailed calculational technique.

Determination of Effective Dose Factors Effective dose transfer factors are calculated by the following equations:

Keff = Z(Kxfi) (B.1) where:

Keff the effective total body dose factor due to gamma emissions from all noble gases released Ki = the total body dose factor due to gamma emissions from each noble gas radionuclide "i" released f= the fractional abundance of noble gas radionuclide "i" relative to the total noble gas activity (L + 1. 1M)w = I [(L + 1. 1Mi)x fi] (B.2) where:

(L + 1. 1 M)eff = the effective skin dose factor due to beta and gamma emissions from all noble gases released (Li + 1.1 Mi) = the skin dose factor due to beta and gamma emissions from each noble gas radionuclide "i" released Meff = I (Mixfi) (B.3) where:

Meff = the effective air dose factor due to gamma emissions from all noble gases released B-2 REV. 11 02/22/2007

Mi the air dose factor due to gamma emissions from each noble gas radionuclide "i" released Nff YZ(Nixf,) (B.4) where:

Neff the effective air dose factor due to beta emissions from all noble gases released Ni = the air dose factor due to beta emissions from each noble gas radionuclide "i" released Normally, it would be expected that past radioactive effluent data would be used for the determination of the effective dose factors. However, the noble gas releases from Kewaunee have been maintained to such negligible quantities that the inherent variability in the data makes any meaningful evaluations difficult. For the years of 2000, 2001 and 2002, the total noble gas releases have been limited to 2.54E-04 Ci for 2000, 1.37E-01 Ci for 2001, and 1.91E-02 Ci for 2002. Therefore, in order to provide a reasonable basis for the derivation of the effective noble gas dose factors, the primary coolant source term from ANSI N237-1976/ANS-18.1, "Source Term Specifications," has been used as representing a typical distribution. The effective dose factors as derived are presented in Table B-1.

Application To provide an additional degree of conservatism, a factor of 0.50 is introduced into the dose calculational process when the effective dose transfer factor is used. This conservatism provides additional assurance that the evaluation of doses by the use of a single effective factor will not significantly underestimate any actual doses in the environment.

For evaluating compliance with the dose limits of ODCM Specification 3.4.2, the following simplified equations may be used:

-=3 . 7 E- 0 8 X/QxMeffXZQi (B.5) 0.50 Df3=3.1 7 E -08 XX/QxNeffx-Qi (B.6) 0.50 where:

Dy = air dose due to gamma emissions for the cumulative release of all noble gases (mrad)

Dp3 = air dose due to beta emissions for the cumulative release of all noble gases (mrad)

X/Q = atmospheric dispersion to the controlling site boundary (sec/m 3 )

B-3 REV. 11 02/22/2007

Meff = 5.3E+02, effective gamma-air dose factor (mrad/yr per gCi/m 3) 3)

Neff = 1.1E+03, effective beta-air dose factor (mrad/yr per ýtCi/m Y_Qi = cumulative release for all noble gas radionuclides (ýLCi) 3.17E-08 = conversion factor (yr/sec) 0.50 = conservatism factor to account for the variability in the effluent data Combining the constants, the dose calculational equations simplify to:

D= 3.5E-05xI/Qx- Qi (B.7) and D T7.OE-05xX/Qx Q (B.8)

The effective dose factors are used on a very limited basis for the purpose of facilitating the timely assessment of radioactive effluent releases, particularly during periods of computer malfunction where a detailed dose assessment may be unavailable. Dose assessments using the detailed, radionuclide dependent calculation are performed at least annually for preparation of the Radioactive Effluent Reports. Comparisons can be performed at this time to assure that the use of the effective dose factors does not substantially underestimate actual doses.

B-4 REV. 11 02/22/2007

Table B-1 Effective Dose Factors - Noble Gases Total Body Effective Skin Effective Dose Factor Dose Factor Keff (L+I.1 M)eff Radionuclide fi (mrem/yr per RCi/m 3) (mrem/yr per RCi/m 3)

Noble Gases - Total Body and Skin Kr-85 0.01 -- 1.4E+01 Kr-88 0.01 1.5E+02 1.9E+02 Xe-133m 0.01 2.5E+00 1.4E+01 Xe-133 0.9 3.OE+02 6.6E+02 Xe-135 0.02 3.6E+01 7.9E+01 TOTAL 4.8E+02 9.6E+02 Noble Gases - Air Gamma Air Effective Beta Air Effective Dose Factor Dose Factor Meff Neff Radionuclide fi (mrad/yr per ptCi/m 3) (mrad/yr per gCi/m 3)

Kr-85 0.01 -- 2.OE+01 Kr-88 0.01 1.5E+02 2.9E+01 Xe-133m 0.01 3.3E+00 1.5E+01 Xe-133 0.95 3.4E+02 1.OE+03 Xe-135 0.02 3.8E+01 4.9E+0I TOTAL 5.3E+02 1.1E+03 B-5 REV. 11 02/22/2007

APPENDIX C EVALUATION OF CONSERVATIVE, DEFAULT EFFECTIVE EC VALUE FOR LIQUID EFFLUENTS C-1 REV. 11 02/22/2007

Appendix C Evaluation of Conservative, Default Effective EC Value for Liquid Effluents In accordance with the requirements of ODCM Specification 3.1 the radioactive liquid effluent monitors shall be operable with alarm setpoints established to ensure that the concentration of radioactive material at the discharge point does not exceed 10 times the value of 10 CFR 20, Appendix B, Table 2, Column 2 for all radionuclides other than noble gases and a value of 2X10-4 tCi/ml for noble gases. The determination of allowable radionuclide concentration and corresponding alarm setpoint is a function of the individual radionuclide distribution and corresponding EC values.

In order to limit the need for routinely having to reestablish the alarm setpoints as a function of changing radionuclide distributions, a default alarm setpoint can be established. This default setpoint can be conservatively based on an evaluation of the radionuclide distribution of the liquid effluents from Kewaunee and the EC, value for this distribution.

The effective EC value for a radionuclide distribution can be calculated by the equation:

-Ce Ci (C.1)

CiEl where:

ECe = an effective EC value for a mixture of radionuclide (gCi/ml)

Ci = concentration of radionuclide "i" in the mixture ECi = the 10 CFR 20, Appendix B, Table 2, Column 2 EC value for radionuclide "i"

(ýICi/ml)

Based on the above equation and the radionuclide distribution in the effluents for past years from Kewaunee, an ECe value can be determined. Effluent release data from 2000-2002 was used to generate the results presented in Table C-1. The most limiting effective EC (for gamma emitting radionuclides) was for the calendar year 2001, with a calculated value of 5.98E-06 gCi/ml. For conservatism in establishing the alarm setpoints, a default effective EC value of 1.OE-06 [iCi/ml was selected. The overall conservatism of this value is reaffirmed for future releases considering that 1.OE-06 tCi/ml is as or more restrictive than the individual EC values for the principal fission and activation products of Co-58, Co-60 and Cs-137. Overall, use of this effective EC value provides a factor of six (6) conservatism based on the 2000-2002 radionuclide distribution for gamma emitters.

C-2 REV. 11 02/22/2007

Being a non-gamma emitter, tritium is not detected by the effluent monitor. While tritium accounts for nearly all of the activity, it is not a significant contributor when determining the alarm setpoint for release rate evaluations. Examining releases over the years 2000-2002, the average, diluted H-3 contribution to its limiting concentration (i.e., fraction of concentration limit - 10 x EC) in liquid effluents was 0.004%. This contribution is not expected to change significantly over time, since the concentration of H-3 in effluents can be expected to remain fairly consistent in effluent releases regardless of fuel conditions, activation product releases, and waste processing.

Based on relative abundances, other non-gamma emitting radionuclides (Fe-55 and Sr-89/90) contributed up to 30% of the concentration limit (30% for CY 2001). It is reasonable to assume that the abundances of these non-gammas will remain the same relative to other fission and!or activation products under varying conditions. Therefore, under conditions of elevated effluent radionuclide levels, the gamma-emitting radionuclides can be expected to be the main contributors to limiting conditions on liquid effluent concentrations, as established in Technical Specification 6.16.b. 1.B and ODCM Specifications 3.3.1. Note that including the non-gammas (excluding tritium) in the evaluation results in a higher effective EC value.

Therefore, under conditions of elevated effluent levels, the main contributor to the limiting conditions of the liquid effluent concentration would be the gamma-emitting radionuclides. The factor of six (6) conservatism in the effective EC determination (discussed above) provides adequate consideration for the contribution from non-gamma emitting radionuclides, and provides a conservative basis for establishing an alarm setpoint consistent with the requirements of Technical Specification 6.16.b. 1.B and ODCM Specifications 3.3.1.

C-3 REV. 11 02/22/2007

Table C-1 Calculation of Effective EC (ECe) 2000  : 2001 - 2002 EC -_

Nuclide Release Release Release

, , (Ci)_ _ Cj/ECi Frac. (Ci) C/ECi Frac. (C) Cj/ECQ Frac.

Na-24 5.OOE-05 1.03E-03 2.06E+01 4.89E-03 2.18E-04 4.35E+00 1.27E-03 0.OOE+00 0.OOE+00 0.OOE+00 Cr-51 5.OOE-04 1.44E-03 2.89E+00 6.85E-04 8.26E-04 1.65E+00 4.83E-04 0.OOE+00 0.OOE+00 0.OOE+00 Mn-54 3.OOE-05 1.49E-04 4.97E+00 1.18E-03 3.30E-04 1.1OE+01 3.22E-03 6.41E-05 2.14E+00 9.83E-04 Fe-55 IOOE-04 4.8 1E-02 4.8 1E+02 1.14E-01 4.85E-02 4.85E+02 1.42E-01 3.69E-02 3.69E+02 1.70E-01 Co-57 6.OOE-05 0.OOE+00 0.OOE+00 0.OOE+00 2.42E-05 4.03E-01 1.18E-04 0.OOE+00 0.OOE+00 0.OOE+00 Co-58 2.OOE-05 8.07E-03 4.04E+02 9.59E-02 4.09E-03 2.05E+02 5.99E-02 4.94E-03 2.47E+02 1.14E-01 Fe-59 IOOE-05 2.77E-04 2.77E+01 6.57E-03 2.44E-04 2.44E+01 7.14E-03 1.65E-04 1.65E+01 7.6 1E-03 Co-60 3.OOE-06 4.71E-03 1.57E+03 3.73E-01 4.31E-03 1.44E+03 4.21E-0I 2.07E-03 6.89E+02 3.17E-0I Br-82 4.OOE-05 4.94E-04 1.23E+01 2.93E-03 1.44E-04 3.59E+00 1.05E-03 0.OOE+00 0.OOE+00 0.OOE+00 Sr-89 8.OOE-06 3.42E-04 4.27E+01 1.01E-02 2.59E-04 3.24E+01 9.48E-03 5.98E-04 7.48E+01 3.44E-02 Sr-90 5.OOE-07 2.25E-04 4.50E+02 1.07E-01 2.50E-04 5.OOE+02 1.46E-01 9.76E-05 1.95E+02 8.98E-02 Zr-95 2.OOE-05 1.16E-04 5.79E+00 1.38E-03 7.18E-05 3.59E+00 1.05E-03 5.24E-05 2.62E+00 1.20E-03 Nb-95 3.OOE-05 3.41E -04 1.14E+01 2.70E-03 2.39E-04 7.95E+00 2.33E-03 2.45E-04 8.17E+00 3.76E-03 Ag- l11m 6.OOE-06 2.85E-03 4.74E+02 1.13E-0I 1.63E-03 2.72E+02 7.97E-02 2.86E-03 4.76E+02 2.19E-01 Sn-113 3.OOE-05 9.65E-05 3.22E+00 7.64E-04 5.08E-05 1.69E+00 4.95E-04 7.06E-05 2.35E+00 1.08E-03 Sb-124 7.OOE-06 5.61E-04 8.01E+01 1.90E-02 1.81E-04 2.59E+01 7.59E-03 4.34E-05 6.20E+00 2.85E-03 Sb-125 3.OOE-05 4.86E-03 1.62E+02 3.85E-02 1.02E-03 3.41E+01 9.99E-03 2.46E-03 8.18E+01 3.76E-02 1-132 1.OOE-04 0.OOE+00 0.OOE+00 0.OOE+00 7.75E-08 7.75E-04 2.27E-07 0.OOE+00 0.OOE+00 0.OOE+00 1-133 7.OOE-06 6.16E-04 8.80E+01 2.09E-02 6.32E-04 9.03E+01 2.65E-02 0.OOE+00 0.OOE+00 0.OOE+00 1-135 3.OOE-05 0.OOE+00 0.OOE+00 0.OOE+00 4.61E-05 1.54E+00 4.50E-04 0.OOE+00 0.OOE+00 0.OOE+00 Cs-137 1.OOE-06 3.70E-04 3.70E+02 8.78E-02 2.74E-04 2.74E+02 8.02E-02 3.04E-06 3.04E+00 1.40E-03 Total 7.46E-02 4.21E+03 L.OOE+00 6.34E-02 3.42E+03 1.OOE+00 5.06E-02 2.17E+03 1.OOE+00 Non-Gamma Fraction 0.23 0.30 0.29 Gamma Fraction 0.77 0.70 0.71 ECe (puCi/ml, total) 1.77E-05 1.86E-05 2.33E-05 ECe (luCi/ml, gammas) 8.03E-06 5.98E-06 8.44E-06 C-4 REV. 11 02/22/2007

APPENDIX D Site Maps D-1 REV. 11 02/22/2007

Appendix D Site Maps Plant drawing A-408, "Radiological Survey Site Map" depicts the site area by illustrating the site boundary and the restricted areas. Plant drawing A-449, "Plan of Plant Area, Fence, Lighting, and CCTV Support Structure" shows the layout of the site buildings. Members of the public are restricted from access to all areas of the Owner Controlled Area (OCA).

Figure D-l presents the locations and elevations of radioactive effluent release points at the plant. The plant drawings referenced above are not included as part of the ODCM but can be found in the plant drawing system.

D-2 REV. 11 02/22/2007

Figure D-1 KEWAUNEE COUNTY n.

LAKE MICHIGAN LEGEND I A CONTAINMENT BUILDING VENT ELEVATION 775' B AUXILARY BUILDING VENT ELEVATION 675' C = EFFLUENT LIQUID DISCHARGE ELEVATION 580'

-1 D-3 REV. 11 02/22/2007

APPENDIX E On-site Disposal of Low-Level Radioactively Contaminated Waste Streams E-1 REV. 11 02/22/2007

Appendix E consists of hard copies of the following reference documents:

DESCRIPTION DATE DOCKET NUMBER Operating License DPR-43 Kewaunee Nuclear Power Plant October 17, 1991 NRC-91-148 Disposal of Low Level Radioactive 50-305 Material Proposed Disposal of Low Level Radioactive Waste Sludge Onsite at the June 17, 1992 K92-119 Kewaunee Nuclear Power Plant (TAC No. 50-305 M75047)

Safety Evaluation For An Amendment To An Approved 10 CFR 20.302 Application September 14, 1994 K-94-195 For The Kewaunee Nuclear Plant (TAC 50-305 No. M89719)

Alternate Disposal Of Contaminated Sewage Treatment Plant Sludge In November 13, 1995 K-95-172 Accordance With 10 CFR 20.2002 (TAC 50-305 No. M93844)

Onsite Disposal Of Contaminated Sludge K-97-64 Pursuant To 10 CFR 20.2002 (TAC No. April 9, 1997 50-305 M97411)

Adapted from N E-2 REV. 11 02/22/2007

WPSC ý414) 433.15ý8 AIRC 91-149 TEt..EC0PIR i1~i4:1-54 WISCONSIN PUBIC SERVICE CORPORATION

\OrO. Acya $s 0 Do 9CG2

• Gre, Bay. W.j5,13r7'-%:2 hc-K M4Bunow, MJ(ti JN N' orrison D2 A J Riege D2ý 1 7 B~oys, WPL, J R Muveller D2 C A Schrock KNP Larry Nielsen, ANFC t.S .Nalepka KNP D R Berg.KNP C .S Smoker KNP L. A Nuthals D2 (NSRAC) C R Steinhardt D2 D A Sollom0 6 RPT Pulec D2 R E.Drahvim~kNp, J I Wattacc KNP I S Richmond 02 K 1HWeinhauer .KN?

K H Evers 131 O5Ristau D2 M L Macl KNP S FWozniak D2 I RsonKNP p QA Vault KNP D L Mlasarik XKNP 7--7 W46ri &AIRJ October L7, 1991, U. S.Nuclear, Regulatory.Commission ATftN: Document Control Desk J;-

Washingt6n; D.C. 20555:

'-i Gentlemen:

Docket 50-305 Operating License DPR-43:

Kewaunee Nuclear Power Plaht Disposal of Low Level Radioactive Mae[ig

References:

I) 'Letter fromK.H.Evers to Document Control Desk dated September 12, 1989

2) Letter fromrMJ.Davis to K.H.Evers dated February 13, 1990

3) Letter .from L-Sridharon OVDNR) to.MVandenbusch dated June 1.3, 199.1 In reference I, pursuant..to the' regulation.oft 10 CFR 20.302, Wisconsin Public Service

Corporation (,PSC) request . -d authorization for the alternative disposal of very-low-level radioactive maiterialsfro6m the KeWaunlee Nuclear Power Plant. In reference 2, the US NRC ildentified additional questions that .needed ,to be addressedin order to complete' their review.

Attachment I provides our response to..the questions.

WPSC ruqtesred the State of Wi0conmin Department of Natral Resources (WDNR) Lt rCvidw the dispq.sal options for the service water pretreatment lagoon sludges. In reference 3, WDNR completed a review of the: most:!appropriate on site disposal methods for the..slighii,.

c0ntamia:ted service".water .pretreatment: lagoon slvdges., The two proposed methods :that the, WDNR evaluated included in-situ capping of the sludge in the wastewater treatment lagoon and on site landspre4ding, In Attachment 1, Appendix A, .WPSC evaluated'the on site landspreading E-3 REV. 11 02/22/2007

Document Control Desk October 17, 1991 Page 2 application which is our preferred disposal method. WPSC does not interd to utilize the in-situ cajpping of the sludge in the lagoon at this time. However, in the letter the WDNR agreed -that either disposal method was acceptable provided:

- if the materialtis to be. left in the lagoon, it would be capped in accordance with Wisconsin State statutes.

-,if the on site landspreading option is utilized, the material, would be spread by either' disking into the soil or by spiking into the ground..

WPSC will. abide by the WDNR landspreading requirements Which include locational and performance standards. Should there be any additional questions please feel free to contact a member of my lsiaff.

Sinncerely, C. A. Schrock Manager - Nuclear Engineering DJM/j ins Attach.

cc -. US NRC - Region .!!i MNr.' Patrick Cas Ieman, US NkC Llc\bjM\N40 E-4 REV. 11 02/22/2007

ATTACHMENT I To Letter from K. H. Evers (WPSC) to Document Control Desk (NRC)

Dated October 17, 1991 E-5 REV. 11 02/22/2007

Document Control Desk October 17, 1991 , Page. 1 References 1) Letter from K. H. Evers to Document Control Desk dated September 1, 1989.

NRC Question #1

'On page 4 of your isubmittal, the average input to the Sewage Treatment System is approximately 11,000 gallons per day. In the Final Environmental Statement, N5is system is to, be operated below its design capacity of 9,000

,gallons per day. Discuss this devidtion fronfi the design.capacity, and provide information to justify the higher output for this system.

WPSC Response The original Sewage Treatment System 7installed at theiKewaunee Nuclear Power Plant,(KNPP) was replaced in 1986'with a-higher capacity system. The original system was designed forzan onsite work force of-around 150 people.

It wasp a limited capacity aerobic treatment system which included the onsite lagoon for additional retention. Because of this limited capacity and more stringent conditions on system effluent to Lake Michigan, an aerobic digester

. system was installed, which has ahigher capacity, and uses-current technology.

The estimated input. volume. to the-Sewage Treatment System used in the September 12, 1989 application was. 11,000 gallons'.per day. This value was.

based on. past operating data.. Thejincrease:in. nfluent from-the original design basis included in the. Final Environmintal Statement is due mainly .to an increase in the:number of individuals and facilities: (e.g., training and simulator building), located onsite. Design changes to:the system.were required to aIccommo*ate ý,these new' facilities.

E-6 REV. 11 02/22/2007

Document Control Desk, October 17, 1991 , Page 2 The current volumes of sewage Sludge were used as the basis for the potential dose analysis and corresponding radionuciide concentration limits. This increase has no significant-effect on the dose modeling. (Refer to the response to NRC Question .#2, below.)

NRC Question #2 Provide information regarding how the disposal plan assures that the annual dose to any exposed individual will be kept below 1 mrem per year.

WPSC Response The dose pathway modeling used. for determining the radioactive material concentrutiotv limits was based on. NRC. modeling, The computer code IMPACTS-BRC was used as the. basis. for calculating the potential doses from the alternative disposal methods. This modeling includes reasonable conservative exposure pathtway scenarios for. the various disposal methods.

Administrative controls will:be establishedjto ensure' that the actual disposal of any.slightly contaminated materials fr0m KNPP are within the bounds ofthie.

evalu.tioný Samples from each of the waste streams will*be collected and analyzed by gamma spectroscopyý prior to rekase for disposal. A system.

lower limit of detection (LLD) of SE-07 ,Ci/ml for the principal gamma e.mitting radionuclides wilibe required. This LLD ensures the identification of

any: contaminated materiils ;at a fraction of the allowable. concentration limits for the alternative disposal.

The results of'these analyses will be:used to ensure that. any detectable levels,.

'or rdioactive material are witihin the *limits for alternative disposal. Any

• materiais with levels of radioactive material.above, the concentration limits E-7 REV. 11 02/22/2007

Document ,Control Desk October 17, 1991 , Page 3 (and of plant origin) will be treated as a radioactive waste and appropriately confrolled.

Records will be maintained to ensure that the cumulative disposal of any contaminated, materials are maintained within the bounds of the evaluation. In addition to a comparison of the individual radionuclide concentration limits, a record of the total amount of radioactive material disposed of -will be maintained. Cumulative totals will be maintained to ensure that the total activity does not exceed the quantity assumed in the derivation of the'limits.

In developing.the concentration limits presented in Table I of reference 1, it was assumed the total annual design basis volume of 27,000 ft3 would be contaminated at, the derived limit. The dose commitment from each radionuclide was individually evaluated as if it were the only radioactive material present. To determine if a mixture of radionuclides meets the limit, the sum-of-the-fractions rule should be applied (i.e., the sum of each radionuclide's concentration divided by its limiting concentration must be less than one).

The concentration limits of Table 1 of reference I also have an implied total activity limit, This limit'is determined by multiplying the individual radionuclide concentration limit by the total :estimated waste volume of 27,000 ft3. These total activity limits are presented in Table A of this response, for each radionuclide individually. For a mixture of radionuclides, a total annual activity limit may be determined by normalizing the concentrations so that the sum-of-the-fractions for the mixture equals one (1). These resultant adjusted concentrations may be multiplied by the 27,000 ft 3 wAste volume to determine the corresponding total activity limit of the m ixture. . . . .. . . . . .

E-8 REV. 11 02/22/2007

Document Control Desk October 17, 1991 , Page 4 A Disposal Log will be maintained on a calendar year basis for all disposals of any very-low-level radioactive materials. The log will contain as a minimum the following information:

• Disposal location

• Description of waste Shipment/disposal date

• Waste volume

" Radionuclide concentrations (gamma emitters)

" Year-to-date radionuclide activity

. Year-to-date waste volume In addition to. the above Disposal Log, .a record file will be kept for each" individual disposal. This file will contain, as a minimum, the following information:

Waste identification

- Sample gamma spectroscopy results

- Identified radionuclide concentrations and total activity NRRC Questin "#3*

Revise Appendix B, Section A of your submittal, "Radiation Exposure During Transport,' by adding the cumulative dose to the exposed population per reactor year for both ýthe transportation worker and the general public (onlookers along route).

WPSC Response The potential exposure to the general public (onlookers along route). is modeled by the IMPACTS-BRC code. As addressed in NUREG/CR-3585, this modeling is based on an integration of the source strength, an assumed E-9 REV. 11 02/22/2007

Document Control Desk October 17, 1991 , Page 5 population density along route and vehicular speed. Fora conservative evaluation of the potential exposure to the general public from .the transport of the KNPP waste, a.population density-of 610 persons/mi2 was assumed. This value is conservative for theKM P, site area where the average population density is less than 53 persons/mi 2 . -Atransport.distance of 4-5 miles was assumed. The IMPACTS-BRC modelingassumes 'five (5) tons of material are transported per shipment. For the assumed KNPP waste volume, this shipment wieight translates ýinto atotalbWof 167 shipments per year, With a vehicular speeW of 20 miles per hour, tbheresultant total population exposure time is 375 person-hours per year. Atthe concentration limits established for the alternative disposal, the' potentibonlooker doses during transport will be less than 0.01 person-remnper year.. Forjthe modeling of the exposure to the transport worker, theIMPACTS-BRC mode l.. assumes two 'drivers per vehicle.,

Aspresented in the September 112, 1989 Submittal, the maximum dose to the driver is less than Lmrem per year(<0.00L rem/yr). Therefore, the total collective dose to the transport workers will be twice the individual dose, .i.e.,

less than 0.002 person-rem. Including'.thle population dose of <0.01 person-rein pei year, the total collective dose t6 both the transport workers and the population is less than 0.02'p:rson-r-em (0.002 pers0n-rem + 0.01 person-remi

< 0.02 perý0n-rern).

For the disposal of thi exisfting 15,000 ft3' f contaminated sludges, the pppulation dose dlue'to :the transportation: of the waste is calculated to be 0.0002, person-rem.. The estimatedcolliecicve exkposre to the transport worker is0.0000,7 person-rem.. The total collective dose:due :to transport of the waste is 0'00027 person-rem..

E-10 REV. 11 02/22/2007

Document Control Desk October 17, 1991 , Page 6 Additional Potential Disposal Method The Wisconsin Department of Natural Resources has requested Wisconsin Public Servicez to examine the feasibility of land application of the lagoon sludges in: lieu of disposal, in, the Kewaunee County Landfill.

Land application is also :ah option; for the disposal of the"sewage sludges, Therefore, WPS requests that :the: option for ontsite disposal atý the KNPP. site ,by land application be included in the altermative disposal.methods which was determined to be acceptable in :our September 12,. 1.989 submittal.

The potential pathways of exposure as evaluated in the September 12, 1989 submittal.co~nservatively bound any additional pathways of exposure that would result:from onsite land -spreading.ofthe waste. Attachment A to this response provide's. an overview .of the land spreading disposal method. Also, the pathways !of exposure applicable to-the onsite la*nd application are evaluated; and a comparison to the controlling pathways and radionuclide concentrations as presented in the ýSeptember '12,. 1989 submittal are discussed. From a modeling standpoint,- the two-exposure scenarios, "Radiation Exposure During Transport' and "Radiation Exposure to, Landfill Operator," appropriately characterize: any poteritial exposure to workers involved with the land spreading of the waste. The other post-disposal exposure scenarios, "Intruder Scenario", "Intruder Well", and "Exposed Waste Scenario," as described in NUREG/CR-3585 (and as discussed in Appendix C of the submittal) reasonably bound.any.potential.exposures from either ground waste migration or post-release from the Kewaunee. site. In no case is,there a higher potential for exposure from land application than the pathways and potential: exposures ihat~were used .for the derivation of the limits for alternative disposal.

Therefore, no revisions are needed to the radi6ouclide concentrationý.limits prpobsedýin the ..September 1-2, 1989 submittal to include the option for' disposal by. onsite laind spreading.of, the :waste.

E-11 REV. 11 02/22/2007

Document Control Desk October 17, 1991 , Page 7 Table A Radionuclide Quantity Limits for Alternative Disposal Limiting Limiting Annual Nuclide Concentration Quantity

(!Ci/ml) (Ci)

H-3 9.65E-04 0.7382 C.-14 4.55E-05 0.0348 Cr-51 3.13E-04 0,2394

'Mn-54 1.14E&05 0.0087, Fe-55 L-OOE-02 7,6500 Fe-59 7.90E-06 0.0060 Co-58 1.16E-05 0.0089 Co-60 3.74E706 0.0029 Ni-63 1.00E-02 7T6500' Sr-90 3.45E-03 2.6393 Zr-95 6,28E-06 0.0048 Nb-95 1.23E-05 0.0094 Mo-99 6.73E-05 0.0515 Tc-.T99 2.70E-04. 0.2066

.[129 2.50E-06 0.0019 1-131 2.68E-05 0.0205 Cs- 134 6.16E-06 0.0047 Cs-137 1.71 E-05 :0.0131.

Ba-140 5.52E-05 0.0422 La-140 4117E-06 0.0032 Transuranics:

STRU (T'A- > 5 yrs) 8.91E;-05 0.0682 PU-24.1 2.85F--03. 2.1803 Crn-m242 I M.OE-02" 7.-6500 Assumes annual quantity of KNPP wastes is 27,000 ft3 or, 7.65E8 mls.

E-12 REV. 11 02/22/2007

Document Control Desk October 17, 1991 , Page 8 Appendix A Evaluation of Onsite Land Application for Altemative Disposal of Very-Low-Level Contaminated Materials Overview Land spreading of lagoon: sludges onsite at the Kewaunee Nuclear Power Plant has been recommended by.personnel from the Wisconsin Depa'rtment of Natural Resources (DNR) :as a desirable alternative to the use of the Kewaunee County Landfill.for disposal. This method ofdisposal is also a recommended practice for dispbsing ofsewage tr:a.menr faility Sludges.

Therefore, W.PS requests that this disposal meth~od be included .in the options'avaiIable fdr the alternative disposal of very-low-level radioactively ceontaminatetdt-materialsýlfromKNPP..

Description of Disposal Method The disposal of KNPP.sludges will be performed by benieficial land application to a dedicated disposal area located onsite-at the Kewaunee Nuclear Power Plant. Typical methods of lafid spreading will be employed. KNPP sludges Will beI oaded onto appropriate vehicles (e~g.,

tanker truck, sludge spreader, etc.) and applied to: the dedicated disposal area. The. dedicated disposal. area will be periodically plowed to a deptl of .6.: inches.

Onsite disposal of water treatment and sewage sludges are allowed by EPA and State of Wisconsin Department ofNatural Resources with the criteria and limits for land spreading being. specified by the potential use of:theland. The two land use, criteria, are 1) Agricultural land that covers any lands upon which. food crops are grown or animals axe grazed for.,

humiran consumnptioni,-and 2) Non-Agricultural land that covers lands which do no represent ingestion pathways to man. To be conservative, the.Agricultural Land Application. limnits of sludge contaminants will be applied to the KNPP wastes. even :though the less.restrictive Non:

Agricultural Land Application sludge contamination limits afe"Allowed. Therefore, no more

,to 64an"50 metric tons Of sl*dge per hectare4will be applied ,the dedicated disposal site. This linii will ensure that an'y and application will not exeeW: the.bounds of the dose analysis ýas E-13 REV. 11 02/22/2007

Document Control Desk October 17, 1991 , Page 9 performed previouslyw In addition, other .limitations as applied to land application by the State of Wisconsin Department. of Natural Resources will be followed (e.g., control of runoff/erosion, proximity to wells/residences~surfacm water, etc.).

Applicable. Pathways of ýExposure The pathways of exposure applicable for land spreading are not appreciably different from the pathways evaluated for the, disposal methods .attthe Kewaunee County Landfill or the Green Bay Metropolitan Sewerage.District facilities, The major exposure pathways are discussed below:

Direct Exposure to Workers Any potential exposures to workers involved in the removal, tiransport and land spreading of the sludges are:reasonably bound by ,the evaluation of the exposure to the transport worker in.the September 12, 1989 submittal, The transport 'woiker, has been assumed to.be exposed for 460 "hours per year at one (1) meter 'from unshielded waste. For the land spreading of these wastes, it is estimated that the total exposure time .for the removal-and disposal of the lagoon sludges will require: n1oIlonger than a three week period per ýyeaif(i.e.,

120 hours0.00139 days <br />0.0333 hours <br />1.984127e-4 weeks <br />4.566e-5 months <br />).

The potential exposure to a worker onsite after land spreading, has been etstimatiedat no more: that 100 hours0.00116 days <br />0.0278 hours <br />1.653439e-4 weeks <br />3.805e-5 months <br /> per year. Such an individual would be inyolyedin.land maintenance activities, such as pIlwing and mowing. As modeled in the September 12, 1989 sdbmittal, an exposure of 2000 hour0.0231 days <br />0.556 hours <br />0.00331 weeks <br />7.61e-4 months <br />sp~er year. to the landfill operator has been ýassumed. For this exposure,. the KNPP materials are mixed, with other landfll Waste: a 1:13 mixing of KNPP materialsto :other waste :is assumed. This mixing isý not significantly different froim the type of mixing that will-occur in the field: with the.sludges being E-14 REV. 11 02/22/2007

Document Control Desk October 17, 1991 , Page 10 plowed into theý soil to a depth of six (6). inches. With a land spreading of 50 metric tons per hectare per year, a mixing ratio of. 1:30 will be achieved.

Therefore, the resultant dose to the exposed worker would, be less than the I mrem per. year"dose to the transport worker as evaluated in the.Septemnber 12, 1989 submittal.

Post Disposal Exposure.. - Intruder Scenario The IMPACTS-BRC model, as:applied to the disposal of the KNPP waste, assumes a; loss of institutional controls 10 years after closure of the site (See Appendix B of the September 12, 1989 submittal). An individual is assumed to reside in a house built on the disposal area. This individual receives a direct exposure (from the uncovered waste), an inhalation exposure (from resuspension), and an ingestion exposure,(from growing 1A .of :his food crops).* For modeling purposes, it is assumed that the,.waste..is mixed at a ratio of 1:13 with other soils during the resident's construction process.

The onsite land application of KNPP waste will be limited by the Agricultural Land Application sludge concentrations even though the less restrictive. Non-Agricultural Land Application~sludge concentrations are applicable since a "dedicated land disposal" site will beused (i.e., no crops will be grown on the disposal site).

Therefore, proVided the KNPP waste does not exceed the Non-Agricultural maximum sludge; concentrations4for heavy metal or: organic chemicals, unlimited application: of waste to the dedicated land disposal site is allowed. However, to be, conservative;, the land application of IKNPP wastes will be limited to 5.metric tons;per hectare per~year.

The intnider6 scenario asevaluated in the. September .12', 1989 submittal conservatively' bounds this exposure pathvay for the on-,site land spreadi~ng.:

E-15 REV. 11 02/22/2007

Document Control Desk October 17, 1991 , Page 11 Post Disposal - Intruder Well The intruder well pathway for onsite land disposal is essentially the same as the

. . . intruder well pathway as evaluated by the IMPACTS-BRC model. It is. conservatively assumed that the well is located at the edge of the disposal site. As modeled, locating the well at the dispos :site edge in "downstream flow" direction maximizes the calculated hypothetical dose. (Additional discussion of this modeling is presented in NUREG/CR-3585, Volume 2).

The potential dose for the intruder well scenario for the land spreading disposal would' be less than 0.001 mrem per year. The modeling as presented in the September 12,:

1989 submittal reasonably bounds any hypothetical well water exposure pathway.

In summary, the. modeling of the exposure scenarios, as presented in the :September 12,1989 submittal, conservatively bounds the hypothetically exposures forthe on-site land spreading. In no.case is ýit likely that any individual, either: oný-site or off-site, will receive a dose in excess of I mrem per year from the disposal of the slightly contaminated materials.

E-16 REV. 11 02/22/2007

.UNITED STATES NUCLEAR REGULATORY COMMISSION -

"WASHINGTON. 0 C. 2OW June 17. 1992 Dockket No, 50-305 Mr. C. A. Schrock Manager- Nuclear Engineering Wisconsin Public Service Corporation P. 0. Box 19002 Green Bay, Wisconsin 54037-9002

SUBJECT:

PROPOSED DISPOSAL OF LOW LEVEL RADIOACTIVE WASTE SLUDGE:ONSITE AT THE KEWAUNEE NUCLEAR POWER PLANT (TAC NO. M75047)

By letters dated September 12, 1989, and October 17, 1991, yOu submitted a request pursuant to 10 CFR 20.302 for the disposal of Waste sludge onsite at the Kewaunee Nuclear Power Plant. We. have completed our review of the request and find your procedures, including documented commitments, to be acceptable,.

This approval is granted provided that -the enclosed safety evaluation is permanently incorporated into your Offsite Dose Calculation Manual (ODEM) as:

an. Appendix, and that future modifications of these lcommitments are reported.

to the NRC.

Issuance of this safety evaluation completes all effort on TAC No. M75047.

Sincerely,:

Allen G. Hansen, Project.Manager Project Directorate: 111-3

'Division of Reactor Projects III/IV/V Office of Nuc~lear. Reactor: Reguation

Enclosure:

As stated cc::w/enclosure:

See next page NRC LEMTER DISTRIBUTION T A HLinsoh (MNG&E) I P Giester,D2 C A Scbromk D2 J D Loock (WPL) M L Marchi KNP C R SteinhardL D2 L.arry Nielsen (ANFC) D L Mas.ik KNp T J Webb KINP I L Belant (NSRAC) R P Pulec D2 (2) S F Wozniak D2

) A Bollom G6 D Ristau D2 QA Vault KNP K1 Evers KNP A J Ruege D2 E-17 REV. 11 02/22/2007

Wisconin Public Strvice.Corporati on K.~n Ke-nauT4p, ic ear

'Nocl a Power oe Plant 1~

David Biaker. Esquire Fulpy And Lardoe'r P..0 Rix 2193 Orka-on. Fialn 12Q82 G& wn snoshFh~map Town of. .anian Kewaunee, wisconsin 54216 Mr. Har6d RekeerCamn Kewaune ThutlBearg hdir Kelaunhe County Cour thous Kewhunee, Wiscons1n QUIP~

Chfroran Public 4rvice Co rpsvin of Wilconsin Hill Frym SnAty Sf~O& RAWid Sho r.W Generdl 014 East. Stato napito jAdi on,.isconsin 5370~2 ucpr~

r.S gui tury rGwnm ISSIon Res id,- 4 ffi ce

U~r Rpote P!, Fo 991 blen Lllyn,:li~nais 601)7 Ai . PoLlr Cullen:

EMUi~r nyineer Wiscr~n. n blcSer~ice Co-ýni'scTný 1;inwiscansi $3707 E3-18 REV. 11 02/22/2007

UJIPTEt0 PTATES

-~ NUCLEAR REGULATORY COMvMISSION INFLATING T00_4SijC IISPL4 OFLW-MEfl R.'DIACTI'V[L..

Q G4S ASN_ ND LE 1ýTtjF CC1P DICKE-i Jp -

In ~Fe~dre1~.W ~ P&Vce'rykC cna-ation (WP~SC requested ypproval Pu~n:'

,pe suano tol 5pytion ?D3AQ of T;Itx 10 of -thy :~dof v d-ryl Re~gulations u1 c~lennto materii nov pre eiou y comidered in the JIM)] Or 1.4 1i spo da-i iharn"17 Additional Jejnne rinal n ironmenta1 Slav onct (PLS) rallted Waerial fromi the liiLrseA from the S 1/4 of Wi-nsonin, yd from Mh

~e 01/4 rd

'siat Meforns 2 thnihm The WPSC NO!u cuolAirs dAetd illoe sc-:ition ij tIhr'icensi- mtrial (ijk e 01nt0mnity Sb ee')asubjec t to twifbrly 20.122 request, based on, r~cloidt aily orhA ro0 11400 di chare -of I c ýd mterl al ,The M~ 000 cubi- fient Df cnmain~ited sludge id jnfil- A the request containk a WIA iainc I Wnid nvenrury of W 17 z.Ci G'C(S fim Un13 an fcoi 4L~16; In itSs subrn tAlj th cEnsheeddrened secific information requested-in accordance wth 0IS 2F..02 ( A), provided a detail Wccipt re ion 'of the hi :is;A~ljaterWi4alibhroughly r~slyied an o vabted thn ifrnmatipn pertinent to thd Iffccts en the 1evfr~inint ~f the rrpmand dikqoal of' ~lcensd materiall Mn cono ito to follow specoifcpwokedu to Wvinim thc.rilk of A&H'iijte U& fewauned, t ie pot -otill exists fr in-plant lrm1oprtion~d proc .ess s.trrams whichi are no normaly-*radioact1/2T to be ome contAminated with very low levels of ~radinactivt later W~s.. Thesomaste str ~Arg~

y ~ re~from the radwilative sirrean!s I or'~ Ic owyr du& aiQi to infrequohnt minoor sv,ýterm aei ntcpto

-14 prai occi rr ice~s the potential existsfor thee sym ms t& bomne sl ightly cionfaminat ci Atu

• KoainVe (he se~uy r yltnN S minoraizi ei rosins, the ektui waitntpre-Ujretreet tjst#ýllludJO's, the make-up wate yse rf-sins, arn-.t ioaq, E-19 REV. 11 02/22/2007

-2 During the ye'arsly test:ig of a batch Of pre-t'reat-onrt sludge, it, was fouhd tlat'appi'oximately 15,000 tubic feet of sludge had b-er, containinated with"

,Cs-137 and'Co-60.

• .3.0 PROPOSED DISPOSAL .METHOD

§PSC.

plans to dispase of thEi 15,000 cubic feet of cohtaminated sludge ansite pursuant to 10 CFU 20.102, The sludge is Cu renrl* contained in an onsife laccon at the KNPP SeL e treatment facility. Tbe dispdsa) of th. sludge wiilt be by land aplcatlon to an area located onsite at KNPP, as shown in iigure 1" hv,:area will b, periodically plowed to a depth of '6 inches.

Tab)le': I lists the pri-ipal nuclides,'identif.ied Iin e sludge. The actility.

i:S b~ssd on me~sureieotS hmde in 19.99,, -edionuclie haThe!.i .* wt~ihi are

.. i.. in

... t .d b y.ea .m. 4.. the staff's D L. 0ý3ý qguidelire r.efTeence 5 whlch .apNT" adlonuci ides ilth ha1l 11 lýes th- 35Al "i

C 1,,7 u~~ ~ ~~.1doIot -Gi A t,ý t

0. 170 A40.. RADIOLOG AL IMPACTS The litteo has, evalujated the foilo,*ing potential e:aoiule paihi.ays to..

ýiember s Of . ,e"genralpublic From thf :adionudcIid&s in thei: s'.udge. (1Y)

.exeernal exposure:cimsed by"'roundshne f~re th-e dispes al ite, (2) internal exposuire from iihalaation, of resuspeoLd  : r dioruui ;and (3j internas exposure frm i"gest'ing ground water. Tha staff nas reviewed the licons Os Ica.lcUatfinal methads and assumptions.and finds La they airea consistent 'Ui.h NRC: R*gul:a'o'y Guide. 1.I09, "Ca.cu1 , tioh of nnualm,D Dos tt :an frn Rou* ie Releases of.Reaftor. Effluents for th* Purpuse: of EýiAuatinqg Comnp iance.:with 1O "CFR Part 50, Appdndix. I," Revision J, Dcotoer 197 sta.Ff ffinds the a:Sse'ssment miethodal 0gY *'ceptbe

[Ta'ble 2 Iitst;s the..doses calculated byt h, eqetrthe x ,aximally

,posed ofmtberfite, p bl"iicý base d n a "totai aIrt' t ivy of" iO .di sd, 2ie of .i

..curreot 1ear a ,el! athe cYulativre impact of Similar s O~alS duint n qSc.eent,* y'ar*". F.bi -h, rope P; ie d pos r.s.

he.:Is eo e rst rpu ly.o

,the 1IRC ".hen a particular di sposal nild cdtd fi1lowin..un,iry n~dition* .'(1)the ainnual o'l mut !b lo tthn . totlactivivty t* of 0 2.

mC.i; (2). t hg'.whal e body dose .to thehphetieal maxi:al I :y exposed ind ivi dual must be less than 0. 1 mrv/ymiy and (3,) ,edispusal J:t -MuSt Le at the Same site a dsc rt id in FIgure L:.

E-20 REV. 11 02/22/2007

.TL.g .,

0x'0 SA l 0O ;d Myi~ua lnd ion Wat TJL 0:0.4.

An shown in Table 2. Lhe dnnu, dow in wputed to bu on the order &.

0.1 mrean r less. Sucha do Q a rmill-fractmn of th EDO! mremrene~ivd anua ly by i-ebersof the 6n raQl p1L .Ftr U sLrces ofriaturm. background r ition.

Tne 9ui deý nes used by the IMW sot*s f poW 1of onsie dts'. O 'I.

Aa roop e~plAn 4 ab. 3, Copy w-i7 th, Jtff's. vanfo o:1 ThW iu eei's proceduwes and commitmens n do N  ! i theK 0 VM mit :are acct-awb provided 0haL.thY ar- Drmarnently ir rorated intot"e KKK-e1~&o .

0Ffit Ar tian Pa-ju 1 CtIO) as an Appen~w a d :-S Future Tocdif'citiq0 AraCrLed to NPR in.accorkd witt thep ippl hDio&4WO hanj Prot cOL.

PAW aor tn. aoe FiANng, the .th 1 Cse prppo I vtff)fnds o

disp!.* P trl.e [W Oval radicctive.waste sludge 6an*.u in .th -. **u ..

Esrivd Yn tf- C lVttir dAtA S&pem .er 12, 198q. tn :L*,ptbl .. The:

YtO of Wi consi hKs also aproved these p o~edu rs,,eee:d 5 E-21 REV. 11 02/22/2007

4-TABLE a 20.302 Guidelhne, for O(site Di~s*sa] Staff's Evilukitr

1. The. radioactive material should 1:. Due tonthe nature of.the be dis'osed of in a mnner that itM. dWspoed matir'al, recycling to the is unlikely that the material would general public is not considered be recycled. likely,

2. Aoses to the otadlbody did any *. Th'is quide ine is addressed in body organ *, X axIwly 61posed TableQ2.

indilvidual (a member of tha yeneral public or a nor occupotionlljK' pxposed ýýorker) from the :Probab]e  :

pathways of exposure to the:disposed miterial..sheuld be lets .that i nreniyeai

3. 8ec U~d th'e mte:rla wi/: ..be

3. DOse. to the totL!boQd, nd a y" body. orgah of an inavefrtent' land-pr d, the tAff corsdr:.the i ntruder from, the proibable pathwayy scana .io o' :a] aoad ress the uf expq iorte oJ!i tio~i tNIan 5 aremi/year 4.. DOW :to the Mtol bory and any yclmingq afterEen..r.

4, *wre to occur rel 1ase *rem* regulat~ory*

body organ df.n in anvidal from' asurned r('cyclinj of thc dispoedd On.r. he dose t. the. maximally material at the tMim Uthedisposa expoed, mrer .of the.mubl is not sAte, s r~eleased fr~om mg~la~ory oxpec ted to *exced 1 .en/yeAr, caontrol from all IikiyV pathways of base oh Oheyexpsure scenrins exposure should be *le.s khanlm 'From consideedin is antAysis.

E-22 REV. 11 02/22/2007

(I) S etter. frqr K. fl. Ev-rs to MIRCDocum2nt C,*ntrol (ksk, Septenmber !]2, i9899 (2) 'Ie o andum from* L. J. Curninghann, DREP, to J. N. Han* , "Request For AdditII na i Informatio.n" Oecember 11, 1989ý (3) NRC letter from M. JM , Davis to K. i.. Evers of WPSC dated february 13, 1990.

(4) WPSC iLttaw from K', Ht. Eve'w to NRc Dscunmat Control DWis, Octob*r 1.

1991.

(5) Letter tf*im L. Sr~idharon' of.the Sat. J Wisconsin DOprtcento..afNattu*a*

eoU~iucs 1 V4 ndepnsb' o.h didý:

dfS

, .Jun .13, 1991, (6) E ..! Fran, gan Jr- ao . F. 3. Cb "Di sposa l

"* nto n . .

Rad WLtSe Waszs frdm Nclie ar rro .!ans, r irý o 1t thh el.t c

D -contninatiionII er:omiss i ni,. Knct.vi: lie TA,. e brTay 6 rCiNF-86D203 )..

Prinoipal ContribUtor: 3, M~nns Date: 3i0ln:eA:',*:'t992:

E-23 REV. 11 02/22/2007

Fn iure -1 Ký-waunee ýiuc-ie--r PQer Plant. Siip- Area-a

'powtg-- kltANT E-24 REV. 11 02/22/2007

UNITED STATES IN NUCLEAR REGULATORY COMMISSION wAsHI*+GTN, v0c. mm?-wXoi Septemb6r 14, 1994 Mr. C. A. Schrock Manager - Nuclear Eng neer:ing Wisconsin Public Service Corporation Post Office Box 19002 Green Bay, WI :54307-9002

SUBJECT:

SAFETY EVALUATION FOR AN"AMENDHEY1T TO AN APPROVED: 10 CFR. 20.302 APPLICATION FOR THE KEWAUNEE NVCLEAR PLANT, (TAC ,X. M89719)

Oe*r Mr. Schrock:..

.By ietter dated June 23 1J994, as supplemented June 29, 1994, you requested approval to use another.onsite area.fo.thejdisposal of contaminated waste sludge in addition to the location approved by the.NRC On: June 17, 1992. The sta-ff has co*pleted its. reviewv of your ,requenst and finýds that youi proposal mets the radiological boundary.condaitins..approved inrvthe'-JOnee.17, 1992.

Safety Evaluation, and is therefore 'acceptabl e. The s taff: also .finds .that your proposal -isin accrdance W~th 10 CFR 202002 .which replaced 20.302 on January 1, 199 4.

This approval Is granted priqyidd that thheenclosed Safety Evaluation -is permanently incorporated into yourOffslte Dose, CalculationManual (ODCM) as an Appendix., and :that future:modifications of: these cmiclinents are. r-eported

• . t.O the NRC.

Sifhcerely, Richard J. Laufer, Acting Project Manager Project Directorate 111-3 Division of Recwto-r iProjects, 1I1/1V Offtce of Nuclear .ReaIctor. Regulation Docket rio. 50-305

Enclosure:

Safety ,Evaluation cc w/enclosure:

TEA [A es RhV. 1 l oNulbalaA LA NSRAC S FwonjaIkl2 P,~Q VuII-I KN M02/22/2007 E-25 REV. 11 02/22/2007

Wisconsin Public Service Corporation Kewaunel Nuclear Power Oant icc:

Foley & Lardner Attention:: Hr. Bradley. 0. Jackson one South Pinckney Str'eet P. Oý 8ox 1497 Madisohn, Wiscons 53701,1497 Chairman Town of Carlton Route. I Kewaunee, Wisconsin .5114216 Mr. airold Reckilbarg. Chairman Kewaunee County Board Kewaunee County Courthouse K"wauneej ýW iscons-in, 5 6, thai rmari Public Service: Coaission"'of Wisconsin Hill Faris, State Office Building Madison, Wisconsrl $3707, Attorney General 114 East, State Capitol Madlson, Wisconsin 5370Z SU

. Nuclear Regullatory-tomnission Resident inspectors Office".

Rou~te 4j, BoX 999 Kewaunee, Wisconsiin 54216.'

Regional Administrator - IRegion III L. .. Nuclear Regulatory Conissi on 801 Warrenville Road Lisle, Illinois" 'O532-453I Mr. Robert-S.S Cullen thiefl Engineer-Wisconsin Public Service Conr issidn:

P. 0.,Box: 7.854 Madidsdon Wisconsin 53701 E-26 REV. 11 02/22/2007

UNITED STATtES NUCLEAR REGULATORY COMMISSION SAFETY EVALUATION BY THE OFFICE OF NUCLEAR-REACTOR REGULATION

.RELATING TO ONS*TE DISPOSAL OF LOW-LEVEL RADIOACTrVELY CONTAMINATED -WASTE SLUDGE AT TIHE KEWAUNEE NUCLEAR EN. KT KISCNSII ý'~JSRVIC

ýCORPQRýATIO WISCONSIN POWER AND LIGHT COMPANY ADISOR .WA AND. ELECTRIr. S, Y DOCKET: NO.

By letter dated June 23, 1994, and as supolemented on June 29, 1994, Wts&nsitn Pubic' Servlce Corporatton (the llcensee)'requested approval to use anothe'r onsite area for the.disposal of contamilnatied waste sl4dge in addition to the location: apprdved by the NRC on June 17, 1.992.

2,0 EVALUATIOM A Safety Evaluation (SE) dated June 17. 1992, approved the lI ensel.'sreqqest, pursUantr to 1,O..CFAR2O.302 for the disposal of 15,000 cubic feet :of cuomn arinated waste' sludge by land application at the Kewaunee Nuclear.Power.

Plant (KNPP) 1tra ,Specific onsite location. The-SE imposed- the fo1llowing b9Undary--conditi ons:

1.. Thle lannu]al disposal Rust be less thanlaltotal activity of O '2 hci..

Z.: Thi he who1e body dse lto the.lhypvtbetlcal maximally exposed Ind iv.Ydual must lbe less than.0.1 m*-rei/year.

1-. the:4lsposal mist-be the same site.

IT he:sizte designated in th6:SE was an u.nused area adjacent to th.e.onsite laý-oon atthe-KPP: sew~a4e ireataent, facility,., .1n 1993, approx-imately '75060 cubIc feet of ,.ithe origina.l 5,000 cubic feet olf .cntfwiated sludge was spread on :that:

olnaitio. hej.cIhnsee has now proposed, to dispose of the rtmaining contarninated sludge. at another, onsite location6 northwest of the plant,.(- Osee6 Attachffent). Thi, ']icerseo liais cintlteithat thes hew ditposal ldcatloti will me t the raIdiol ogical boundary conditions contained in the St for*lhe

-ll 10 CR 20.30Zlapplication approved on June 1?, 1992.l dditionallythe licensc-e has -,statedýthat. thi s addIti onal dispasal site will meet all1 applicable Wisconsin Oepartmnent. of Natural Resources fWONR) application requirements, (Le., sludge application rate and frequency, of spreading rate).

in addition to .WBR_.3Ilandspreading requirements regarding location.dnd perf ormance s.t and~ardsý that were requi red. at, the'ori jinal di sposal ste.

E-27 REV. 11 02/22/2007

3.0 CONCLUSIQN The staff finds the licensee's proposal to dispose of the. low-level radioactive waste sludge in the additional onsite location to be within the radiological boundary conditions approved in the June 17, 1992, SE ,and is therefore acceptable. The staff also findsthat your,:proposal is in

'accordance with 10 CFR 20.2002 which replaced 20.302 on.January 1,. 19g4.

As stated.in the NRC's June 17, 1992, approval of the licensee's 10 CFR 20.302 appl.IcAtion, the licensee is required to percanently incorporate this.

Mowi.cd ation into the Offsite Dose Calculation Manual as ahn Apotpendltx, and that future modificatIn of this commitment be reported to the.iNRC..

PrincipaltContributor: S. Klementowicz Date- September 14, 1994 Attachimnt: KNPP Site Area Map E-28 REV. 11 02/22/2007

- ~e -----------

E-29 REV. 11 02/22/2007

UNITED STATES It~c'.I NUCLEAR REGULATORY COMMISSION WAS"HONTON, DC. 2OW&-

Novembtr 13, 19.95

]r. H. L. Marchl Manager - Nuclear Business Group WisConsin Public Service Corporation Post IOffice Box 19002 Gr@' Bay, WI 54307G9002 SUBJ ECT: ALTERNATE DI SPSAL OF CONTAN IHATED SEWASE TREATMENT. PLANT SLUDGE IN ACCORDAIE WIT14 10 CFR Z{0.2042 (t9C p0. :193844)

Dear Mr. Marchi :

By lette'r dated October 17, 1,995,4as supplemented on Noveber 3, .'1995, you requested approval for.the onsiteýdisposal o f contain-lted sewage' treatment sludge in accordance with 10 CFR ,Z0."*002. This request was similar to- a previous disposal request tat, -s-approve by the - RC on June 1,7, 19921.

The staff has c3mpleted its reviev of your roquest and finds that your proposal meets the radiological bou*dary ccnditi.ns approved 4n the June 17, 1992,, Safety Evaluat10n, and lis therefore'acceptable.

This*approval is granteld provided that the enclosed safety evaluation Is permanently incorporated Into youOffslte'Dose Calculation Manual.A(0).M, as an,

'Appendix, and that future %odifications of. there .o itments.are. reported to the NRC.

Sincerely, 5I Richard J. La r, Project .Manager.

PrejkeVbirectoiateýn 11-'3 Divsioi06 of:tReactor Projects III/;V Office'of NucleiiReact6r keguiation Docket SNo

-MS-305 Enclosure., Safety Evaluation cc: See next page NRC ~, WPSCL~1TE1 D~IR~tfl' ue~

LISir:io (WPL)Mý JK lubn N5LR)(c CA Sm~yKP(~

1)A B~iD~omU S.Y Y(znialý 12-D F Ey "CýASkhrc-xk KN P E-30 REV. 11 02/22/2007

Mr. H. L. MarcM WiscOnsin Public Service Corporatlon Kewaunee Nuclear Power Plant Foley A Lardner.

Attention: Mr. Bradley D. Jackson One 'South, Pl nckney Street P. 0. Box 1497 Hadison, Wisconsin 53701-1497 Chairt.an Town: of Carlton Route I IKewaunee, Wisconsin S41

ýMr.

.Kewa Harold Reckelberg, unee Uounty: Board Chairman Kewaunee County- Courthouse WiPconsin 54216 j.nKewjunee Chair'an Public Service :vi 1ssion of kWisconsin ill Farms State Office.Building

)Idison, Visconsin 537o0 Attorney G.eneral.

11 4 :Ea st, State Capitol Madison,' Wisconsin 53702 U.S. Nuclear Regulatory Comrvatssion

!Resident Inspectors Office, ROute #I, Box 9.9

.K'egatne, Wisconsin. S 4216 RegionaluAd;ifstrator - Regiont In NS uclear Regulatory Coission 8061.Warrenville Road LIlle, Illinois 60532-4531 14r..Robert S. CUllen

,Chief IEngineer 1Wisconsin Public Service. Comtission F.-. 0;. fBox 7854

.kadivson, WIsconsin 553707 E-31 REV. 11 02/22/2007

A, oUNITED STATES NUCLEAR REGULATORY GOMMISSION WASHINGTON, 2,C Q-SAE E.fE¥A1LUAT ION 0 pYJUL0*Y- 1E ILNIJLER ;I REEULAfl0,

~EATN~ OONSITE DISMOAL OE RK-EELIDOATVLUM CONTAM]RnATED SEWAGE TREMEA SLQUGE 81 TJlE ME~UME 3 &NULA MOER PLM4 WISCONSIN PUBLIC SERVICE CORPORAT-IO1 WICNSI!N_ POWEEBAN.OL:I ...1 CO*P*iY_

DOCKET N.5-0 Oy letter dteMADISONe 1 AS AND,4,uplwne C~PHov onCTT 3 9$

Wisconsin Public Service Corpration (the licensee) requ*sted approval folr the onsite disposal of contaminated .sewage sludge similar to a previous disposal request that was approved by the NRC on'Jne;17, 1992.

In a, letter dated September 12;,1989, the licensee ý.requested authorization for the alterinate disposal of ve4ry-lo--level 'radioact}ive-'mAteril.** *In: a Safety Evaluation (SE) dated June.. 17., 1992, the NRC approved Ithe licensee's request pursuant to 10 CFR 20:.302 (new 10, CFR 20.002) for~the:disposal. of15,000 cubic feet of cohtaninated Waste,,sludge by land appl1qation.at the. Ke6aunee Nuclear opower Plant (KPPp) location. The SE i Wose the fllowi.nf.. boundary' conditions:

1. The annual disposal:must, be less than a total activity off .2 Ci.

2. The whole body :dose, to the hypothetical maxdmally exposed individual Must be less th'a'n0. I aremyyear.

31., The di sposali ust be:at the sai site.

The icensee .coaplete d the disposal of the contamiated wastesludge discussed in the SE dated June 17, 1992. The licensee is now requesti'ng athorization t0odispose of additional contaminated waste sludge withi'n.t-he boundary.

condi ti 6ns -of the previously approved disposal.

)i0 EVALUATIONI The licensee; has proposed, to! dispose, of approximately 6000.galions (800 cubic fee16t) of:tseae sludge:-slilar to the 0aterial approved for. disposal in the SE dated June 17, 1992'. The6 principal. rdionuclIdes identifldin thewasto sludge 'and their activity Iasedo" measurements In May 1995are:; Co058, E-32 REV. 11 02/22/2007

- 2 0.0009 nCi; Co-60, 0.0008 mCi; and Cr-S1, 0.0006 m*i. The total combined activity' is 0.0023 m(. This activityis twell below the boundary value of O.2 mCi. Additionally, Cr-51 with itý.short half-life (27.7 day) will have undergone, sgnificant decay froa Its fnitlil value ofO.0006 MiC.

The licensee has comittedthat the hew dfsposal will meet all the radiological boundary conditions, on a cuLulative basis, contained in the SE for the 10 CFR'20.302 appl]:ication:approved on June: 17, 1992. Additionally, the lTicensee has stated rthat all applicable permits. for this disposal have been obta Ined from the Wis cons In Departaent' of Natural Resources.

4.0 UNLUIO The staff finds"the licensee's proposal tod:dispose of:the low-level radioactive waste sludge pursuant to 10,CFR 20.2002, on the licensee's site (see Attachment), is within the radiologt.ical ýboundary conditions approved in the June 17, 1992; SER and'is ther6efore-aceptable.

The licensee i's' required to 'permanently Ihcorporate this: xodification Into the Off*ite Oose ,Calc ul atin Hanual as an'Appeidix, andit0o ensure that future modi ficati o'ns' of these' fotsents , ar eýepcr-ted

, 'tor the NRC.

Principal Contributor; S. Kiementowlcz Date: Nove nb-r 13, 1995

Attachment:

(KNPP Site Area Nap E-33 REV. 11 02/22/2007

NULEAR poWt~ LAT~A 4~

f 1

1:

I, *,

I JLL E-34 REV. 11 02/22/2007

0*

K'Wy6 UNITED STATES NUCLEAR REGULATORY COMMISSION S WASHINGTON, D.C. 2t;6.O1 i;.

ýý*ý* U-*

,pHIi 9, 19, 7 Mr. M:*.L., Marchi tianager - ?uclear, Business Group i scoii n, Public 5cr e-.Corporation Post. Offiml oy 19002 Gree .n Bay. WI 5307-9002' SUBJECTy: ONSITE 1YISPOSAL OF CONTAMINATEDOSLUDC-E PURSUANT TO 10t:CFR.20.2002 (TAC*-NO. rO9741 )

PO , r Mr, ýMarchi:,

Flt* e date*: Oecernber 10,; 4996, you requastqd that the U.S. 'Nuclear, 1t1ter:

Regulatory C (NR.C review.he appl icabil ity of a 10, CFR20.203 (now i;oJirmdsin

.20200?) app iciation approved en J*une 17,"1992, for additional 'disposals of a.

sitmila!:r nature..

,The staff has completed its review of your request and agrees with yqur determination*.that the 10,CFR 20.203 application for onsite di"sposal of:,sludge contaminatedwith liicensed radioactive material, which was 'a.pproved on Jjune 17,.1H92, contains bouinding c6oditions that are applicable for addi~tfonal

.onsite

enclo)sed.disposals

" " o" " a similar nature, A"copy of the Safety Evaluation'is Sincerely, Richard.J. Laufer, Project Manager.

Project Directorate 111-3 Divi'sion of Reactor Projects .III/IV Office of Nuclear .Reactor Regulation DOcket No0.:.501305

Enclosure:

Safety Evaluation.

c-c: Sek next page tn WP~C I PITPU flI~ThIjj~-l~~

T A H~won Njd M"W Saitz (WPL) C S Srra*at KNP' 1i D Cuto ;PQ PýNlwý uýNp )

D A Bollow6 D 1,DILY 1)1.

CA ShrockXNP. DO~IIkRRCb~kKN?

- CrmUS A P.)

E-35 REV. 11 02/22/2007

Mr, M. L. Marchi Wisconsin Public Service Corporation Kewaunee ffuclear Power Plant cc:

Foley & Lardner Attention: Mr, Bradley D. Jackson One Sootth Pincdney Street P. 0. Box 1497 Madison, Wisconsin

• Chairm~n .

Town of Carl ton Route I K.ewaunee, Wisconsin 54216 Mr. Harold Reckelberg, Chairman Kewaunee County Board Kewaunee County:Courthouse Kewaonee, Wisconsin 54216 Chairman" Wisconsin Public :Service Commission 610 N. Whitney Way Madison, Wisconsin 53705-2729 Attorney Genera 114 East, State Capitol Madison, Wisconsin 537.02 UI. S. Nuclear Regulatory. Commission Resident Inspectors Office Route.1, Box 99-Kewýine, Wisconsin 54216 Regional Administrator - Region III U. S. Nuclear Regulatory Commission 801 Warrenville Road Lisle, Illinois 60532-4531 Mr. Robert S.o Cullen Chief ,Engineer.

Wisconsin Public Service Commission

• 10 N, Whitney Way ....... . . ..

Madison, Wisconsin 53705-2829 E-36 REV. 11 02/22/2007

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, DC, iAET VALUATION BY THE OFFIE.. F NUCL.EAR REACTOR REGULAT IONi RELATING TO ONSITE TDISEAL OF CONTAMINATED RIflQ

.AT THE K~EWAUNEE NUC LEAR PýOWE-R PLANTý WISCONSIN.PUBLIC SERVICE CORPOATION WISCONSIN .POWER AND LIGHT COMPANY MADISON GAS ANOW. ,.1CTRIC COMPANY 1.0 [ITRODUCTION By letter dated 13iecember 10,. 1996, .Wisconsin Public Se.rVice Corporation (the licensee) requested: that the U.+.S Noclea:r Reqiflatory Codssion (NRC) review its determination that NRC approiv al, puruat to 10 CFR 20*2002, for the onsite disposal of contaminated sudge:at the Kowaunce Nuchnar Power Piant (KNPP) is not required, providd. such disposals are conductWed within the limits and bounding conditions a1pproved by, the NRC. in its' June 17, 1992, Safety Evaluation (SE).

2.0 BACKGROUND

In a letter dated September 12, 1989, the lic'en'see reque-sted authorization for the alternate disposal of sludge contaminated:3with licensed radioactive" material. In an SE: dated June. 17, 1'9920, the NIC approiv'ed the li ceisese's request .pursuant to II0 rCFR 20.302 (ne~w 10 CFR' 70200.2) fOr the disposal of,

15,000 cubic feet of contaminated waste sslud9e by land aPplicarati:,n at the' KNPP location. The SE imposed bouridiry canditions as followiis-

1. Threannual di:sposal inust bo less han ia totl Actvity of, 0.2* mti:

2. The whole-body dose to.the,hypothet:ical maxi'mally exposed indi~vidual must :be les's than 0.1 mgem/year; and

3. The disposal must be at theesame. site.

The. SE also stated NIRC that any repetitive disposalsthe icensee must re.apply to the when for a par,tic¢ular cisposal idol exc'ee the bounda ry conditions,.

3.0 U:ALUA ION:

The licensýee has determined that..NRC approval for future onsite disposals of sludge contaaminatedwith .licensed Iradioactive materiial is not required provided t1fhe disd'Psal:s"comply "with'the limits and 'coeditions 'of.the SE Aissued on June. 7.,. 199Z., The licen'see has' 'alsodevelope i a.sluidgj'ge .samplinig. a and analysis 'procedure that implemneh t. the-gidaicec ontaned iA NRC Information E-37 REV. 11 02/22/2007

Notice 88-2M Specifically, the licensee's procedure will require the analysis of sludge san:plesUnf9a edte*tion system .design and operating characteristics that yield- a, loder limi-.of detection for Co-58. Con-,

Cs-134 and Css 137 consiste.t Wih measurements, of 'environmontal Sa les. The licefisee has provi*ded a site-map (attached) that specifies the acceptable onsite disposal ,areas For týhe coatirated s ludge.

4.o0 INCr I. ON" The Staff ýaqteesz.:with the Iicernsee' s determination -that additional onsite disposals of-contaminated sludge,. ',hich are conducted withi n th e bounding 1jtannd coindi.tions cdont.ined 'inthe June6 17, 1992, SE and within the ar~eas spec1tfdin the attached ýsite Imap, do-noI require speci f ic NRC approval.

The licensee .shoulwd pernaiiently incorp6rate this Safety ,Evaluation into the Offsite DoeCailation Malnual as an Aopendlx.

Pr incipal Codtributor- S-iJrementowjcz Date: ,Ipri:. 9, 1.997ý Att ach inent .- KNP'P Site Map" E-38 REV. 11 02/22/2007

4, KEWAUI1 EE COUNTY Im

~aj LACE ~aGAi4 On . w41C~kN

-v -~----~

E-39 REV. 11 02/22/2007